Publications

Nordén ES, Bendiksen BA, Bergo KK, Espe EKS, McGinley G, Hasic A, Hauge-Iversen IM, Ugland HK, Shen X, Frisk M, Mabotuwana NS, Louch WE, Hussain RI, Zhang L, Sjaastad I, Cataliotti A, Christensen G (2024)
Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats
ESC Heart Fail (in press)
DOI 10.1002/ehf2.15145, PubMed 39696842

Olsen E, Jamerson K, Schmieder RE, Søraas CL, Mariampillai JE, Mancia G, Kjeldsen SE, Heimark S, Mehlum MH, Liestøl K, Larstorp ACK, Halvorsen LV, Høieggen A, Burnier M, Rostrup M, Julius S, Weber MA (2024)
Effects of valsartan vs amlodipine and achieved lower blood pressure on the incidence of end-stage kidney disease: The VALUE Trial
Eur J Intern Med (in press)
DOI 10.1016/j.ejim.2024.12.021, PubMed 39694747

Kjeldsen SE, Elmula FEMF, Fossum E, Høieggen A (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (15)
DOI 10.4045/tidsskr.24.0584, PubMed 39692655

Gurholt TP, Elvsåshagen T, Bahrami S, Rahman Z, Shadrin A, Askeland-Gjerde DE, van der Meer D, Frei O, Kaufmann T, Sønderby IE, Halvorsen S, Westlye LT, Andreassen OA (2024)
Large-scale brainstem neuroimaging and genetic analyses provide new insights into the neuronal mechanisms of hypertension
HGG Adv, 100392 (in press)
DOI 10.1016/j.xhgg.2024.100392, PubMed 39663699

Palatini P, Kjeldsen SE, Burnier M (2024)
Orthostatic hypertension: the forgotten phenotype
Blood Press, 33 (1), 2431565
DOI 10.1080/08037051.2024.2431565, PubMed 39584479

Kjeldsen SE, Brunström M, Burnier M, Egan B, Narkiewicz K, Kreutz R, Mancia G (2024)
Should treatment of 'elevated' blood pressure, especially in older people, be based on global risk estimation?
Blood Press, 33 (1), 2430228
DOI 10.1080/08037051.2024.2430228, PubMed 39564976

Narum M, Seljeflot I, Bratseth V, Berg TJ, Sveen KA (2024)
Intestinal fatty acid binding protein is associated with coronary artery disease in long-term type 1 diabetes-the Dialong study
Cardiovasc Diabetol, 23 (1), 419
DOI 10.1186/s12933-024-02509-3, PubMed 39563343

Engebretsen I, Malene Ødegaard K, Halvorsen S, Bugge C, Kristiansen IS, Støvring H, Munkhaugen J (2024)
Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy
Eur Heart J Qual Care Clin Outcomes (in press)
DOI 10.1093/ehjqcco/qcae099, PubMed 39562279

Sternberg Z, Podolsky R, Yu J, Hua S, Halvorsen S, Hojnacki D, Schaller BJ (2024)
Anti-Hypertensives Reduce the Rate of Alzheimer's Disease Progression: A Cohort Study Linked with Genetic and Neuropathological Analyses
J Prev Alzheimers Dis, 11 (6), 1634-1646
DOI 10.14283/jpad.2024.156, PubMed 39559876

Bonnevie-Svendsen M, Nyborg C, Bratseth V, Melau J, Hisdal J (2024)
Transient changes in L-arginine, asymmetric and symmetric dimethyl arginine in triathletes following Norseman Xtreme Triathlon
Front Physiol, 15, 1451038
DOI 10.3389/fphys.2024.1451038, PubMed 39493861

Bratseth V, Nendl A, Raju SC, Holm K, Broch K, Hov JR, Seljeflot I, Trøseid M, Awoyemi A (2024)
Gut dysbiosis and neutrophil extracellular traps in chronic heart failure
Int J Cardiol, 419, 132689
DOI 10.1016/j.ijcard.2024.132689, PubMed 39489348

Bahlmann E, Gerdts E, Einarsen E, Midtbø H, Pedersen ER, Rossebø A, Willems S, Cramariuc D (2024)
Impact of sex-specific thresholds for low flow in assessment of prognosis in concordantly and discordantly graded aortic valve stenosis
Eur Heart J Cardiovasc Imaging (in press)
DOI 10.1093/ehjci/jeae272, PubMed 39467305

Jortveit J, Andersen GØ, Halvorsen S (2024)
Short- and long-term outcomes of patients with acute myocardial infarction complicated by cardiac arrest: A nationwide cohort study 2013-2022
Eur Heart J Acute Cardiovasc Care (in press)
DOI 10.1093/ehjacc/zuae121, PubMed 39441985

Langslet G, Nyström T, Vistisen D, Carstensen B, Grip ET, Casajust P, Tskhvarashvili G, Hoti F, Klement R, Karlsdotter K, Tuovinen M, Ofstad AP, Lajer M, Shay C, Koeneman L, Farsani SF, Niskanen L, Halvorsen S (2024)
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study
J Diabetes Res, 2024, 6142211
DOI 10.1155/2024/6142211, PubMed 39430801

Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Damås JK, Kleveland O (2024)
Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI
Int J Cardiol, 418, 132613
DOI 10.1016/j.ijcard.2024.132613, PubMed 39374793

Bondjers K, Glad AK, Wøien H, Wentzel-Larsen T, Atar D, Reitan SK, Rosseland LA, Zwart JA, Dyb G, Stensland SØ (2024)
Moral distress and protective work environment for healthcare workers during public health emergencies
BMC Med Ethics, 25 (1), 103
DOI 10.1186/s12910-024-01098-w, PubMed 39354454

Egan BM, Rich MW, Sutherland SE, Wright JT, Kjeldsen SE (2024)
General Principles, Etiologies, Evaluation, and Management in Older Adults
Clin Geriatr Med, 40 (4), 551-571
DOI 10.1016/j.cger.2024.04.008, PubMed 39349031

Jensenius M, Mørch K, Yaqub S, Halvorsen DS, Reims HM, Björk IG, Røsok BI, Oltmanns G, Helbak K, Øines Ø, Lier T (2024)
Correction: Alveolar echinococcosis
Tidsskr Nor Laegeforen, 144
DOI 10.4045/tidsskr.24.0494, PubMed 39319794

Olsen MB, Louwe MC, Yang K, Øgaard J, Dahl TB, Gregersen I, Alfsnes K, Lauritzen KH, Murphy SL, Ahmed MS, Aukrust P, Vinge LE, Yndestad A, Holven KB, Halvorsen B, Fosshaug LE (2024)
Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling
Biochem Biophys Res Commun, 733, 150706
DOI 10.1016/j.bbrc.2024.150706, PubMed 39305571

Nendl A, Andersen GØ, Seljeflot I, Trøseid M, Awoyemi A (2024)
Intestinal fatty acid binding protein is associated with infarct size and cardiac function in acute heart failure following myocardial infarction
Open Heart, 11 (2)
DOI 10.1136/openhrt-2024-002868, PubMed 39277188

Tsaban G, Perez RV, Krychtiuk KA, Ahrens I, Halvorsen S, Hassager C, Huber K, Schiele F, Sionis A, Claeys MJ (2024)
Lipid-lowering therapy after acute coronary syndromes: a multinational European survey
Coron Artery Dis, 36 (1), 51-58
DOI 10.1097/MCA.0000000000001420, PubMed 39263716

Halvorsen S, Vranckx P, van Diepen S (2024)
Should renin-angiotensin system inhibitors be stopped or not before non-cardiac surgery?
Eur Heart J Acute Cardiovasc Care, 13 (9), 670-671
DOI 10.1093/ehjacc/zuae101, PubMed 39257308

Jensenius M, Mørch K, Yaqub S, Halvorsen DS, Reims HM, Björk IG, Røsok BI, Oltmanns G, Helbak K, Øines Ø, Lier T (2024)
Alveolar echinococcosis
Tidsskr Nor Laegeforen, 144 (10)
DOI 10.4045/tidsskr.24.0121, PubMed 39254012

Boskovic M, Jortveit J, Haraldsen MB, Berge T, Engdahl J, Løchen ML, Schuster P, Sandberg EL, Grimsmo J, Atar D, Anfinsen OG, Pripp AH, Grenne BL, Halvorsen S (2024)
The NORwegian atrial fibrillation self-SCREENing (NORSCREEN) trial: rationale and design of a randomized controlled trial
Europace, 26 (10)
DOI 10.1093/europace/euae228, PubMed 39248170

Kindberg KM, Broch K, Andersen GØ, Anstensrud AK, Åkra S, Woxholt S, Tøllefsen IM, Ueland T, Amundsen BH, Kløw NE, Halvorsen B, Dahl TB, Huse C, Murphy SL, Damås JK, Opdahl A, Wiseth R, Gullestad L, Aukrust P, Santos-Gallego C, Seljeflot I, Stokke MK, Helseth R (2024)
Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size
JACC Adv, 3 (9), 101193
DOI 10.1016/j.jacadv.2024.101193, PubMed 39247678

Kreutz R, Brunström M, Kjeldsen SE, Narkiewicz K, Egan B, Burnier M (2024)
Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study
Blood Press, 33 (1), 2394448
DOI 10.1080/08037051.2024.2394448, PubMed 39241222

Atar D, Munkhaugen J, Sverre E (2024)
Statin discontinuation: How can we improve on the multiple pathways that contribute to suboptimal statin adherence?
Kardiol Pol (in press)
DOI 10.33963/v.phj.102335, PubMed 39240921

Mecinaj A, Gulati G, Omland T, Heck SL (2024)
Reply: Probing the Anthracycline-Induced Myocardial Injury: A Glimpse Through the Lens of the PRADA Trial
JACC CardioOncol, 6 (4), 630
DOI 10.1016/j.jaccao.2024.05.010, PubMed 39239351

Gigante B, Tamargo J, Agewall S, Atar D, Ten Berg J, Campo G, Cerbai E, Christersson C, Dobrev D, Ferdinandy P, Geisler T, Gorog DA, Grove EL, Kaski JC, Rubboli A, Wassmann S, Wallen H, Rocca B (2024)
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
Eur Heart J Cardiovasc Pharmacother, 10 (7), 614-645
DOI 10.1093/ehjcvp/pvae064, PubMed 39237457

Ni W, Stafoggia M, Zhang S, Ljungman P, Breitner S, Bont J, Jernberg T, Atar D, Agewall S, Schneider A (2024)
Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden
J Am Coll Cardiol, 84 (13), 1149-1159
DOI 10.1016/j.jacc.2024.07.006, PubMed 39230547

Schnabel RB, Benezet-Mazuecos J, Becher N, McIntyre WF, Fierenz A, Lee SF, Goette A, Atar D, Bertaglia E, Benz AP, Chlouverakis G, Birnie DH, Dichtl W, Blomstrom-Lundqvist C, Camm AJ, Erath JW, Simantirakis E, Kutyifa V, Lip GYH, Mabo P, Marijon E, Rivard L, Schotten U, Alings M, Sehner S et al. (2024)
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials
Eur Heart J, 45 (46), 4902-4916
DOI 10.1093/eurheartj/ehae596, PubMed 39222018

Lunde IG, Rypdal KB, Van Linthout S, Diez J, González A (2024)
Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact
Matrix Biol, 134, 1-22
DOI 10.1016/j.matbio.2024.08.008, PubMed 39214156

Holme FA, Huse C, Kong XY, Broch K, Gullestad L, Anstensrud AK, Andersen GØ, Amundsen BH, Kleveland O, Quiles-Jimenez A, Holm S, Aukrust P, Alseth I, Halvorsen B, Dahl TB (2024)
Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction
Int J Mol Sci, 25 (16)
DOI 10.3390/ijms25169014, PubMed 39201700

Opdal MS, Rognstad S, Edvardsen F, Halvorsen LV, Mo R, Gustavsen I, Larstorp ACK, Søraas CL, Helland A (2024)
Usefulness of measuring the serum concentration of antihypertensive drugs in uncontrolled hypertension
Tidsskr Nor Laegeforen, 144 (9)
DOI 10.4045/tidsskr.24.0167, PubMed 39167005

Opdal MS, Rognstad S, Edvardsen F, Halvorsen LV, Mo R, Gustavsen I, Larstorp ACK, Søraas CL, Helland A (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144
DOI 10.4045/tidsskr.24.0407, PubMed 39149754

Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K, de Boer RA, Maack C, Lutgens E, Rassaf T, Fradley MG et al. (2024)
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
Eur J Heart Fail, 26 (10), 2055-2076
DOI 10.1002/ejhf.3340, PubMed 39087551

Andel PM, Aamodt AH, Gleditsch J, Melin E, Rootwelt-Revheim ME, Steine K, Atar D (2024)
Elective Direct Current Cardioversion of Atrial Fibrillation: Silent Brain Infarction and Health-Related Quality of Life
Cardiology, 149 (6), 571-579
DOI 10.1159/000540007, PubMed 39025051

Havnes IA, Henriksen HCB, Johansen PW, Bjørnebekk A, Neupane SP, Hisdal J, Seljeflot I, Wisløff C, Jørstad ML, McVeigh J, Jørgensen AP (2024)
Off-label use of clomiphene citrate to treat anabolic androgenic steroid induced hypogonadism upon cessation among men (CloTASH) - A pilot study protocol
MethodsX, 13, 102810
DOI 10.1016/j.mex.2024.102810, PubMed 39022178

Lopes RD, Granger CB, Wojdyla DM, McIntyre WF, Alings M, Mani T, Ramasundarahettige C, Rivard L, Atar D, Birnie DH, Boriani G, Amit G, Leong-Sit P, Rinne C, Duray GZ, Gold MR, Hohnloser SH, Kutyifa V, Benezet-Mazuecos J, Cosedis Nielsen J, Sticherling C, Benz AP, Linde C, Kautzner J, Mabo P et al. (2024)
Apixaban vs Aspirin According to CHA₂DS₂-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA
J Am Coll Cardiol, 84 (4), 354-364
DOI 10.1016/j.jacc.2024.05.002, PubMed 39019530

Alrahimi J, Ahmed FA, Atar D (2024)
The Interplay of Atherothrombotic Factors and the Evolving Landscape of Atherosclerotic Cardiovascular Disease: Comprehensive Insights from Recent Studies
Anatol J Cardiol, 28 (8), 375-80 (in press)
DOI 10.14744/AnatolJCardiol.2024.4632, PubMed 39011832

Alehagen U, Aaseth J, Schomburg L, Larsson A, Opstad T, Alexander J (2024)
Selenoprotein P increases upon selenium and coenzyme Q₁₀ supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality
Free Radic Biol Med, 222, 403-413
DOI 10.1016/j.freeradbiomed.2024.06.027, PubMed 38960007

Melberg MB, Flaa A, Andersen GØ, Sunde K, Bellomo R, Eastwood G, Olasveengen TM, Qvigstad E (2024)
Effects of mild hypercapnia on myocardial injury after out-of-hospital cardiac arrest. A sub-study of the TAME trial
Resuscitation, 201, 110295
DOI 10.1016/j.resuscitation.2024.110295, PubMed 38936652

Ihle-Hansen H, Ihle-Hansen H, Steen T, Hagberg G (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (8)
DOI 10.4045/tidsskr.24.0227, PubMed 38934310

Lambert AT, Sætre DO, Ratajczak-Tretel B, Gleditsch J, Høie G, Al-Ani R, Pesonen M, Atar D, Aamodt AH (2024)
Imaging features for the identification of atrial fibrillation in cryptogenic stroke patients
J Neurol, 271 (8), 5343-5356
DOI 10.1007/s00415-024-12397-y, PubMed 38904781

Schlotter F, Huber K, Hassager C, Halvorsen S, Vranckx P, Pöss J, Krychtiuk K, Lorusso R, Bonaros N, Calvert PA, Montorfano M, Thiele H (2024)
Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the ESC Working Group on Cardiovascular Surgery
Eur Heart J, 45 (28), 2478-2492
DOI 10.1093/eurheartj/ehae363, PubMed 38888906

Falcão-Pires I, Ferreira AF, Trindade F, Bertrand L, Ciccarelli M, Visco V, Dawson D, Hamdani N, Van Laake LW, Lezoualc'h F, Linke WA, Lunde IG, Rainer PP, Abdellatif M, Van der Velden J, Cosentino N, Paldino A, Pompilio G, Zacchigna S, Heymans S, Thum T, Tocchetti CG (2024)
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
Eur J Heart Fail, 26 (7), 1454-1479
DOI 10.1002/ejhf.3264, PubMed 38837573

Aune SK, Helseth R, Kalstad AA, Laake K, Åkra S, Arnesen H, Solheim S, Seljeflot I (2024)
Links Between Adipose Tissue Gene Expression of Gut Leakage Markers, Circulating Levels, Anthropometrics, and Diet in Patients with Coronary Artery Disease
Diabetes Metab Syndr Obes, 17, 2177-2190
DOI 10.2147/DMSO.S438818, PubMed 38827167

Sandberg EL, Halvorsen S, Berge T, Grimsmo J, Atar D, Leangen Grenne B, Jortveit J (2024)
Digital recruitment and compliance to treatment recommendations in the Norwegian Atrial Fibrillation self-screening pilot study
Eur Heart J Digit Health, 5 (3), 371-378
DOI 10.1093/ehjdh/ztae026, PubMed 38774377

Andrup S, Andersen GØ, Hoffmann P, Eritsland J, Seljeflot I, Halvorsen S, Vistnes M (2024)
Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality
PLoS One, 19 (5), e0302732
DOI 10.1371/journal.pone.0302732, PubMed 38739599

Vrsalovic M, Heimark S, Søraas CL, Mehlum MH, Kjeldsen SE, Mancia G, Julius S, Weber MA (2024)
Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial
Hypertension, 81 (7), 1628-1636
DOI 10.1161/HYPERTENSIONAHA.124.22832, PubMed 38716657

Alehagen U, Alexander J, Aaseth JO, Larsson A, Opstad TB (2024)
Supplementation with selenium and coenzyme Q₁₀ in an elderly Swedish population low in selenium - positive effects on thyroid hormones, cardiovascular mortality, and quality of life
BMC Med, 22 (1), 191
DOI 10.1186/s12916-024-03411-1, PubMed 38714999

Halvorsen LV, Søraas CL, Larstorp ACK, Hjørnholm U, Kjær VN, Liestøl K, Aune A, Olsen E, Brobak KM, Bergland OU, Rognstad S, Aarskog NR, Heimark S, Fadl Elmula FEM, Gerdts E, Mo R, Solbu MD, Opdal MS, Kjeldsen SE, Rostrup M, Høieggen A (2024)
Effect of Therapeutic Drug Monitoring on Adherence and Blood Pressure: A Multicenter Randomized Clinical Trial
Am J Hypertens, 37 (10), 826-836
DOI 10.1093/ajh/hpae059, PubMed 38713475

Enge K, Tveit A, Enger S, Onarheim S, Pripp AH, Rønningen PS, Solberg MG, Byrkjeland R, Andresen K, Halsen A, Aulie HA, Steinsvik T, Hall C, Ulimoen SR (2024)
Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 10 (6), 515-525
DOI 10.1093/ehjcvp/pvae032, PubMed 38702844

Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, Kjeldsen SE, Muiesan ML, Thomopoulos C, Tsioufis K, Mancia G (2024)
Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern
J Hypertens, 42 (6), 966-967
DOI 10.1097/HJH.0000000000003735, PubMed 38690902

Fyksen TS, Seljeflot I, Vanberg P, Atar D, Halvorsen S (2024)
Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes
Thromb Res, 238, 60-66
DOI 10.1016/j.thromres.2024.04.027, PubMed 38676967

Bergum H, Grimsmo J, Anderssen SA, Klemsdal TO (2024)
Effects on physical activity, physical fitness and well-being in a 36-months randomized controlled study, comparing a multimodal hospital-based intervention programme for primary cardiovascular prevention with usual care
BMC Cardiovasc Disord, 24 (1), 225
DOI 10.1186/s12872-024-03892-1, PubMed 38664620

Engebretsen I, Bugge C, Støvring H, Husebye E, Sverre E, Dammen T, Halvorsen S, Munkhaugen J (2024)
Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event
Atherosclerosis, 393, 117550
DOI 10.1016/j.atherosclerosis.2024.117550, PubMed 38657552

Sambola A, Halvorsen S, Adlam D, Hassager C, Price S, Rosano G, Schiele F, Holmvang L, de Riva M, Rakisheva A, Sulzgruber P, Swahn E (2024)
Management of cardiac emergencies in women: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the Heart Failure Association (HFA), and the European Heart Rhythm Association (EHRA) of the ESC, and the ESC Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Open, 4 (2), oeae011
DOI 10.1093/ehjopen/oeae011, PubMed 38628674

van Diepen S, Halvorsen S, Menon V (2024)
The REDUCE-AMI trial: an important step in cardiovascular drug de-prescription
Eur Heart J Acute Cardiovasc Care, 13 (4), 370-372
DOI 10.1093/ehjacc/zuae049, PubMed 38608152

Gulati G, Broberg AM, Offersen BV (2024)
The Nordic Cardio-Oncology Society: mission and future goals
Eur Heart J, 45 (21), 1869-1871
DOI 10.1093/eurheartj/ehae014, PubMed 38607440

Kjeldsen SE, Grassi G (2024)
The role of β-blockers in medical treatment
Curr Med Res Opin, 40 (sup1), 1-2
DOI 10.1080/03007995.2024.2324138, PubMed 38597062

Rubboli A, Atar D, Sibbing D (2024)
De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigm
Intern Emerg Med, 19 (6), 1537-1548
DOI 10.1007/s11739-024-03590-y, PubMed 38594458

Sandberg EL, Halvorsen S, Berge T, Grimsmo J, Atar D, Grenne BL, Jortveit J (2024)
Screening for Atrial Fibrillation by Digital Health Technology in Older People in Homecare Settings: A Feasibility Trial
Int J Telemed Appl, 2024, 4080415
DOI 10.1155/2024/4080415, PubMed 38567031

Kluge KE, Langseth MS, Andersen GØ, Halvorsen S, Opstad TB, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2022)
Complement activation in association with clinical outcomes in ST-elevation myocardial infarction
Am Heart J Plus, 24, 100228
DOI 10.1016/j.ahjo.2022.100228, PubMed 38560636

Kjeldsen SE, Egan BM, Burnier M, Narkiewicz K, Kreutz R, Mancia G (2024)
Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?
Blood Press, 33 (1), 2329571
DOI 10.1080/08037051.2024.2329571, PubMed 38555859

Vistnes M (2024)
Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis
Pharmaceuticals (Basel), 17 (3)
DOI 10.3390/ph17030267, PubMed 38543053

Aune A, Ohldieck A, Halvorsen LV, Brobak KM, Olsen E, Rognstad S, Larstorp ACK, Søraas CL, Rossebø AB, Rösner A, Grytaas MA, Gerdts E (2024)
Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence
High Blood Press Cardiovasc Prev, 31 (2), 157-166
DOI 10.1007/s40292-024-00632-6, PubMed 38530572

Mecinaj A, Gulati G, Ree AH, Gravdehaug B, Røsjø H, Steine K, Wisløff T, Geisler J, Omland T, Heck SL (2024)
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac Dysfunction
JACC CardioOncol, 6 (1), 83-95
DOI 10.1016/j.jaccao.2023.10.008, PubMed 38510299

Mancia G, Brunström M, Burnier M, Grassi G, Januszewicz A, Kjeldsen SE, Muiesan ML, Thomopoulos C, Tsioufis K, Kreutz R (2024)
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines
Hypertension, 81 (5), 1021-1030
DOI 10.1161/HYPERTENSIONAHA.124.22821, PubMed 38477109

Jortveit J, Boskovic M, Sandberg EL, Vegsundvåg J, Halvorsen S (2024)
High Diagnostic Accuracy of Long-Term Electrocardiogram Interpretation by General Practitioners
Int J Telemed Appl, 2024, 6624344
DOI 10.1155/2024/6624344, PubMed 38425473

Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Nienaber CA, Ray SG, Rossebø AB, Wachtell K, Dominguez H, Valeur N, Carstensen HG, Nielsen OW (2024)
Development and validation of the ASGARD risk score for safe monitoring in asymptomatic nonsevere aortic stenosis
Eur J Prev Cardiol (in press)
DOI 10.1093/eurjpc/zwae086, PubMed 38416125

Skjøth F, Larsen TB, Dun AR, Lilja M, Rahman I, Abdelgawwad K, Halvorsen S, Coleman C, Rivera M (2024)
Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
Am J Med, 137 (6), 520-528.e13
DOI 10.1016/j.amjmed.2024.02.005, PubMed 38387539

Vistnes M (2024)
Survival of the strongest: can muscular strength measurements be used in prevention of heart failure in patients with acute coronary syndromes?
Eur J Prev Cardiol, 31 (7), 832-833
DOI 10.1093/eurjpc/zwae047, PubMed 38381591

Ariansen I, Larsen IK (2024)
[Premature mortality from noncommunicable diseases]
Tidsskr Nor Laegeforen, 144 (2)
DOI 10.4045/tidsskr.23.0849, PubMed 38349090

Raju SC, Molinaro A, Awoyemi A, Jørgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegård KT, Halvorsen B, Kristiansen K, Hov JR, Trøseid M (2024)
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
Genome Med, 16 (1), 27
DOI 10.1186/s13073-024-01296-6, PubMed 38331891

McClintick DJ, O'Donoghue ML, De Ferrari GM, Ferreira J, Ran X, Im K, López JAG, Elliott-Davey M, Wang B, Monsalvo ML, Atar D, Keech A, Giugliano RP, Sabatine MS (2024)
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
J Am Coll Cardiol, 83 (6), 652-664
DOI 10.1016/j.jacc.2023.11.029, PubMed 38325990

Rypdal KB, Apte SS, Lunde IG (2024)
Emerging roles for the ADAMTS-like family of matricellular proteins in cardiovascular disease through regulation of the extracellular microenvironment
Mol Biol Rep, 51 (1), 280
DOI 10.1007/s11033-024-09255-5, PubMed 38324186

De Bortoli A, Nordøy I, Connelly JP, Viermyr HK, Bjerkreim RH, Broch K, Olsen PAS, Gude E, Fevang B, Jørgensen SF, Trøseid M, Steen T, Aukrust P, Andreassen AK, Skarpengland T (2024)
Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohort
Int J Cardiol, 400, 131809
DOI 10.1016/j.ijcard.2024.131809, PubMed 38272129

Nordlund D, Lav T, Jablonowski R, Khoshnood A, Ekelund U, Atar D, Erlinge D, Engblom H, Arheden H (2024)
Contractility, ventriculoarterial coupling, and stroke work after acute myocardial infarction using CMR-derived pressure-volume loop data
Clin Cardiol, 47 (1), e24216
DOI 10.1002/clc.24216, PubMed 38269628

Mancia G, Brunström M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, Tsioufis K, Kjeldsen SE, Kreutz R (2024)
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines
Eur J Intern Med, 121, 4-8
DOI 10.1016/j.ejim.2023.12.015, PubMed 38216445

Aaseth E, Christiansen JR (2024)
Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients
ESC Heart Fail, 11 (2), 871-876
DOI 10.1002/ehf2.14645, PubMed 38204282

Landi A, Aboyans V, Angiolillo DJ, Atar D, Capodanno D, Fox KAA, Halvorsen S, James S, Jüni P, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Valgimigli M (2024)
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines
Eur Heart J Acute Cardiovasc Care, 13 (1), 173-180
DOI 10.1093/ehjacc/zuad158, PubMed 38170562

Aaseth JO, Alehagen U, Opstad TB, Alexander J (2023)
Vitamin K and Calcium Chelation in Vascular Health
Biomedicines, 11 (12)
DOI 10.3390/biomedicines11123154, PubMed 38137375

Lundin M, Heiberg E, Nordlund D, Gyllenhammar T, Steding-Ehrenborg K, Engblom H, Carlsson M, Atar D, van der Pals J, Erlinge D, Borgquist R, Khoshnood A, Ekelund U, Nickander J, Themudo R, Nordin S, Kozor R, Bhuva AN, Moon JC, Maret E, Caidahl K, Sigfridsson A, Sörensson P, Schelbert EB, Arheden H et al. (2023)
Prognostic utility and characterization of left ventricular hypertrophy using global thickness
Sci Rep, 13 (1), 22806
DOI 10.1038/s41598-023-48173-7, PubMed 38129418

Fadl Elmula FEM, Mariampillai JE, Heimark S, Kjeldsen SE, Burnier M (2024)
Medical Measures in Hypertensives Considered Resistant
Am J Hypertens, 37 (5), 307-317
DOI 10.1093/ajh/hpad118, PubMed 38124494

Sasi A, Romaine A, Erusappan PM, Melleby AO, Hasic A, Dahl CP, Broch K, Almaas VM, Puertas RD, Roderick HL, Lunde IG, Sjaastad I, Vistnes M, Christensen G (2023)
Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development
Matrix Biol Plus, 19-20, 100135
DOI 10.1016/j.mbplus.2023.100135, PubMed 38076279

Halvorsen S, Mehilli J, Choorapoikayil S, Zacharowski K (2023)
Extract from the 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery - Patient Blood Management
Blood Transfus, 22 (2), 122-129
DOI 10.2450/BloodTransfus.708, PubMed 38063786

López-Fernández T, Farmakis D, Ameri P, Asteggiano R, de Azambuja E, Aznar M, Barac A, Bayes-Genis A, Bax JJ, Bergler-Klein J, Boriani G, Celutkiene J, Coats A, Cohen-Solal A, Córdoba R, Cosyns B, Filippatos G, Fox K, Gulati G, Inciardi RM, Lee G, Mamas MA, Novo G, Plummer C, Psyrri A et al. (2023)
European Society of Cardiology Core Curriculum for cardio-oncology
Eur J Heart Fail, 26 (4), 754-771
DOI 10.1002/ejhf.3102, PubMed 38059343

Persu A, Stoenoiu MS, Maes F, Kreutz R, Mancia G, Kjeldsen SE (2023)
Late outcomes of renal denervation are more favourable than early ones: facts or fancies?
Clin Kidney J, 16 (12), 2357-2364
DOI 10.1093/ckj/sfad231, PubMed 38046011

Pope MK, Hall TS, Virdone S, Atar D, John Camm A, Pieper KS, Jansky P, Haas S, Goto S, Panchenko E, Baron-Esquivias G, Angchaisuksiri P, Kakkar AK, GARFIELD-AF Investigators (2023)
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry
Int J Cardiol Heart Vasc, 49, 101302
DOI 10.1016/j.ijcha.2023.101302, PubMed 38020059

Kristensen AMD, Munkhaugen J, Halvorsen S, Olsen MH, Bakken A, Sehested TSG, Ruddox V, Lange T, Fagerland MW, Torp-Pedersen C, Prescott E, Atar D (2024)
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics
Eur Heart J Cardiovasc Pharmacother, 10 (3), 175-183
DOI 10.1093/ehjcvp/pvad093, PubMed 38017624

Young J, Seeberg KA, Aakre KM, Borgeraas H, Nordstrand N, Wisløff T, Hjelmesæth J, Omland T, Hertel JK (2023)
The liver-heart axis in patients with severe obesity: The association between liver fibrosis and chronic myocardial injury may be explained by shared risk factors of cardiovascular disease
Clin Biochem, 123, 110688
DOI 10.1016/j.clinbiochem.2023.110688, PubMed 37995847

Vistnes M (2023)
How can we improve the follow-up of patients with heart failure?
Tidsskr Nor Laegeforen, 143 (17)
DOI 10.4045/tidsskr.23.0735, PubMed 37987060

Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, Atar D, Birnie DH, Boriani G, Camm AJ, Conen D, Erath JW, Gold MR, Hohnloser SH, Ip J, Kautzner J, Kutyifa V, Linde C, Mabo P, Mairesse G, Benezet Mazuecos J, Cosedis Nielsen J, Philippon F, Proietti M, Sticherling C et al. (2023)
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
N Engl J Med, 390 (2), 107-117
DOI 10.1056/NEJMoa2310234, PubMed 37952132

Wimmer H, Stensønes SH, Benth JŠ, Lundqvist C, Andersen GØ, Draegni T, Sunde K, Nakstad ER (2023)
Outcome prediction in comatose cardiac arrest patients with initial shockable and non-shockable rhythms
Acta Anaesthesiol Scand, 68 (2), 263-273
DOI 10.1111/aas.14337, PubMed 37876138

Rist A, Sevre K, Wachtell K, Devereux RB, Aurigemma GP, Smiseth OA, Kjeldsen SE, Julius S, Pitt B, Burnier M, Kreutz R, Oparil S, Mancia G, Zannad F (2023)
The current best drug treatment for hypertensive heart failure with preserved ejection fraction
Eur J Intern Med, 120, 3-10
DOI 10.1016/j.ejim.2023.10.008, PubMed 37865559

Reichenbach A, Alteheld L, Henriksen J, Nakstad ER, Andersen GØ, Sunde K, Šaltytė Benth J, Lundqvist C (2023)
Transcranial Doppler during the first week after cardiac arrest and association with 6-month outcomes
Front Neurol, 14, 1222401
DOI 10.3389/fneur.2023.1222401, PubMed 37859655

Xiong W, Agewall S, Yamashita Y (2024)
Anticoagulation in cancer-associated thrombosis: how long should the therapy be?
Eur Heart J Cardiovasc Pharmacother, 10 (1), 3-4
DOI 10.1093/ehjcvp/pvad075, PubMed 37827545

Mancia G, Kjeldsen SE (2023)
Randomized Clinical Outcome Trials in Hypertension
Hypertension, 81 (1), 17-23
DOI 10.1161/HYPERTENSIONAHA.123.21725, PubMed 37795644

Wärme J, Sundqvist MO, Hjort M, Agewall S, Collste O, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Spaak J, Sörensson P, Y-Hassan S, Svensson P, Lindahl B, Hofmann R, Tornvall P (2023)
Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease
Int J Mol Sci, 24 (18)
DOI 10.3390/ijms241814143, PubMed 37762446

Opstad TB, Papotti B, Åkra S, Hansen CH, Braathen B, Tønnessen T, Solheim S, Seljeflot I (2023)
Sirtuin1, not NAMPT, possesses anti-inflammatory effects in epicardial, pericardial and subcutaneous adipose tissue in patients with CHD
J Transl Med, 21 (1), 644
DOI 10.1186/s12967-023-04518-4, PubMed 37730614

Burnier M, Narkiewicz K, Kjeldsen SE (2023)
How to optimize the use of diuretics in patients with heart failure?
Kardiol Pol, 81 (10), 944-949
DOI 10.33963/v.kp.97315, PubMed 37718589

Melberg MB, Flaa A, Andersen GØ, Sunde K, Bellomo R, Eastwood G, Olasveengen TM, Qvigstad E (2023)
Cardiovascular changes induced by targeted mild hypercapnia after out of hospital cardiac arrest. A sub-study of the TAME cardiac arrest trial
Resuscitation, 193, 109970
DOI 10.1016/j.resuscitation.2023.109970, PubMed 37716401

Serebruany VL, Tanguay JF, Gurvich ML, Marciniak TA, Atar D (2023)
Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet Therapy
Am J Ther, 30 (5), e411-e415
DOI 10.1097/MJT.0000000000001622, PubMed 37713684

Mariampillai JE, Halvorsen LV, Larstorp AC, Heimark S, Waldum-Grevbo B, Kjeldsen SE, Nordby G, Stenehjem AE, Berg JP, Høieggen A (2023)
[Diabetes and chronic kidney disease]
Tidsskr Nor Laegeforen, 143 (12)
DOI 10.4045/tidsskr.22.0822, PubMed 37668137

Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SF et al. (2023)
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
Cardiovasc Diabetol, 22 (1), 233
DOI 10.1186/s12933-023-01963-9, PubMed 37653496

Dodgson CS, Beitnes JO, Kløve SF, Herstad J, Opdahl A, Undseth R, Eek CH, Broch K, Gullestad L, Aaberge L, Lunde K, Bendz B, Lie ØH (2023)
An investigator-sponsored pragmatic randomized controlled trial of AntiCoagulation vs AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation: Rationale and design of ACASA-TAVI
Am Heart J, 265, 225-232
DOI 10.1016/j.ahj.2023.08.010, PubMed 37634655

Holm NR, Andreasen LN, Neghabat O, Laanmets P, Kumsars I, Bennett J, Olsen NT, Odenstedt J, Hoffmann P, Dens J, Chowdhary S, O'Kane P, Bülow Rasmussen SH, Heigert M, Havndrup O, Van Kuijk JP, Biscaglia S, Mogensen LJH, Henareh L, Burzotta F, H Eek C, Mylotte D, Llinas MS, Koltowski L, Knaapen P et al. (2023)
OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions
N Engl J Med, 389 (16), 1477-1487
DOI 10.1056/NEJMoa2307770, PubMed 37634149

Fröhlich H, Bossmeyer A, Kazmi S, Goode KM, Agewall S, Atar D, Grundtvig M, Frey N, Cleland JGF, Frankenstein L, Clark AL, Täger T (2023)
Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus
Clin Res Cardiol, 113 (6), 822-830
DOI 10.1007/s00392-023-02268-3, PubMed 37608126

Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Ryan L, Bendz B, Hopp E, Kløw NE, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Amundsen BH, Damas JK, Kleveland O (2023)
Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
Open Heart, 10 (2)
DOI 10.1136/openhrt-2023-002301, PubMed 37591633

Sevre K, Rist A, Wachtell K, Devereux RB, Aurigemma GP, Smiseth OA, Kjeldsen SE, Julius S, Pitt B, Burnier M, Kreutz R, Oparil S, Mancia G, Zannad F (2024)
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence
Am J Hypertens, 37 (1), 1-14
DOI 10.1093/ajh/hpad073, PubMed 37551929

Atar D, Auricchio A, Blomström-Lundqvist C (2023)
Cardiac device infection: removing barriers to timely and adequate treatment
Eur Heart J, 44 (35), 3323-3326
DOI 10.1093/eurheartj/ehad490, PubMed 37529893

Myhre PL, Berge T, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Solheim S, Arnesen H, Seljeflot I, Tveit A (2023)
Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial
Clin Nutr, 42 (9), 1657-1660
DOI 10.1016/j.clnu.2023.07.002, PubMed 37515843

Sundqvist MG, Sörensson P, Ekenbäck C, Lundin M, Agewall S, Brolin EB, Cederlund K, Collste O, Daniel M, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Winnberg O, Caidahl K, Ugander M, Tornvall P (2023)
CMR Is Often Abnormal Despite Normal Echocardiography in Suspected Myocardial Infarction With Nonobstructed Coronary Arteries
JACC Cardiovasc Imaging, 16 (12), 1626-1628
DOI 10.1016/j.jcmg.2023.05.024, PubMed 37498255

Tjessum L, Agewall S (2023)
Evaluation of a Structuralized Sick-Leave Programme Compared with usual Care Sick-Leave Management for Patients after an Acute Myocardial Infarction
J Rehabil Med, 55, jrm4569
DOI 10.2340/jrm.v55.4569, PubMed 37486246

Agewall S (2023)
Atrial fibrillation has gone from a boring disease to a very hot condition. Why is that?
Eur Heart J Cardiovasc Pharmacother, 9 (5), 401-402
DOI 10.1093/ehjcvp/pvad049, PubMed 37486237

Gorog DA, Ferreiro JL, Ahrens I, Ako J, Geisler T, Halvorsen S, Huber K, Jeong YH, Navarese EP, Rubboli A, Sibbing D, Siller-Matula JM, Storey RF, Tan JWC, Ten Berg JM, Valgimigli M, Vandenbriele C, Lip GYH (2023)
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis
Nat Rev Cardiol, 20 (12), 830-844
DOI 10.1038/s41569-023-00901-2, PubMed 37474795

Alehagen U, Alexander J, Aaseth JO, Larsson A, Svensson E, Opstad TB (2023)
Effects of an Intervention with Selenium and Coenzyme Q₁₀ on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial
Cells, 12 (13)
DOI 10.3390/cells12131773, PubMed 37443807

Mariampillai JE, Kjeldsen SE (2023)
Real-world data show the effect of statins in primary prevention
Eur J Prev Cardiol, 30 (17), 1881-1882
DOI 10.1093/eurjpc/zwad231, PubMed 37439146

Gragnano F, Cao D, Pirondini L, Franzone A, Kim HS, von Scheidt M, Pettersen AR, Zhao Q, Woodward M, Chiarito M, McFadden EP, Park KW, Kastrati A, Seljeflot I, Zhu Y, Windecker S, Kang J, Schunkert H, Arnesen H, Bhatt DL, Steg PG, Calabrò P, Pocock S, Mehran R, Valgimigli M et al. (2023)
P2Y₁₂ Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
J Am Coll Cardiol, 82 (2), 89-105
DOI 10.1016/j.jacc.2023.04.051, PubMed 37407118

Brunström M, Carlberg B, Kjeldsen SE (2023)
Effect of antihypertensive treatment in isolated systolic hypertension (ISH) - systematic review and meta-analysis of randomised controlled trials
Blood Press, 32 (1), 2226757
DOI 10.1080/08037051.2023.2226757, PubMed 37395100

Feinberg JB, Nielsen EE, Kjeldsen SE, Devereux RB, Gerdts E, Wachtell K, Olsen MH (2023)
Sex Differences in Atrial Fibrillation and Associated Complications in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study
Am J Hypertens, 36 (10), 536-541
DOI 10.1093/ajh/hpad057, PubMed 37382177

Nilsen DWT, Myhre PL, Solheim S, Tveit SH, Kalstad AA, Laake K, Tveit A, Seljeflot I (2023)
Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly
Antioxidants (Basel), 12 (6)
DOI 10.3390/antiox12061157, PubMed 37371887

Heimark S, Mehlum MH, Mancia G, Søraas CL, Liestøl K, Wachtell K, Larstorp AC, Rostrup M, Mariampillai JE, Kjeldsen SE, Julius S, Weber MA (2023)
Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg
Hypertension, 80 (8), 1739-1748
DOI 10.1161/HYPERTENSIONAHA.123.21454, PubMed 37350267

Simeunovic A, Brunborg C, Heier M, Seljeflot I, Dahl-Jørgensen K, Margeirsdottir HD (2023)
Sustained low-grade inflammation in young participants with childhood onset type 1 diabetes: The Norwegian atherosclerosis and childhood diabetes (ACD) study
Atherosclerosis, 379, 117151
DOI 10.1016/j.atherosclerosis.2023.05.020, PubMed 37349194

Holt MF, Flø A, Bjørnø V, Husebye T, Knudsen EC, Hodt A, Gustavsen A, Kristiansen HA, Raki M, Broch K, Wien TN, Gude E (2023)
A man in his seventies with fatigue and renal failure
Tidsskr Nor Laegeforen, 143 (9)
DOI 10.4045/tidsskr.22.0679, PubMed 37341412

Nendl A, Raju SC, Broch K, Mayerhofer CCK, Holm K, Halvorsen B, Lappegård KT, Moscavitch S, Hov JR, Seljeflot I, Trøseid M, Awoyemi A (2023)
Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
Front Cardiovasc Med, 10, 1160030
DOI 10.3389/fcvm.2023.1160030, PubMed 37332580

Eastwood G, Nichol AD, Hodgson C, Parke RL, McGuinness S, Nielsen N, Bernard S, Skrifvars MB, Stub D, Taccone FS, Archer J, Kutsogiannis D, Dankiewicz J, Lilja G, Cronberg T, Kirkegaard H, Capellier G, Landoni G, Horn J, Olasveengen T, Arabi Y, Chia YW, Markota A, Hænggi M, Wise MP et al. (2023)
Mild Hypercapnia or Normocapnia after Out-of-Hospital Cardiac Arrest
N Engl J Med, 389 (1), 45-57
DOI 10.1056/NEJMoa2214552, PubMed 37318140

Warlo EMK, Kalstad AA, Myhre PL, Solheim S, Arnesen H, Tveit A, Holme PA, Seljeflot I, Bratseth V (2023)
von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
Res Pract Thromb Haemost, 7 (4), 100164
DOI 10.1016/j.rpth.2023.100164, PubMed 37255854

Semb AG, Vesterbekkmo EK, Retterstøl K, Atar D, Solberg EE, Schirmer H, Løchen ML, Kask A, Grimsmo J, Ingul CB, Munkhaugen J (2023)
[PCSK9 inhibitors on reimbursable prescription: who is eligible?]
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.23.0191, PubMed 37254976

Andel PM, Aukrust P, Gleditsch J, Gude E, Haugeberg G, Høie S, Salte T, Steine K, Atar D (2023)
Recurrent pericarditis
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.22.0580, PubMed 37254974

Vinter N, Halminen O, Lehto M, Airaksinen KEJ, Andersson T, Wändell P, Holzmann M, Rutherford OC, Halvorsen S, Cordsen P, Frost L, Johnsen SP (2023)
Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway and Finland
Basic Clin Pharmacol Toxicol, 133 (2), 168-178
DOI 10.1111/bcpt.13902, PubMed 37230945

Vistnes M, Erusappan PM, Sasi A, Nordén ES, Bergo KK, Romaine A, Lunde IG, Zhang L, Olsen MB, Øgaard J, Carlson CR, Wang CH, Riise J, Dahl CP, Fiane AE, Hauge-Iversen IM, Espe E, Melleby AO, Tønnessen T, Aronsen JM, Sjaastad I, Christensen G (2023)
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
Cardiovasc Res, 119 (10), 1915-1927
DOI 10.1093/cvr/cvad078, PubMed 37216909

Kjeldsen SE, Mariampillai JE, Høieggen A (2023)
Uric acid and left ventricular mass in prediction of cardiovascular risk-New insight from the URRAH study
Eur J Intern Med, 114, 45-46
DOI 10.1016/j.ejim.2023.05.016, PubMed 37179137

Tamargo J, Agewall S, Borghi C, Ceconi C, Cerbai E, Dan GA, Ferdinandy P, Grove EL, Rocca B, Sulzgruber P, Semb AG, Sossalla S, Niessner A, Kaski JC, Dobrev D (2023)
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
Eur Heart J Cardiovasc Pharmacother, 9 (4), 353-70 (in press)
DOI 10.1093/ehjcvp/pvad034, PubMed 37169875

Ratajczak-Tretel B, Lambert AT, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth HMO, Bjerkeli V, Eldøen G, Gulsvik AK, Halvorsen B, Høie GA, Ihle-Hansen H, Ihle-Hansen H, Ingebrigtsen S, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Næss H, Qazi R, Rezaj MK, Rørholt DM, Steffensen LH et al. (2023)
Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study
J Neurol, 270 (8), 4049-4059
DOI 10.1007/s00415-023-11680-8, PubMed 37162578

Halvorsen S, Mehilli J, Geisler T (2023)
Continue or discontinue aspirin before non-cardiac surgery?
Eur Heart J, 44 (26), 2410
DOI 10.1093/eurheartj/ehad246, PubMed 37155334

Jervan Ø, Haukeland-Parker S, Gleditsch J, Tavoly M, Klok FA, Steine K, Johannessen HH, Spruit MA, Atar D, Holst R, Astrup Dahm AE, Sirnes PA, Stavem K, Ghanima W (2023)
The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
Chest, 164 (4), 981-991
DOI 10.1016/j.chest.2023.04.042, PubMed 37149257

Atar D, Bakken A, Munkhaugen J (2023)
Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarction
Kardiol Pol, 81 (4), 327-329
DOI 10.33963/KP.a2023.0087, PubMed 37144720

Atar D, Rosseland LA, Jammer I, Aakre KM, Wiseth R, Molund M, Gualandro DM, Omland T (2023)
Implementing screening for myocardial injury in non-cardiac surgery: perspectives of an ad-hoc interdisciplinary expert group
Scand Cardiovasc J, 57 (1), 31-39
DOI 10.1080/14017431.2022.2112071, PubMed 37141087

Knutsen TM, Skretteberg PT, Vanberg P, Kamal Z, Halvorsen S, Liestøl K, Steen T, Platou E (2023)
Transvenous lead extractions in a single high-volume center over a 24-year period: High success rate and low complication rate
Heart Rhythm O2, 4 (4), 232-240
DOI 10.1016/j.hroo.2023.01.003, PubMed 37124554

Valgimigli M, Aboyans V, Angiolillo D, Atar D, Capodanno D, Halvorsen S, James S, Jüni P, Kunadian V, Landi A, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Fox KAA (2023)
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
Eur Heart J Cardiovasc Pharmacother, 9 (5), 462-496
DOI 10.1093/ehjcvp/pvad032, PubMed 37120728

Halvorsen S, Mehilli J, Mueller C (2023)
The roles of cardiac troponins before non-cardiac surgery
Eur Heart J, 44 (23), 2130-2131
DOI 10.1093/eurheartj/ehad226, PubMed 37098747

Kjeldsen SE, Burnier M, Narkiewicz K, Kreutz R, Mancia G (2023)
Key questions regarding the SYMPLICITY HTN-3 trial
Lancet, 401 (10385), 1336-1337
DOI 10.1016/S0140-6736(23)00340-9, PubMed 37087164

Burnier M, Brguljan J, Algharably EAE, Kjeldsen SE, Narkiewicz K, Egan B, Oparil S, Kreutz R (2023)
Women's health, cardiovascular risk and hypertension: the perspective still needs to improve
Blood Press, 32 (1), 2193648
DOI 10.1080/08037051.2023.2193648, PubMed 37066492

Ratajczak-Tretel B, Tancin Lambert A, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth H, Bjerkeli V, Eldøen G, Gulsvik A, Halvorsen B, Høie GA, Ihle-Hansen H, Ihle-Hansen H, Ingebrigtsen S, Johansen H, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Næss H, Qazi R, Rezaj MK, Rørholt DM et al. (2022)
Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
Eur Stroke J, 8 (1), 148-156
DOI 10.1177/23969873221123122, PubMed 37021182

Bondjers K, Lingaas I, Stensland S, Atar D, Zwart JA, Wøien H, Dyb G (2023)
"I've kept going" - a multisite repeated cross-sectional study of healthcare workers' pride in personal performance during the COVID-19 pandemic
BMC Health Serv Res, 23 (1), 322
DOI 10.1186/s12913-023-09246-5, PubMed 37004056

Opstad TB, Alexander J, Aaseth J, Larsson A, Seljeflot I, Alehagen U (2023)
Increased SIRT1 Concentration Following Four Years of Selenium and Q₁₀ Intervention Associated with Reduced Cardiovascular Mortality at 10-Year Follow-Up-Sub-Study of a Previous Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial
Antioxidants (Basel), 12 (3)
DOI 10.3390/antiox12030759, PubMed 36979007

Sandberg EL, Halvorsen S, Berge T, Grimsmo J, Atar D, Fensli R, Grenne BL, Jortveit J (2023)
Fully digital self-screening for atrial fibrillation with patch electrocardiogram
Europace, 25 (5)
DOI 10.1093/europace/euad075, PubMed 36945146

Ratajczak-Tretel B, Lambert AT, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth HMO, Bjerkeli V, Eldøen G, Gulsvik AK, Halvorsen B, Høie GA, Ihle-Hansen H, Ingebrigtsen S, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Naess H, Qazi R, Rezaj MK, Rørholt DM, Steffensen LH, Sømark J et al. (2023)
Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study - the importance of comprehensive clinical evaluation
BMC Neurol, 23 (1), 115
DOI 10.1186/s12883-023-03155-0, PubMed 36944929

Papotti B, Opstad TB, Åkra S, Tønnessen T, Braathen B, Hansen CH, Arnesen H, Solheim S, Seljeflot I, Ronda N (2023)
Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease
Front Cardiovasc Med, 10, 1055069
DOI 10.3389/fcvm.2023.1055069, PubMed 36937936

Berger SG, Witczak BN, Reiseter S, Schwartz T, Andersson H, Hetlevik SO, Berntsen KS, Sanner H, Lilleby V, Gunnarsson R, Molberg Ø, Sjaastad I, Stokke MK (2023)
Cardiac dysfunction in mixed connective tissue disease: a nationwide observational study
Rheumatol Int, 43 (6), 1055-1065
DOI 10.1007/s00296-023-05308-3, PubMed 36933069

Schneider A, Atar D, Agewall S (2023)
RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action
J Am Coll Cardiol, 81 (11), 1130-1132
DOI 10.1016/j.jacc.2022.10.041, PubMed 36922095

Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Kesäniemi YA, Nienaber CA, Ray SG, Rossebø AB, Wachtell K, Nielsen OW (2023)
Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial
EClinicalMedicine, 58, 101875
DOI 10.1016/j.eclinm.2023.101875, PubMed 36915288

Menon V, Halvorsen S (2023)
The second strategic reperfusion early after myocardial infarction (STREAM-2) study
Eur Heart J Acute Cardiovasc Care, 12 (4), 219-221
DOI 10.1093/ehjacc/zuad024, PubMed 36895183

Navarese EP, Landi A, Oliva A, Piccolo R, Aboyans V, Angiolillo D, Atar D, Capodanno D, Fox KAA, Halvorsen S, James S, Jüni P, Kunadian V, Leonardi S, Mehran R, Montalescot G, Niebauer J, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Valgimigli M (2023)
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
Eur Heart J Cardiovasc Pharmacother, 9 (3), 271-290
DOI 10.1093/ehjcvp/pvad016, PubMed 36869784

Marstein HS, Witczak BN, Godang K, Olarescu NC, Schwartz T, Flatø B, Molberg Ø, Bollerslev J, Sjaastad I, Sanner H (2023)
Adipokine profile in long-term juvenile dermatomyositis, and associations with adipose tissue distribution and cardiac function: a cross-sectional study
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002815, PubMed 36828644

Serebruany VL, Tanguay JF, Gurvich ML, Marciniak TA, Atar D (2023)
Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 Year
Am J Med, 136 (5), 484-488
DOI 10.1016/j.amjmed.2023.01.029, PubMed 36828207

Sverre E, Halvorsen S, Løchen ML, Munkhaugen J (2023)
[E. Sverre et al. respond]
Tidsskr Nor Laegeforen, 143 (3)
DOI 10.4045/tidsskr.23.0062, PubMed 36811436

Tancin Lambert A, Ratajczak-Tretel B, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth HMO, Bjerkeli V, Eldøen G, Gulsvik AK, Halvorsen B, Høie GA, Ihle-Hansen H, Ihle-Hansen H, Ingebrigtsen S, Johansen H, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Naess H, Qazi R, Rezai MK, Rørholt DM et al. (2023)
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study
Eur J Neurol, 30 (5), 1352-1363
DOI 10.1111/ene.15746, PubMed 36786305

Nguyen THP, Fagerland MW, Hollan I, Whist JE, Feinberg MW, Agewall S (2023)
High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis
PLoS One, 18 (2), e0281155
DOI 10.1371/journal.pone.0281155, PubMed 36763689

Lyng CS, Gude E, Hodt A, Knudsen EC (2023)
First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant
Scand Cardiovasc J, 57 (1), 2174269
DOI 10.1080/14017431.2023.2174269, PubMed 36734834

Forfang E, Larsen KT, Salman RA, Bell SM, Wester P, Berge E, Wyller TB, Rønning OM (2023)
Antithrombotic treatment after intracerebral hemorrhage: Surveys among stroke physicians in Scandinavia and the United Kingdom
Health Sci Rep, 6 (1), e1059
DOI 10.1002/hsr2.1059, PubMed 36698713

Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, De Hert S, de Laval I, Geisler T, Hinterbuchner L, Ibanez B, Lenarczyk R, Mansmann UR, McGreavy P, Mueller C, Muneretto C, Niessner A, Potpara TS, Ristić A, Sade LE, Schirmer H, Schüpke S, Sillesen H, Skulstad H, Torracca L et al. (2023)
[2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)]
G Ital Cardiol (Rome), 24 (1 Suppl 1), e1-e102
DOI 10.1714/3956.39326, PubMed 36645369

Åkra S, Seljeflot I, Braathen B, Bratseth V, Hansen CH, Arnesen H, Tønnessen T, Solheim S (2022)
The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
Atheroscler Plus, 48, 47-54
DOI 10.1016/j.athplu.2022.03.005, PubMed 36644557

Drexel H, Saely CH, Agewall S (2023)
Fibrates: one more lost paradise in lipid treatment
Eur Heart J Cardiovasc Pharmacother, 9 (2), 121
DOI 10.1093/ehjcvp/pvac072, PubMed 36610735

Karasik A, Lanzinger S, Chia-Hui Tan E, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nyström T, Niskanen L, Linnemann Jensen M, Hoti F, Klement R, Déruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G et al. (2023)
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes Metab, 49 (2), 101418
DOI 10.1016/j.diabet.2022.101418, PubMed 36608816

Nickander J, Ekenbäck C, Agewall S, Bacsovics Brolin E, Caidahl K, Cederlund K, Collste O, Daniel M, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Winnberg O, Sundqvist M, Ugander M, Tornvall P, Sörensson P (2022)
Comprehensive Follow-Up Cardiac Magnetic Resonance of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
JACC Cardiovasc Imaging, 16 (1), 128-129
DOI 10.1016/j.jcmg.2022.07.021, PubMed 36599558

Opstad TB, Nordeng J, Pettersen AR, Åkra S, Bratseth V, Zaidi H, Helseth R, Solheim S, Seljeflot I (2022)
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome
J Immunol Res, 2022, 2366695
DOI 10.1155/2022/2366695, PubMed 36582742

Krychtiuk KA, Ahrens I, Drexel H, Halvorsen S, Hassager C, Huber K, Kurpas D, Niessner A, Schiele F, Semb AG, Sionis A, Claeys MJ, Barrabes J, Montero S, Sinnaeve P, Pedretti R, Catapano A (2022)
Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Acute Cardiovasc Care, 11 (12), 939-949
DOI 10.1093/ehjacc/zuac123, PubMed 36574353

Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, Beger B, Brobert G, Casadei B, Ceccarelli C, Cowie MR, Crea F, Cronin M, Denaxas S, Derix A, Fitzsimons D, Fredriksson M, Gale CP, Gkoutos GV, Goettsch W, Hemingway H, Ingvar M, Jonas A, Kazmierski R et al. (2022)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
BMJ, 378, e069048
DOI 10.1136/bmj-2021-069048, PubMed 36562446

Hokstad I, Greco D, Deyab G, Fagerland MW, Agewall S, Hjeltnes G, Zimetti F, Bernini F, Ronda N, Hollan I (2022)
Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
J Clin Med, 11 (24)
DOI 10.3390/jcm11247330, PubMed 36555946

Berge T, Myhre PL, Kalstad AA, Laake K, Tveit SH, Onarheim S, Solheim S, Seljeflot I, Arnesen H, Tveit A (2022)
Screen-Detected Atrial Fibrillation and "Micro-Atrial Fibrillation" and Risk of Cardiovascular Events after Myocardial Infarction in Elderly Patients
Cardiology, 148 (1), 72-77
DOI 10.1159/000528726, PubMed 36538900

Mehilli J, Halvorsen S (2023)
The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
Eur Heart J, 44 (5), 336-337
DOI 10.1093/eurheartj/ehac703, PubMed 36527277

Fontaine MAC, Jin H, Gagliardi M, Rousch M, Wijnands E, Stoll M, Li X, Schurgers L, Reutelingsperger C, Schalkwijk C, van den Akker NMS, Molin DGM, Gullestad L, Eritsland J, Hoffman P, Skjelland M, Andersen GØ, Aukrust P, Karel J, Smirnov E, Halvorsen B, Temmerman L, Biessen EAL (2022)
Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma Repair
Adv Sci (Weinh), 10 (5), e2203053
DOI 10.1002/advs.202203053, PubMed 36526599

Awoyemi A, Hov JR, Trøseid M (2022)
Phenylacetylglutamine From the Gut Microbiota: A Future Therapeutic Target in Heart Failure?
Circ Heart Fail, 16 (1), e010222
DOI 10.1161/CIRCHEARTFAILURE.122.010222, PubMed 36524473

Agewall S (2022)
Pharmacological treatment of CVD
Eur Heart J Cardiovasc Pharmacother, 9 (1), 1-3
DOI 10.1093/ehjcvp/pvac068, PubMed 36519600

Gulati G, Tjessem KH, Horndalsveen H, Halvorsen S, Haakensen VD (2022)
[Checkpoint inhibitor-induced myocarditis]
Tidsskr Nor Laegeforen, 142 (18)
DOI 10.4045/tidsskr.21.0817, PubMed 36511752

Martínez-Montesinos L, Rivera-Caravaca JM, Agewall S, Soler E, Lip GYH, Marín F, Roldán V (2022)
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Biomed Pharmacother, 158, 114064
DOI 10.1016/j.biopha.2022.114064, PubMed 36495662

Andreotti F, Geisler T, Collet JP, Gigante B, Gorog DA, Halvorsen S, Lip GYH, Morais J, Navarese EP, Patrono C, Rocca B, Rubboli A, Sibbing D, Storey RF, Verheugt FWA, Vilahur G (2023)
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
Eur Heart J, 44 (4), 262-279
DOI 10.1093/eurheartj/ehac515, PubMed 36477865

Warlo EMK, Bratseth V, Pettersen AR, Holme PA, Arnesen H, Seljeflot I, Opstad TB (2022)
Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
Clin Appl Thromb Hemost, 28, 10760296221141893
DOI 10.1177/10760296221141893, PubMed 36474435

Agewall S (2022)
To treat or not to treat
Eur Heart J Cardiovasc Pharmacother, 8 (8), 754-755
DOI 10.1093/ehjcvp/pvac062, PubMed 36458860

Neglia D, Liga R, Gimelli A, Podlesnikar T, Cvijić M, Pontone G, Miglioranza MH, Guaricci AI, Seitun S, Clemente A, Sumin A, Vitola J, Saraste A, Paunonen C, Sia CH, Paleev F, Sade LE, Zamorano JL, Maroz-Vadalazhskaya N, Anagnostopoulos C, Macedo F, Knuuti J, Edvardsen T, Cosyns B, Petersen SE et al. (2023)
Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry
Eur Heart J, 44 (2), 142-158
DOI 10.1093/eurheartj/ehac640, PubMed 36452988

Engebretsen I, Munkhaugen J, Bugge C, Halvorsen S, Ødegaard KM, Støvring H, Kristiansen IS (2022)
Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs
Eur Heart J Open, 2 (6), oeac070
DOI 10.1093/ehjopen/oeac070, PubMed 36440353

Bahlmann E, Einarsen E, Cramariuc D, Pedersen ER, Rossebø AB, Midtbø H, Willems S, Gerdts E (2022)
Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area
Open Heart, 9 (2)
DOI 10.1136/openhrt-2022-002159, PubMed 36428084

Kjeldsen SE, Brunström M, Thomopoulos C, Carlberg B, Kreutz R, Mancia G (2022)
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes
Lancet Diabetes Endocrinol, 10 (12), 840
DOI 10.1016/S2213-8587(22)00312-6, PubMed 36427519

Sverre E, Halvorsen S, Løchen ML, Munkhaugen J (2022)
Personalised cardiovascular disease prevention in the new guidelines
Tidsskr Nor Laegeforen, 142 (17)
DOI 10.4045/tidsskr.22.0508, PubMed 36416647

Opstad TB, Farup PG, Rootwelt H, Aaseth JO (2022)
Changes in circulating sirtuin 1 after bariatric surgery
Nutr Metab Cardiovasc Dis, 32 (12), 2858-2864
DOI 10.1016/j.numecd.2022.09.009, PubMed 36404480

van der Meer D, Gurholt TP, Sønderby IE, Shadrin AA, Hindley G, Rahman Z, de Lange AG, Frei O, Leinhard OD, Linge J, Simon R, Beck D, Westlye LT, Halvorsen S, Dale AM, Karlsen TH, Kaufmann T, Andreassen OA (2022)
The link between liver fat and cardiometabolic diseases is highlighted by genome-wide association study of MRI-derived measures of body composition
Commun Biol, 5 (1), 1271
DOI 10.1038/s42003-022-04237-4, PubMed 36402844

Molvaer AK, Iversen MM, Igland J, Peyrot M, Tell GS, Holte KB, Monnier VM, Seljeflot I, Berg TJ (2022)
Metabolic predictors of pain, fatigue, depression and quality of life in people with long-term type 1 diabetes-the Dialong study
Diabet Med, 40 (3), e15009
DOI 10.1111/dme.15009, PubMed 36398424

Kjeldsen SE, Egan BM, Narkiewicz K, Kreutz R, Burnier M, Oparil S, Mancia G (2023)
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension
Blood Press, 32 (1), 1-3
DOI 10.1080/08037051.2022.2142512, PubMed 36369908

Heiberg E, Engblom H, Carlsson M, Erlinge D, Atar D, Aletras AH, Arheden H (2022)
Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor data
J Cardiovasc Magn Reson, 24 (1), 53
DOI 10.1186/s12968-022-00888-8, PubMed 36336693

Lee GA, Aktaa S, Baker E, Gale CP, Yaseen IF, Gulati G, Asteggiano R, Szmit S, Cohen-Solal A, Abdin A, Jurczak W, Garrido Lopez P, Sverdlov AL, Tocchetti CG, Barac A, Parrini I, Zamorano P, Iakobishvili Z, Pudil R, Badimon L, Kirby AM, Blaes AH, Farmakis D, Curigliano G, Stephens R et al. (2022)
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
Eur Heart J Qual Care Clin Outcomes, 9 (1), 1-7
DOI 10.1093/ehjqcco/qcac070, PubMed 36316010

Johannessen TR, Halvorsen S, Atar D, Munkhaugen J, Nore AK, Wisløff T, Vallersnes OM (2022)
Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting
BMC Health Serv Res, 22 (1), 1274
DOI 10.1186/s12913-022-08697-6, PubMed 36271364

Ødegaard KM, Lirhus SS, Melberg HO, Hallén J, Halvorsen S (2022)
Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020
ESC Heart Fail, 10 (1), 405-415
DOI 10.1002/ehf2.14206, PubMed 36266969

Gevaert SA, Halvorsen S, Sinnaeve PR, Sambola A, Gulati G, Lancellotti P, Van Der Meer P, Lyon AR, Farmakis D, Lee G, Boriani G, Wechalekar A, Okines A, Asteggiano R, Combes A, Pfister R, Bergler-Klein J, Lettino M (2022)
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias
Eur Heart J Acute Cardiovasc Care, 11 (11), 865-874
DOI 10.1093/ehjacc/zuac107, PubMed 36226746

Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, Beger B, Brobert G, Casadei B, Ceccarelli C, Cowie MR, Crea F, Cronin M, Denaxas S, Derix A, Fitzsimons D, Fredriksson M, Gale CP, Gkoutos GV, Goettsch W, Hemingway H, Ingvar M, Jonas A, Kazmierski R et al. (2022)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
Eur Heart J, 43 (37), 3578-3588
DOI 10.1093/eurheartj/ehac426, PubMed 36208161

von Kemp B, Halvorsen S, Nohria A (2022)
The new 2022 ESC Guidelines on Cardio-oncology and their impact on the Acute Cardiovascular Care Society
Eur Heart J Acute Cardiovasc Care, 11 (11), 844-849
DOI 10.1093/ehjacc/zuac129, PubMed 36205095

Agewall S (2022)
Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding
Eur Heart J Cardiovasc Pharmacother, 8 (7), 645-647
DOI 10.1093/ehjcvp/pvac048, PubMed 36172980

Bratseth V, Nordeng J, Helseth R, Solheim S, Åkra S, Arnesen H, Chiva-Blanch G, Seljeflot I (2022)
Circulating Microvesicles in Association with the NLRP3 Inflammasome in Coronary Thrombi from STEMI Patients
Biomedicines, 10 (9)
DOI 10.3390/biomedicines10092196, PubMed 36140297

Wimmer H, Benth JŠ, Lundqvist C, Andersen GØ, Henriksen J, Drægni T, Solberg P, Stær-Jensen H, Sunde K, Nakstad ER (2022)
Changes in health status and health related quality of life from six months to five years in out-of-hospital cardiac arrest survivors - A NORCAST sub study
Resuscitation, 181, 182-189
DOI 10.1016/j.resuscitation.2022.08.019, PubMed 36084805

Halvorsen LV, Bergland OU, Søraas CL, Larstorp ACK, Hjørnholm U, Kjær VN, Kringen MK, Clasen PE, Haldsrud R, Kjeldsen SE, Rostrup M, Fadl Elmula FEM, Opdal MS, Høieggen A (2022)
Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7-Year Follow-Up of Patients Considered Adherent by Directly Observed Therapy
J Am Heart Assoc, 11 (18), e025879
DOI 10.1161/JAHA.121.025879, PubMed 36073648

Jortveit J, Pripp AH, Langørgen J, Halvorsen S (2022)
Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013-19
Eur Heart J Open, 2 (5), oeac052
DOI 10.1093/ehjopen/oeac052, PubMed 36071696

Gencer B, Gale CP, Aktaa S, Halvorsen S, Beska B, Abdelhamid M, Mueller C, Tutarel O, McGreavy P, Schirmer H, Geissler T, Sillesen H, Niessner A, Zacharowski K, Mehilli J, Potpara T (2023)
European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology and Intensive Care
Eur Heart J Qual Care Clin Outcomes, 9 (4), 331-341
DOI 10.1093/ehjqcco/qcac057, PubMed 36069905

Agewall S (2022)
Prevention is still the key to success
Eur Heart J Cardiovasc Pharmacother, 8 (6), 537-538
DOI 10.1093/ehjcvp/pvac046, PubMed 36057770

Larsen AI, Løland KH, Hovland S, Bleie Ø, Eek C, Fossum E, Trovik T, Juliebø V, Hegbom K, Moer R, Larsen T, Uchto M, Rotevatn S (2022)
Guideline-Recommended Time Less Than 90 Minutes From ECG to Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Is Associated with Major Survival Benefits, Especially in Octogenarians: A Contemporary Report in 11 226 Patients from NORIC
J Am Heart Assoc, 11 (17), e024849
DOI 10.1161/JAHA.122.024849, PubMed 36056722

Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, Beger B, Brobert G, Casadei B, Ceccarelli C, Cowie MR, Crea F, Cronin M, Denaxas S, Derix A, Fitzsimons D, Fredriksson M, Gale CP, Gkoutos GV, Goettsch W, Hemingway H, Ingvar M, Jonas A, Kazmierski R et al. (2022)
CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research
Lancet Digit Health, 4 (10), e757-e764
DOI 10.1016/S2589-7500(22)00151-0, PubMed 36050271

Butt JH, Dewan P, Jhund PS, Anand IS, Atar D, Ge J, Desai AS, Echeverria LE, Køber L, Lam CSP, Maggioni AP, Martinez F, Packer M, Rouleau JL, Sim D, Van Veldhuisen DJ, Vrtovec B, Zannad F, Zile MR, Gong J, Lefkowitz MP, Rizkala AR, Solomon SD, McMurray JJV (2022)
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
J Am Coll Cardiol, 80 (12), 1130-1143
DOI 10.1016/j.jacc.2022.06.037, PubMed 36050227

O'Donoghue ML, Giugliano RP, Wiviott SD, Atar D, Keech A, Kuder JF, Im K, Murphy SA, Flores-Arredondo JH, López JAG, Elliott-Davey M, Wang B, Monsalvo ML, Abbasi S, Sabatine MS (2022)
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
Circulation, 146 (15), 1109-1119
DOI 10.1161/CIRCULATIONAHA.122.061620, PubMed 36031810

Esler M, Kjeldsen SE, Pathak A, Grassi G, Kreutz R, Mancia G (2022)
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified
Blood Press, 31 (1), 210-224
DOI 10.1080/08037051.2022.2110858, PubMed 36029011

Opstad TB, Alexander J, Aaseth JO, Larsson A, Seljeflot I, Alehagen U (2022)
Selenium and Coenzyme Q₁₀ Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial
Nutrients, 14 (16)
DOI 10.3390/nu14163346, PubMed 36014852

Opstad TB, Solheim S, Pettersen AR, Kalstad AA, Arnesen H, Seljeflot I (2022)
TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients-A Possible Link to Clonal Hematopoiesis
Biomedicines, 10 (8)
DOI 10.3390/biomedicines10082027, PubMed 36009574

Halvorsen S, Smith JA, Söderdahl F, Thuresson M, Solli O, Ulvestad M, Jonasson C (2022)
Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study
BMC Prim Care, 23 (1), 214
DOI 10.1186/s12875-022-01824-6, PubMed 36008778

Triska J, Maitra N, Deshotels MR, Haddadin F, Angiolillo DJ, Vilahur G, Jneid H, Atar D, Birnbaum Y (2022)
A Comprehensive Review of the Pleiotropic Effects of Ticagrelor
Cardiovasc Drugs Ther, 38 (4), 775-797
DOI 10.1007/s10557-022-07373-5, PubMed 36001200

Atar D, Sarkar S, Kolev E, Mura C, Brosstad F, Theodorsen L, Westen GI, Stribolt-Halvorsen PE (2022)
Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet
Int J Clin Pharmacol Ther, 60 (10), 430-438
DOI 10.5414/CP204271, PubMed 35979901

Serebruany VL, Tanguay JF, Kuliczkowski W, Heidel E, Kim MH, Atar D (2022)
Impact of Bleeding on Myocardial Infarction, Stroke, and Death During 12 Months Dual Antiplatelet Therapy After Acute Coronary Syndrome
Am J Med, 135 (11), 1342-1348
DOI 10.1016/j.amjmed.2022.07.022, PubMed 35977606

Narkiewicz K, Kjeldsen SE, Egan BM, Kreutz R, Burnier M (2022)
Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure
Blood Press, 31 (1), 207-209
DOI 10.1080/08037051.2022.2107483, PubMed 35941816

De Caterina R, Agewall S, Andreotti F, Angiolillo DJ, Bhatt DL, Byrne RA, Collet JP, Eikelboom J, Fanaroff AC, Gibson CM, Goette A, Hindricks G, Lip GYH, Potpara T, Thiele H, Lopes RD, Galli M (2022)
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
Eur Heart J, 43 (37), 3512-3527
DOI 10.1093/eurheartj/ehac294, PubMed 35925556

Tamargo J, Hasegawa K, Agewall S (2022)
Toward personalized medicine for cardiovascular pharmacotherapy
Eur Heart J, 43 (45), 4719-4721
DOI 10.1093/eurheartj/ehac413, PubMed 35924414

Hellgren T, Blöndal M, Jortveit J, Ferenci T, Faxén J, Lewinter C, Eha J, Lõiveke P, Marandi T, Ainla T, Saar A, Veldre G, Andréka P, Halvorsen S, Jánosi A, Edfors R (2022)
Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries
Eur Heart J Open, 2 (4), oeac042
DOI 10.1093/ehjopen/oeac042, PubMed 35919580

Egan BM, Kjeldsen SE, Narkiewicz K, Kreutz R, Burnier M (2022)
Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions
Blood Press, 31 (1), 164-168
DOI 10.1080/08037051.2022.2095254, PubMed 35876172

Zaidi H, Aksnes T, Åkra S, Eggesbø HB, Byrkjeland R, Seljeflot I, Opstad TB (2022)
Abdominal Adipose Tissue Associates With Adiponectin and TNFα in Middle-Aged Healthy Men
Front Endocrinol (Lausanne), 13, 874977
DOI 10.3389/fendo.2022.874977, PubMed 35872989

Agewall S (2022)
Focus on optimizing treatment of coronary heart disease
Eur Heart J Cardiovasc Pharmacother, 8 (5), 431-433
DOI 10.1093/ehjcvp/pvac039, PubMed 35856265

Tamargo J, Kaski JC, Kimura T, Barton JC, Yamamoto K, Komiyama M, Drexel H, Lewis BS, Agewall S, Hasegawa K (2022)
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
Eur Heart J Cardiovasc Pharmacother, 8 (7), 738-751
DOI 10.1093/ehjcvp/pvac040, PubMed 35848895

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
[2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]
G Ital Cardiol (Rome), 23 (6 Suppl 1), e3-e115
DOI 10.1714/3808.37926, PubMed 35708476

Mariampillai JE, Kjeldsen SE, Gjesdal K, Skretteberg PT (2022)
Blood pressure during moderate or maximal exercise: hardly two sides of the same coin
J Hypertens, 40 (6), 1243-1244
DOI 10.1097/HJH.0000000000003121, PubMed 35703887

Kjeldsen SE, Egan BM, Narkiewicz K, Kreutz R, Burnier M, Oparil S (2022)
Thirty years with LIFE-a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy
Blood Press, 31 (1), 125-128
DOI 10.1080/08037051.2022.2083578, PubMed 35674494

Agewall S (2022)
Focus on different aspects of atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 8 (4), 323-324
DOI 10.1093/ehjcvp/pvac035, PubMed 35674202

Steen T (2022)
[Are doctors the right people to assess driving ability?]
Tidsskr Nor Laegeforen, 142 (8)
DOI 10.4045/tidsskr.22.0329, PubMed 35635419

Bahit MC, Vora AN, Li Z, Wojdyla DM, Thomas L, Goodman SG, Aronson R, Jordan JD, Kolls BJ, Dombrowski KE, Vinereanu D, Halvorsen S, Berwanger O, Windecker S, Mehran R, Granger CB, Alexander JH, Lopes RD (2022)
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial
JAMA Cardiol, 7 (7), 682-689
DOI 10.1001/jamacardio.2022.1166, PubMed 35612866

Cwikiel J, Fagerland MW, Wachtell K, Arnesen H, Seljeflot I, Flaa A (2022)
Exercise-induced change in circulating NT-proBNP could not distinguish between patients with and without coronary artery disease: the CADENCE study
Scand Cardiovasc J, 56 (1), 107-113
DOI 10.1080/14017431.2022.2075562, PubMed 35593516

Marstein HS, Witczak BN, Godang K, Schwartz T, Flatø B, Bollerslev J, Sjaastad I, Sanner H (2023)
Adipose tissue distribution is associated with cardio-metabolic alterations in adult patients with juvenile-onset dermatomyositis
Rheumatology (Oxford), 62 (SI2), SI196-SI204
DOI 10.1093/rheumatology/keac293, PubMed 35575380

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Angelantonio ED, Franco OH, Halvorsen S, Richard Hobbs FD, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Rev Esp Cardiol (Engl Ed), 75 (5), 429
DOI 10.1016/j.rec.2022.04.003, PubMed 35525570

Romaine A, Melleby AO, Alam J, Lobert VH, Lu N, Lockwood FE, Hasic A, Lunde IG, Sjaastad I, Stenmark H, Herum KM, Gullberg D, Christensen G (2022)
Integrin α11β1 and syndecan-4 dual receptor ablation attenuate cardiac hypertrophy in the pressure overloaded heart
Am J Physiol Heart Circ Physiol, 322 (6), H1057-H1071
DOI 10.1152/ajpheart.00635.2021, PubMed 35522553

Atar D, Langslet G, Tonstad S (2022)
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Kardiol Pol, 80 (7-8), 741-749
DOI 10.33963/KP.a2022.0117, PubMed 35521719

Komiyama M, Agewall S, Hasegawa K (2022)
Future of antithrombotic therapy for heart failure with coronary artery disease
Eur Heart J Cardiovasc Pharmacother, 8 (5), e25
DOI 10.1093/ehjcvp/pvac030, PubMed 35521703

Huse C, Anstensrud AK, Michelsen AE, Ueland T, Broch K, Woxholt S, Yang K, Sharma K, Tøllefsen IM, Bendz B, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Quiles-Jiménez A, Bjerkeli V, Bendz C, Kleveland O, Stensaeth KH, Opdahl A, Kløw NE, Andersen GØ, Wiseth R, Halvorsen B, Gullestad L et al. (2022)
Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
EBioMedicine, 80, 104013
DOI 10.1016/j.ebiom.2022.104013, PubMed 35504178

Omland T, Heck SL, Gulati G (2022)
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
JACC CardioOncol, 4 (1), 19-37
DOI 10.1016/j.jaccao.2022.01.101, PubMed 35492815

Kluge KE, Seljeflot I, Arnesen H, Jensen T, Halvorsen S, Helseth R (2022)
Coagulation factors XI and XII as possible targets for anticoagulant therapy
Thromb Res, 214, 53-62
DOI 10.1016/j.thromres.2022.04.013, PubMed 35490644

Nordeng J, Solheim S, Åkra S, Schandiz H, Hoffmann P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2022)
Gene expression of fibrinolytic markers in coronary thrombi
Thromb J, 20 (1), 23
DOI 10.1186/s12959-022-00383-1, PubMed 35488283

Aune SK, Bonnevie-Svendsen M, Nyborg C, Trøseid M, Seljeflot I, Hisdal J, Helseth R (2022)
Gut Leakage and Cardiac Biomarkers after Prolonged Strenuous Exercise
Med Sci Sports Exerc, 54 (9), 1476-1482
DOI 10.1249/MSS.0000000000002948, PubMed 35482788

Fyksen TS, Vanberg P, Gjesdal K, von Lueder TG, Bjørnerheim R, Steine K, Atar D, Halvorsen S (2022)
Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes
Scand J Med Sci Sports, 32 (8), 1170-1181
DOI 10.1111/sms.14172, PubMed 35460300

Hansen CH, Cwikiel J, Bratseth V, Arnesen H, Flaa A, Seljeflot I (2022)
Effect of Revascularization on Exercise-Induced Changes in Cardiac and Prothrombotic Biomarkers in Patients with Coronary Artery Disease
Clin Appl Thromb Hemost, 28, 10760296221094029
DOI 10.1177/10760296221094029, PubMed 35437054

Agewall S (2022)
New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials
Eur Heart J Cardiovasc Pharmacother, 8 (3), 213-215
DOI 10.1093/ehjcvp/pvac019, PubMed 35435962

Burnier M, Kjeldsen SE, Narkiewicz K, Egan B, Kreutz R (2022)
Hypertension management during the COVID-19 pandemic: what can we learn for the future?
Blood Press, 31 (1), 47-49
DOI 10.1080/08037051.2022.2058909, PubMed 35426323

Korthauer LE, Giugliano RP, Guo J, Sabatine MS, Sever P, Keech A, Atar D, Kurtz C, Ruff CT, Mach F, Ott BR (2022)
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab
PLoS One, 17 (4), e0266615
DOI 10.1371/journal.pone.0266615, PubMed 35404972

Jortveit J, Sandberg EL, Pripp AH, Halvorsen S (2022)
Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction
Open Heart, 9 (1)
DOI 10.1136/openhrt-2021-001934, PubMed 35387862

Mancia G, Kjeldsen SE, Kreutz R, Pathak A, Grassi G, Esler M (2022)
Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines
Hypertension, 79 (6), 1153-1166
DOI 10.1161/HYPERTENSIONAHA.122.19020, PubMed 35378981

Johannessen TR, Halvorsen S, Atar D, Vallersnes OM (2022)
Performance of the Novel Observation Group Criteria of the European Society of Cardiology (ESC) 0/1-Hour Algorithm in a Low-Risk Population
J Am Heart Assoc, 11 (7), e024927
DOI 10.1161/JAHA.121.024927, PubMed 35352564

Lilja-Cyron A, Bang CN, Gerdts E, Larstorp AC, Kjeldsen SE, Julius S, Okin PM, Wachtell K, Devereux RB (2022)
Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy-Application of A New Multivariate Predictive Model. The Life Study
Rev Cardiovasc Med, 23 (3), 95
DOI 10.31083/j.rcm2303095, PubMed 35345262

Kyte KH, Stensrud T, Berg TJ, Seljeflot I, Hisdal J (2022)
Vascular Function in Norwegian Female Elite Runners: A Cross-Sectional, Controlled Study
Sports (Basel), 10 (3)
DOI 10.3390/sports10030037, PubMed 35324646

Ødegaard KM, Lirhus SS, Melberg HO, Hallén J, Halvorsen S (2022)
A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
BMC Cardiovasc Disord, 22 (1), 88
DOI 10.1186/s12872-022-02522-y, PubMed 35247979

Steen T (2022)
[The Journal as a forum for debate on immigration policy?]
Tidsskr Nor Laegeforen, 142 (4)
DOI 10.4045/tidsskr.22.0105, PubMed 35239275

Saldarriaga C, Atar D, Stebbins A, Lewis BS, Abidin IZ, Blaustein RO, Butler J, Ezekowitz JA, Hernandez AF, Lam CSP, O'Connor CM, Pieske B, Ponikowski P, Roessig L, Voors AA, Anstrom KJ, Armstrong PW, VICTORIA Study Group (2022)
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
Eur J Heart Fail, 24 (5), 782-790
DOI 10.1002/ejhf.2468, PubMed 35239245

Nguyen THP, Hokstad I, Fagerland MW, Mollnes TE, Hollan I, Feinberg MW, Hjeltnes G, Eilertsen GØ, Mikkelsen K, Agewall S (2022)
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
PLoS One, 17 (2), e0264628
DOI 10.1371/journal.pone.0264628, PubMed 35213675

Welsh RC, Dehghani P, Lopes R, Wojdyla DM, Aronson R, Granger CB, Windecker S, Vora AN, Vinereanu D, Halvorsen S, Parkhomenko A, Mehran R, Alexander JH, Goodman S (2022)
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial
Open Heart, 9 (1)
DOI 10.1136/openhrt-2021-001892, PubMed 35172988

Ye R, Jneid H, Alam M, Uretsky BF, Atar D, Kitakaze M, Davidson SM, Yellon DM, Birnbaum Y (2022)
Do We Really Need Aspirin Loading for STEMI?
Cardiovasc Drugs Ther, 36 (6), 1221-1238
DOI 10.1007/s10557-022-07327-x, PubMed 35171384

Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Kesäniemi YA, Nienaber CA, Ray SG, Rossebø AB, Willenheimer R, Wachtell K, Nielsen OW (2022)
Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial
JAMA Cardiol, 7 (4), 435-444
DOI 10.1001/jamacardio.2021.5916, PubMed 35171199

Udjus C, Sjaastad I, Hjørnholm U, Tunestveit TK, Hoffmann P, Hinojosa A, Espe EKS, Christensen G, Skjønsberg OH, Larsen KO, Rostrup M (2022)
Extreme altitude induces divergent mass reduction of right and left ventricle in mountain climbers
Physiol Rep, 10 (3), e15184
DOI 10.14814/phy2.15184, PubMed 35146955

Ratajczak-Tretel B, Lambert AT, Atar D, Aamodt AH (2022)
Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
Acta Neurol Scand, 145 (5), 641-646
DOI 10.1111/ane.13590, PubMed 35146751

Gløersen M, Steen Pettersen P, Neogi T, Jafarzadeh SR, Vistnes M, Thudium CS, Bay-Jensen AC, Sexton J, Kvien TK, Hammer HB, Haugen IK (2022)
Associations of Body Mass Index With Pain and the Mediating Role of Inflammatory Biomarkers in People With Hand Osteoarthritis
Arthritis Rheumatol, 74 (5), 810-817
DOI 10.1002/art.42056, PubMed 35137553

Nordeng J, Schandiz H, Solheim S, Åkra S, Hoffman P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2022)
TIMP-1 expression in coronary thrombi associate with myocardial injury in ST-elevation myocardial infarction patients
Coron Artery Dis, 33 (6), 446-455
DOI 10.1097/MCA.0000000000001128, PubMed 35102064

Tamargo J, Kjeldsen KP, Delpón E, Semb AG, Cerbai E, Dobrev D, Savarese G, Sulzgruber P, Rosano G, Borghi C, Wassmann S, Torp-Pedersen CT, Agewall S, Drexel H, Baumgartner I, Lewis B, Ceconi C, Kaski JC, Niessner A (2022)
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (4), 406-419
DOI 10.1093/ehjcvp/pvac005, PubMed 35092425

Aukrust SG, Holte KB, Opstad TB, Seljeflot I, Berg TJ, Helseth R (2022)
NETosis in Long-Term Type 1 Diabetes Mellitus and Its Link to Coronary Artery Disease
Front Immunol, 12, 799539
DOI 10.3389/fimmu.2021.799539, PubMed 35069582

Burnier M, Kjeldsen SE (2022)
A 30th anniversary and a glimpse of the future
Blood Press, 31 (1), 1-3
DOI 10.1080/08037051.2021.2021638, PubMed 35060412

Hall TS, Ørn S, Zannad F, Rossignol P, Duarte K, Solomon SD, Atar D, Agewall S, Dickstein K, Girerd N (2022)
The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction
J Womens Health (Larchmt), 31 (3), 310-320
DOI 10.1089/jwh.2021.0326, PubMed 35049355

Ingul CB, Grimsmo J, Mecinaj A, Trebinjac D, Berger Nossen M, Andrup S, Grenne B, Dalen H, Einvik G, Stavem K, Follestad T, Josefsen T, Omland T, Jensen T (2022)
Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19
J Am Heart Assoc, 11 (3), e023473
DOI 10.1161/JAHA.121.023473, PubMed 35048715

Agewall S (2022)
Optimizing individual heart failure treatment
Eur Heart J Cardiovasc Pharmacother, 8 (2), 105-107
DOI 10.1093/ehjcvp/pvab087, PubMed 35039827

Moschetti K, Kwong RY, Petersen SE, Lombardi M, Garot J, Atar D, Rademakers FE, Sierra-Galan LM, Mavrogeni S, Li K, Fernandes JL, Schneider S, Pinget C, Ge Y, Antiochos P, Deluigi C, Bruder O, Mahrholdt H, Schwitter J (2022)
Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries
JACC Cardiovasc Imaging, 15 (4), 607-625
DOI 10.1016/j.jcmg.2021.11.008, PubMed 35033498

Birnbaum Y, Rankinen J, Jneid H, Atar D, Nikus K (2022)
The Role of ECG in the Diagnosis and Risk Stratification of Acute Coronary Syndromes: an Old but Indispensable Tool
Curr Cardiol Rep, 24 (2), 109-118
DOI 10.1007/s11886-021-01628-7, PubMed 35028816

Thind M, Zareba W, Atar D, Crijns HJGM, Zhu J, Pak HN, Reiffel J, Ludwigs U, Wieloch M, Stewart J, Kowey P (2022)
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials
Clin Cardiol, 45 (1), 101-109
DOI 10.1002/clc.23765, PubMed 35019175

Witczak BN, Schwartz T, Barth Z, Taraldsrud E, Lund MB, Aaløkken TM, Flatø B, Sjaastad I, Sanner H (2022)
Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis-a cross-sectional study
Rheumatol Int, 42 (7), 1213-1220
DOI 10.1007/s00296-021-05071-3, PubMed 34984516

Agewall S (2022)
Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient
Eur Heart J Cardiovasc Pharmacother, 8 (1), 1-3
DOI 10.1093/ehjcvp/pvab078, PubMed 34984441

Myhre PL, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Solheim S, Arnesen H, Seljeflot I (2022)
Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial
J Intern Med, 291 (5), 637-647
DOI 10.1111/joim.13442, PubMed 34982486

Gulati G (2022)
Cardioprotection in breast cancer patients: one size fits all?
Eur Heart J, 43 (27), 2570-2572
DOI 10.1093/eurheartj/ehab810, PubMed 34951626

Omland T, Prebensen C, Jonassen C, Svensson M, Berdal JE, Seljeflot I, Myhre PL (2021)
Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001884, PubMed 34933965

Tøllefsen IM, Shetelig C, Seljeflot I, Eritsland J, Hoffmann P, Andersen GØ (2021)
High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001869, PubMed 34933964

Andersen GØ (2022)
Comments on-The noradrenaline dosing in the new 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Eur Heart J Cardiovasc Pharmacother, 8 (3), E11
DOI 10.1093/ehjcvp/pvab086, PubMed 34918059

Thomas AM, Chaban V, Pischke SE, Orrem HL, Bosnes V, Sunde K, Seljeflot I, Lundqvist C, Nakstad ER, Andersen GØ, Schjalm C, Mollnes TE, Barratt-Due A (2021)
Complement ratios C3bc/C3 and sC5b-9/C5 do not increase the sensitivity of detecting acute complement activation systemically
Mol Immunol, 141, 273-279
DOI 10.1016/j.molimm.2021.11.016, PubMed 34906905

Oberprieler NG, Farahmand B, Cameron J, Brobert G, Jonasson C, Atar D (2021)
Characteristics, treatment patterns, and residual cardiovascular risk of patients with a first acute myocardial infarction: A nationwide population-based cohort study in Norway
Fundam Clin Pharmacol, 36 (3), 563-571
DOI 10.1111/fcp.12744, PubMed 34904750

Meyer-Myklestad MH, Medhus AW, Stiksrud B, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Trøseid M, Reikvam DH (2022)
Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
J Acquir Immune Defic Syndr, 89 (1), 77-86
DOI 10.1097/QAI.0000000000002817, PubMed 34878437

Task Force for the management of COVID-19 of the European Society of Cardiology, Baigent C, Windecker S, Andreini D, Arbelo E, Barbato E, Bartorelli AL, Baumbach A, Behr ER, Berti S, Bueno H, Capodanno D, Cappato R, Chieffo A, Collet JP, Cuisset T, de Simone G, Delgado V, Dendale P, Dudek D, Edvardsen T, Elvan A, González-Juanatey JR, Gori M, Grobbee D et al. (2022)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovasc Res, 118 (6), 1385-1412
DOI 10.1093/cvr/cvab342, PubMed 34864874

Gonzales RA, Seemann F, Lamy J, Mojibian H, Atar D, Erlinge D, Steding-Ehrenborg K, Arheden H, Hu C, Onofrey JA, Peters DC, Heiberg E (2021)
MVnet: automated time-resolved tracking of the mitral valve plane in CMR long-axis cine images with residual neural networks: a multi-center, multi-vendor study
J Cardiovasc Magn Reson, 23 (1), 137
DOI 10.1186/s12968-021-00824-2, PubMed 34857009

Chivulescu M, Aabel E, Dejgaard L, Steen T, Dunlop O, Haugaa KH (2021)
Cardiac Arrest in a Patient With Arrhythmic Mitral Valve Prolapse Syndrome: Multiple Possible Etiologies
JACC Case Rep, 3 (16), 1769-1773
DOI 10.1016/j.jaccas.2021.08.019, PubMed 34825207

Svenungsson E, Spaak J, Strandberg K, Wallén HN, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Malmqvist K, Elvin K, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P (2021)
Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries
J Intern Med, 291 (3), 327-337
DOI 10.1111/joim.13409, PubMed 34820922

Chiang CH, Chiang CH, Pickering JW, Stoyanov KM, Chew DP, Neumann JT, Ojeda F, Sörensen NA, Su KY, Kavsak P, Worster A, Inoue K, Johannessen TR, Atar D, Amann M, Hochholzer W, Mokhtari A, Ekelund U, Twerenbold R, Mueller C, Bahrmann P, Buttinger N, Dooley M, Ruangsomboon O, Nowak RM et al. (2021)
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis
Ann Intern Med, 175 (1), 101-113
DOI 10.7326/M21-1499, PubMed 34807719

Blom KB, Åsberg A, Sjaastad I, Kalleberg KT, Søraas A, Midtvedt K, Birkeland JA (2021)
Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway
Kidney Med, 4 (2), 100389
DOI 10.1016/j.xkme.2021.09.006, PubMed 34805967

Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2021)
Adiponectin in relation to exercise and physical performance in patients with type 2 diabetes and coronary artery disease
Adipocyte, 10 (1), 612-620
DOI 10.1080/21623945.2021.1996699, PubMed 34779349

Sandberg EL, Grenne BL, Berge T, Grimsmo J, Atar D, Halvorsen S, Fensli R, Jortveit J (2021)
Diagnostic Accuracy and Usability of the ECG247 Smart Heart Sensor Compared to Conventional Holter Technology
J Healthc Eng, 2021, 5230947
DOI 10.1155/2021/5230947, PubMed 34765102

Chiva-Blanch G, Bratseth V, Laake K, Arnesen H, Solheim S, Schmidt EB, Badimon L, Seljeflot I (2021)
One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction
Clin Nutr, 40 (12), 5674-5677
DOI 10.1016/j.clnu.2021.10.007, PubMed 34742136

Agewall S (2021)
Unsolved pharmacological issues with cardiology
Eur Heart J Cardiovasc Pharmacother, 7 (6), 461-462
DOI 10.1093/ehjcvp/pvab077, PubMed 34734246

Witczak BN, Bollerslev J, Godang K, Schwartz T, Flatø B, Molberg Ø, Sjaastad I, Sanner H (2022)
Body composition in long-standing juvenile dermatomyositis: associations with disease activity, muscle strength and cardiometabolic measures
Rheumatology (Oxford), 61 (7), 2959-2968
DOI 10.1093/rheumatology/keab805, PubMed 34718443

Kjeldsen SE, Grassi G, Kreutz R, Mancia G (2021)
Attended vs. unattended blood pressure - learnings beyond SPRINT
Blood Press, 30 (6), 439-440
DOI 10.1080/08037051.2021.1995981, PubMed 34714207

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2021)
The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug
Blood Press, 30 (6), 327-331
DOI 10.1080/08037051.2021.1995975, PubMed 34714185

Pope MK, Hall TS, Schirripa V, Radic P, Virdone S, Pieper KS, Le Heuzey JY, Jansky P, Fitzmaurice DA, Cappato R, Atar D, Camm AJ, Kakkar AK, GARFIELD-AF investigators (2021)
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
BMJ, 375, e066450
DOI 10.1136/bmj-2021-066450, PubMed 34706884

Nilsen DWT, Myhre PL, Kalstad A, Schmidt EB, Arnesen H, Seljeflot I (2021)
Serum Levels of Dihomo-Gamma (γ)-Linolenic Acid (DGLA) Are Inversely Associated with Linoleic Acid and Total Death in Elderly Patients with a Recent Myocardial Infarction
Nutrients, 13 (10)
DOI 10.3390/nu13103475, PubMed 34684479

Alehagen U, Opstad TB, Alexander J, Larsson A, Aaseth J (2021)
Impact of Selenium on Biomarkers and Clinical Aspects Related to Ageing. A Review
Biomolecules, 11 (10)
DOI 10.3390/biom11101478, PubMed 34680111

Falk RS, Mariampillai JE, Prestgaard EE, Heir T, Bodegård J, Robsahm TE, Grundvold I, Skretteberg PT, Engeseth K, Bjornholt JV, Stavem K, Liestøl K, Sandvik L, Thaulow E, Erikssen G, Kjeldsen SE, Gjesdal K, Erikssen JE (2021)
The Oslo Ischaemia Study: cohort profile
BMJ Open, 11 (10), e049111
DOI 10.1136/bmjopen-2021-049111, PubMed 34645662

Narkiewicz K, Burnier M, Kjeldsen SE, Oparil S (2021)
Combining proteomics, home blood pressure telemonitoring and patient empowerment to improve cardiovascular and renal protection
Blood Press, 30 (5), 267-268
DOI 10.1080/08037051.2021.1975878, PubMed 34586009

Aune SK, Cwikiel J, Flaa A, Arnesen H, Solheim S, Awoyemi A, Trøseid M, Seljeflot I, Helseth R (2021)
Gut Leakage Markers in Response to Strenuous Exercise in Patients with Suspected Coronary Artery Disease
Cells, 10 (9)
DOI 10.3390/cells10092193, PubMed 34571843

Nyborg C, Bonnevie-Svendsen M, Melsom HS, Melau J, Seljeflot I, Hisdal J (2021)
Reduced L-Arginine and L-Arginine-ADMA-Ratio, and Increased SDMA after Norseman Xtreme Triathlon
Sports (Basel), 9 (9)
DOI 10.3390/sports9090120, PubMed 34564325

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur J Prev Cardiol, 29 (1), 5-115
DOI 10.1093/eurjpc/zwab154, PubMed 34558602

Agewall S (2021)
More knowledge about atrial fibrillation, still we need to learn
Eur Heart J Cardiovasc Pharmacother, 7 (5), 361-362
DOI 10.1093/ehjcvp/pvab067, PubMed 34545933

Täger T, Frankenstein L, Atar D, Agewall S, Frey N, Grundtvig M, Clark AL, Cleland JGF, Fröhlich H (2021)
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis
Clin Res Cardiol, 111 (4), 428-439
DOI 10.1007/s00392-021-01913-z, PubMed 34498169

Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ (2022)
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (1), 100-103
DOI 10.1093/ehjcvp/pvab063, PubMed 34463331

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur Heart J, 42 (34), 3227-3337
DOI 10.1093/eurheartj/ehab484, PubMed 34458905

Aktaa S, Abdin A, Arbelo E, Burri H, Vernooy K, Blomström-Lundqvist C, Boriani G, Defaye P, Deharo JC, Drossart I, Foldager D, Gold MR, Johansen JB, Leyva F, Linde C, Michowitz Y, Kronborg MB, Slotwiner D, Steen T, Tolosana JM, Tzeis S, Varma N, Glikson M, Nielsen JC, Gale CP (2022)
European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology
Europace, 24 (1), 165-172
DOI 10.1093/europace/euab193, PubMed 34455442

Gevaert SA, Halvorsen S, Sinnaeve PR, Sambola A, Gulati G, Lancellotti P, Van Der Meer P, Lyon AR, Farmakis D, Lee G, Boriani G, Wechalekar A, Okines A, Asteggiano R (2021)
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases
Eur Heart J Acute Cardiovasc Care, 10 (8), 947-959
DOI 10.1093/ehjacc/zuab056, PubMed 34453829

Bahlmann E, Einarsen E, Cramariuc D, Midtbø H, Mancusi C, Rossebø A, Willems S, Gerdts E (2021)
Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001720, PubMed 34426527

Taegtmeyer H, Atar D (2021)
Icons in Cardiology
Cardiology, 146 (6), 667
DOI 10.1159/000519019, PubMed 34412055

Holm S, Kared H, Michelsen AE, Kong XY, Dahl TB, Schultz NH, Nyman TA, Fladeby C, Seljeflot I, Ueland T, Stensland M, Mjaaland S, Goll GL, Nissen-Meyer LS, Aukrust P, Skagen K, Gregersen I, Skjelland M, Holme PA, Munthe LA, Halvorsen B (2021)
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
Eur Heart J, 42 (39), 4064-4072
DOI 10.1093/eurheartj/ehab506, PubMed 34405870

Broberg AM, Tuohinen S, Skytta T, Geisler J, Hrafnkelsdóttir ÞJ, Smáradóttir A, Nielsen KM, Offersen BV, Jarfelt M, Gulati G (2020)
The Establishment of the Nordic Cardio-Oncology Society
JACC CardioOncol, 2 (2), 333-335
DOI 10.1016/j.jaccao.2020.04.004, PubMed 34396242

Brar V, Worley SJ, Eldadah Z, O Donoghue S, Makanjee B, Steen T, Bansal S, Oza S (2021)
"Retained wire femoral lead removal and fibroplasty" for obtaining venous access in patients with refractory venous obstruction
J Cardiovasc Electrophysiol, 32 (10), 2729-2736
DOI 10.1111/jce.15197, PubMed 34374160

Broch K, Anstensrud AK, Woxholt S, Andersen GØ, Gullestad L (2021)
Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial
J Am Coll Cardiol, 78 (6), 637-638
DOI 10.1016/j.jacc.2021.06.005, PubMed 34353542

Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K (2021)
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
EBioMedicine, 70, 103511
DOI 10.1016/j.ebiom.2021.103511, PubMed 34329947

Böhm F, Mogensen B, Östlund O, Engstrøm T, Fossum E, Stankovic G, Angerås O, Ērglis A, Menon M, Schultz C, Berry C, Liebetrau C, Laine M, Held C, Rück A, James SK (2021)
The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial
Am Heart J, 241, 92-100
DOI 10.1016/j.ahj.2021.07.007, PubMed 34310907

Burnier M, Kjeldsen SE, Narkiewicz K, Oparil S (2021)
Cuff-less measurements of blood pressure: are we ready for a change?
Blood Press, 30 (4), 205-207
DOI 10.1080/08037051.2021.1956178, PubMed 34308727

Agewall S (2021)
Adherence to pharmacological treatment: how can we improve?
Eur Heart J Cardiovasc Pharmacother, 7 (4), 261-262
DOI 10.1093/ehjcvp/pvab049, PubMed 34298551

Bergland OU, Halvorsen LV, Søraas CL, Hjørnholm U, Kjær VN, Rognstad S, Brobak KM, Aune A, Olsen E, Fauchald YM, Heimark S, Thorstensen CW, Liestøl K, Solbu MD, Gerdts E, Mo R, Rostrup M, Kjeldsen SE, Høieggen A, Opdal MS, Larstorp ACK, Fadl Elmula FEM (2021)
Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations
Hypertension, 78 (3), 617-628
DOI 10.1161/HYPERTENSIONAHA.121.17514, PubMed 34275336

Rubboli A, Atar D (2021)
Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not?
Am J Cardiovasc Drugs, 22 (2), 113-115
DOI 10.1007/s40256-021-00488-4, PubMed 34254254

Allahham M, Lerman A, Atar D, Birnbaum Y (2021)
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era
Cardiovasc Drugs Ther, 36 (3), 525-532
DOI 10.1007/s10557-021-07224-9, PubMed 34245446

Halvorsen S, Johnsen SP, Madsen M, Linder M, Sulo G, Ghanima W, Gislason G, Hohnloser SH, Jenkins A, Al-Khalili F, Tell GS, Ehrenstein V (2022)
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study
Eur Heart J Qual Care Clin Outcomes, 8 (5), 577-587
DOI 10.1093/ehjqcco/qcab048, PubMed 34244745

Deyab G, Reine TM, Vuong TT, Jenssen T, Hjeltnes G, Agewall S, Mikkelsen K, Førre Ø, Fagerland MW, Kolset SO, Hollan I (2021)
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
PLoS One, 16 (7), e0253247
DOI 10.1371/journal.pone.0253247, PubMed 34242246

Brunström M, Kjeldsen SE, Kreutz R, Gjesdal K, Narkiewicz K, Burnier M, Oparil S, Mancia G (2021)
Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective
Hypertension, 78 (2), 555-558
DOI 10.1161/HYPERTENSIONAHA.121.17356, PubMed 34232677

Kreutz R, Kjeldsen SE, Mancia G (2021)
Why we do not need a single independent international hypertension clinical practice guideline
J Hypertens, 39 (11), 2125-2127
DOI 10.1097/HJH.0000000000002940, PubMed 34224539

Nyborg C, Melsom HS, Bonnevie-Svendsen M, Melau J, Seljeflot I, Hisdal J (2021)
Transient Reduction of FMD-Response and L-Arginine Accompanied by Increased Levels of E-Selectin, VCAM, and ICAM after Prolonged Strenuous Exercise
Sports (Basel), 9 (6)
DOI 10.3390/sports9060086, PubMed 34204566

Myhre P, Seljeflot I, Arnesen H (2021)
[Myhre, Seljeflot and Arnesen respond]
Tidsskr Nor Laegeforen, 141 (10)
DOI 10.4045/tidsskr.21.0470, PubMed 34182730

Drexel H, Pocock SJ, Lewis BS, Saely CH, Kaski JC, Rosano GMC, Tautermann G, Huber K, Dopheide JF, Mader A, Niessner A, Savarese G, Schmidt TA, Semb AG, Tamargo J, Wassmann S, Clodi M, Kjeldsen KP, Agewall S (2022)
Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (3), 302-310
DOI 10.1093/ehjcvp/pvab048, PubMed 34180504

Nguyen THP, Fagerland MW, Deyab G, Hjeltnes G, Hollan I, Feinberg MW, Eilertsen GØ, Mikkelsen K, Agewall S (2021)
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
PLoS One, 16 (6), e0253793
DOI 10.1371/journal.pone.0253793, PubMed 34170978

Nordeng J, Schandiz H, Solheim S, Åkra S, Hoffman P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2021)
The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI
Mediators Inflamm, 2021, 5525917
DOI 10.1155/2021/5525917, PubMed 34135690

Chaban V, Nakstad ER, Stær-Jensen H, Schjalm C, Seljeflot I, Vaage J, Lundqvist C, Benth JŠ, Sunde K, Mollnes TE, Andersen GØ, Pischke SE (2021)
Complement activation is associated with poor outcome after out-of-hospital cardiac arrest
Resuscitation, 166, 129-136
DOI 10.1016/j.resuscitation.2021.05.038, PubMed 34126135

Kasiakogias A, Rosei EA, Camafort M, Ehret G, Faconti L, Ferreira JP, Brguljan J, Januszewicz A, Kahan T, Manolis A, Tsioufis K, Weber T, von Lueder TG, Smiseth OA, Wachtell K, Kjeldsen SE, Zannad F, Mancia G, Kreutz R (2021)
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
J Hypertens, 39 (8), 1522-1545
DOI 10.1097/HJH.0000000000002910, PubMed 34102660

Mariampillai JE, Prestgaard EE, Kjeldsen SE, Liestøl K, Grundvold I, Bodegård J, Gjesdal K, Erikssen JE, Skretteberg PT (2021)
Novel insights into stroke risk beyond resting and maximal bicycle exercise systolic blood pressure
J Hypertens, 39 (10), 2022-2029
DOI 10.1097/HJH.0000000000002894, PubMed 34102659

Ariansen I, Degerud E, Gjesdal K, Tell GS, Næss Ø (2020)
Examining the lower range of the association between alcohol intake and risk of incident hospitalization with atrial fibrillation
Int J Cardiol Heart Vasc, 31, 100679
DOI 10.1016/j.ijcha.2020.100679, PubMed 34095445

Rubboli A, Atar D (2021)
The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confused
Eur J Intern Med, 90, 125-126
DOI 10.1016/j.ejim.2021.05.009, PubMed 34090747

Ghanima W, Schultze A, Donaldson R, Brodin E, Halvorsen S, Graham S, Carroll R, Ulvestad M, Lambrelli D (2021)
Oral Anticoagulation Therapy for Venous Thromboembolism in Norway: Time Trends and Treatment Patterns
Clin Ther, 43 (7), 1179-1190.e3
DOI 10.1016/j.clinthera.2021.04.017, PubMed 34083030

Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO (2021)
Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
Sci Rep, 11 (1), 11593
DOI 10.1038/s41598-021-90976-z, PubMed 34078971

Pinho-Gomes AC, Azevedo L, Copland E, Canoy D, Nazarzadeh M, Ramakrishnan R, Berge E, Sundström J, Kotecha D, Woodward M, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K, Blood Pressure Lowering Treatment Trialists’ Collaboration (2021)
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
PLoS Med, 18 (6), e1003599
DOI 10.1371/journal.pmed.1003599, PubMed 34061831

Chieffo A, Dudek D, Hassager C, Combes A, Gramegna M, Halvorsen S, Huber K, Kunadian V, Maly J, Møller JE, Pappalardo F, Tarantini G, Tavazzi G, Thiele H, Vandenbriele C, van Mieghem N, Vranckx P, Werner N, Price S (2021)
Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
Eur Heart J Acute Cardiovasc Care, 10 (5), 570-583
DOI 10.1093/ehjacc/zuab015, PubMed 34057173

Chieffo A, Dudek D, Hassager C, Combes A, Gramegna M, Halvorsen S, Huber K, Kunadian V, Maly J, Møller JE, Pappalardo F, Tarantini G, Tavazzi G, Thiele H, Vandenbriele C, Van Mieghem N, Vranckx P, Werner N, Price S (2021)
Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
EuroIntervention, 17 (4), e274-e286
DOI 10.4244/EIJY21M05_01, PubMed 34057071

Rønning P, Helseth E, Skaansar O, Tverdal C, Andelic N, Bhatnagar R, Melberg M, Skaga NO, Aarhus M, Halvorsen S, Helseth R (2021)
Impact of Preinjury Antithrombotic Therapy on 30-Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)
Front Neurol, 12, 650695
DOI 10.3389/fneur.2021.650695, PubMed 34054695

Agewall S (2021)
Different aspects of giving the optimal antiplatelet treatment
Eur Heart J Cardiovasc Pharmacother, 7 (3), 169-170
DOI 10.1093/ehjcvp/pvab037, PubMed 34023878

Heck SL, Mecinaj A, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, Røsjø H, Steine K, Geisler J, Gulati G, Omland T (2021)
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
Circulation, 143 (25), 2431-2440
DOI 10.1161/CIRCULATIONAHA.121.054698, PubMed 33993702

Hoel H, Pettersen EM, Høiseth LØ, Mathiesen I, Seternes A, Seljeflot I, Hisdal J (2021)
Effects of intermittent negative pressure treatment on circulating vascular biomarkers in patients with intermittent claudication
Vasc Med, 26 (5), 489-496
DOI 10.1177/1358863X211007933, PubMed 33985385

Rutherford OW, Jonasson C, Ghanima W, Söderdahl F, Halvorsen S (2021)
Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
Heart, 108 (5), 345-352
DOI 10.1136/heartjnl-2020-318753, PubMed 33975877

Opstad TB, Sundfør T, Tonstad S, Seljeflot I (2021)
Effect of intermittent and continuous caloric restriction on Sirtuin1 concentration depends on sex and body mass index
Nutr Metab Cardiovasc Dis, 31 (6), 1871-1878
DOI 10.1016/j.numecd.2021.03.005, PubMed 33975734

Helseth R, Kleveland O, Ueland T, Wiseth R, Damas JK, Broch K, Michelsen A, Bendz B, Gullestad L, Aukrust P, Seljeflot I (2021)
Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
Open Heart, 8 (1)
DOI 10.1136/openhrt-2020-001492, PubMed 33972404

Zou F, Worley SJ, Steen T, McKillop M, Padala S, O'Donoghue S, Candemir B, Kanjwal K, Kaufman M, Mouram S, Sellers M, Strouse D, Thomaides A, Nair D, Hadadi CA, Kushnir A (2021)
The combination of coronary sinus ostial atresia/abnormalities and a small persistent left superior vena cava-Opportunity for left ventricular lead implantation and unrecognized source of thromboembolic stroke
Heart Rhythm, 18 (7), 1064-1073
DOI 10.1016/j.hrthm.2021.05.004, PubMed 33971333

Krogager ML, Kragholm K, Thomassen JQ, Søgaard P, Lewis BS, Wassmann S, Baumgartner I, Ceconi C, Schmidt TA, Kaski JC, Drexel H, Semb AG, Agewall S, Niessner A, Savarese G, Kjeldsen KP, Borghi C, Tamargo J, Torp-Pedersen C (2021)
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 7 (6), 557-567
DOI 10.1093/ehjcvp/pvab038, PubMed 33956964

Hall TS, Atar D (2021)
The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation
Eur J Intern Med, 88, 21-22
DOI 10.1016/j.ejim.2021.04.008, PubMed 33934970

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2021)
Better drug adherence improves blood pressure control and lowers cardiovascular disease outcomes - from single pill combinations to monitoring of a nationwide health insurance database
Blood Press, 30 (3), 143-144
DOI 10.1080/08037051.2021.1917192, PubMed 33910432

Marstein HS, Godang K, Flatø B, Sjaastad I, Bollerslev J, Sanner H (2021)
Bone mineral density and explanatory factors in children and adults with juvenile dermatomyositis at long term follow-up; a cross sectional study
Pediatr Rheumatol Online J, 19 (1), 56
DOI 10.1186/s12969-021-00543-z, PubMed 33902632

Myhre PL, Seljeflot I, Arnesen H (2021)
Omega-3 supplements do not prevent cardiovascular disease
Tidsskr Nor Laegeforen, 141 (6)
DOI 10.4045/tidsskr.21.0033, PubMed 33876607

Broch K, Anstensrud AK, Woxholt S, Sharma K, Tøllefsen IM, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Bendz C, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2021)
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
J Am Coll Cardiol, 77 (15), 1845-1855
DOI 10.1016/j.jacc.2021.02.049, PubMed 33858620

Peterson BE, Bhatt DL, Gabriel Steg P, Oldgren J, Maeng M, Zeymer U, Halvorsen S, Hohnloser SH, Lip GYH, Kimura T, Nordaby M, Miede C, Kleine E, Ten Berg JM, Cannon CP, RE-DUAL PCI Steering Committee and Investigators (2021)
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial
JACC Cardiovasc Interv, 14 (7), 768-780
DOI 10.1016/j.jcin.2021.02.022, PubMed 33826497

Pope MK, Atar D, Svilaas A, Hole T, Nielsen JD, Hintze U, Crisby M, Raatikainen P, Airaksinen KEJ, Virdone S, Pieper K, Kayani G, Le Heuzey JY, Steffel J, Stepinska J, Bassand JP, Camm AJ, GARFIELD-AF Investigators (2021)
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry
Ann Med, 53 (1), 485-494
DOI 10.1080/07853890.2021.1893897, PubMed 33818226

Aune SK, Byrkjeland R, Solheim S, Arnesen H, Trøseid M, Awoyemi A, Seljeflot I, Helseth R (2021)
Gut related inflammation and cardiorespiratory fitness in patients with CAD and type 2 diabetes: a sub-study of a randomized controlled trial on exercise training
Diabetol Metab Syndr, 13 (1), 36
DOI 10.1186/s13098-021-00655-2, PubMed 33794977

Copland E, Canoy D, Nazarzadeh M, Bidel Z, Ramakrishnan R, Woodward M, Chalmers J, Teo KK, Pepine CJ, Davis BR, Kjeldsen S, Sundström J, Rahimi K, Blood Pressure Lowering Treatment Trialists' Collaboration (2021)
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
Lancet Oncol, 22 (4), 558-570
DOI 10.1016/S1470-2045(21)00033-4, PubMed 33794209

Agewall S (2021)
Antiplatelet treatment in coronary syndrome
Eur Heart J Cardiovasc Pharmacother, 7 (2), 81-82
DOI 10.1093/ehjcvp/pvab015, PubMed 33720341

Blöndal M, Ainla T, Eha J, Lõiveke P, Marandi T, Saar A, Veldre G, Edfors R, Lewinter C, Jernberg T, Jortveit J, Halvorsen S, Becker D, Csanádi Z, Ferenci T, Andréka P, Jánosi A (2022)
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries
Eur Heart J Qual Care Clin Outcomes, 8 (3), 307-314
DOI 10.1093/ehjqcco/qcaa098, PubMed 33710273

Marcks N, Aimo A, Januzzi JL, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C, Sanders-van Wijk S et al. (2021)
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data
Clin Res Cardiol, 110 (8), 1280-1291
DOI 10.1007/s00392-021-01822-1, PubMed 33704552

Gehin JE, Warren DJ, Syversen SW, Lie E, Sexton J, Loli L, Wierød A, Bjøro T, Kvien TK, Bolstad N, Goll GL (2021)
Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study
Scand J Rheumatol, 50 (6), 445-454
DOI 10.1080/03009742.2021.1875040, PubMed 33650469

Kalstad AA, Myhre PL, Laake K, Opstad TB, Tveit A, Solheim S, Arnesen H, Seljeflot I (2021)
Biomarkers of ageing and cardiac remodeling are associated with atrial fibrillation
Scand Cardiovasc J, 55 (4), 213-219
DOI 10.1080/14017431.2021.1889653, PubMed 33650449

Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ (2022)
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (1), 85-99
DOI 10.1093/ehjcvp/pvab018, PubMed 33638977

Johannessen TR, Atar D, Vallersnes OM, Larstorp ACK, Mdala I, Halvorsen S (2021)
Comparison of a single high-sensitivity cardiac troponin T measurement with the HEART score for rapid rule-out of acute myocardial infarction in a primary care emergency setting: a cohort study
BMJ Open, 11 (2), e046024
DOI 10.1136/bmjopen-2020-046024, PubMed 33627355

Krychtiuk KA, Speidl WS, Giannitsis E, Gigante B, Gorog DA, Jaffe AS, Mair J, Möckel M, Mueller C, Storey RF, Vilahur G, Wojta J, Huber K, Halvorsen S, Geisler T, Morais J, Lindahl B, Thygesen K (2021)
Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis
Eur Heart J Acute Cardiovasc Care, 10 (3), 343-355
DOI 10.1093/ehjacc/zuaa025, PubMed 33620437

Edfors R, Jernberg T, Lewinter C, Blöndal M, Eha J, Lõiveke P, Marandi T, Ainla T, Saar A, Veldre G, Ferenci T, Andréka P, Jánosi A, Jortveit J, Halvorsen S (2022)
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries
Eur Heart J Qual Care Clin Outcomes, 8 (4), 429-436
DOI 10.1093/ehjqcco/qcab013, PubMed 33605415

Alm-Kruse K, Sørensen G, Osbakk SA, Sunde K, Bendz B, Andersen GØ, Fiane A, Hagen OA, Kramer-Johansen J (2021)
Outcome in refractory out-of-hospital cardiac arrest before and after implementation of an ECPR protocol
Resuscitation, 162, 35-42
DOI 10.1016/j.resuscitation.2021.01.038, PubMed 33581226

Wimmer H, Lundqvist C, Šaltytė Benth J, Stavem K, Andersen GØ, Henriksen J, Drægni T, Sunde K, Nakstad ER (2021)
Health-related quality of life after out-of-hospital cardiac arrest – a five-year follow-up study
Resuscitation, 162, 372-380
DOI 10.1016/j.resuscitation.2021.01.036, PubMed 33571604

Voll M, Øystese KA, Høiskar E, Johansen O, Nyvold C, Norheim I, von Lueder TG, Andersen GØ (2021)
Case report: a patient with thyroid storm, refractory cardiogenic shock, and cardiac arrest treated with Lugol's iodine solution and veno-arterial extra corporal membrane oxygenation support
Eur Heart J Case Rep, 5 (2), ytab017
DOI 10.1093/ehjcr/ytab017, PubMed 33569532

Schiele F, Aktaa S, Rossello X, Ahrens I, Claeys MJ, Collet JP, Fox KAA, Gale CP, Huber K, Iakobishvili Z, Keys A, Lambrinou E, Leonardi S, Lettino M, Masoudi FA, Price S, Quinn T, Swahn E, Thiele H, Timmis A, Tubaro M, Vrints CJM, Walker D, Bueno H, ESC Scientific Document Group et al. (2021)
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group
Eur Heart J Acute Cardiovasc Care, 10 (2), 224-233
DOI 10.1093/ehjacc/zuaa037, PubMed 33550362

Frisk M, Le C, Shen X, Røe ÅT, Hou Y, Manfra O, Silva GJJ, van Hout I, Norden ES, Aronsen JM, Laasmaa M, Espe EKS, Zouein FA, Lambert RR, Dahl CP, Sjaastad I, Lunde IG, Coffey S, Cataliotti A, Gullestad L, Tønnessen T, Jones PP, Altara R, Louch WE (2021)
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
J Am Coll Cardiol, 77 (4), 405-419
DOI 10.1016/j.jacc.2020.11.044, PubMed 33509397

Nordén ES, Bendiksen BA, Andresen H, Bergo KK, Espe EK, Hasic A, Hauge-Iversen IM, Veras I, Hussain RI, Sjaastad I, Christensen G, Cataliotti A (2021)
Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
ESC Heart Fail, 8 (2), 918-927
DOI 10.1002/ehf2.13177, PubMed 33497525

Birnbaum Y, Nikus K, Atar D, Jneid H (2021)
Is RBBB the new LBBB? Are we going to repeat the same mistakes?
J Electrocardiol, 65, 34-36
DOI 10.1016/j.jelectrocard.2020.12.010, PubMed 33477070

Atar D, Jukema JW, Molemans B, Taub PR, Goto S, Mach F, CerezoOlmos C, Underberg J, Keech A, Tokgözoğlu L, Bonaca MP (2021)
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
Atherosclerosis, 319, 51-61
DOI 10.1016/j.atherosclerosis.2020.12.013, PubMed 33476944

Hijazi Z, Alexander JH, Li Z, Wojdyla DM, Mehran R, Granger CB, Parkhomenko A, Bahit MC, Windecker S, Aronson R, Berwanger O, Halvorsen S, de Waha-Thiele S, Sinnaeve P, Darius H, Storey RF, Lopes RD (2021)
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Circulation, 143 (12), 1215-1223
DOI 10.1161/CIRCULATIONAHA.120.051020, PubMed 33461308

Camm AJ, Atar D (2021)
Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and Prospects
Thromb Haemost, 121 (6), 716-730
DOI 10.1055/s-0040-1721665, PubMed 33412613

Saeed M, Tapia G, Ariansen I, Stene LC, Seljeflot I, Tell GS, Skrivarhaug T, Joner G (2021)
Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study
Diabetes Care, 44 (3), 810-816
DOI 10.2337/dc20-1712, PubMed 33408220

Olsen E, Holzhauer B, Julius S, Kjeldsen SE, Larstorp ACK, Mancia G, Mehlum MH, Mo R, Rostrup M, Søraas CL, Zappe D, Weber MA (2021)
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk
Blood Press, 30 (2), 90-97
DOI 10.1080/08037051.2020.1856642, PubMed 33403890

Olsen E, Holzhauer B, Julius S, Kjeldsen SE, Larstorp ACK, Mancia G, Mehlum MH, Mo R, Rostrup M, Søraas CL, Zappe D, Weber MA (2021)
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension
Blood Press, 30 (2), 82-89
DOI 10.1080/08037051.2020.1855968, PubMed 33403886

Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J (2021)
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis
Hypertension, 77 (2), 692-705
DOI 10.1161/HYPERTENSIONAHA.120.15781, PubMed 33390044

Agewall S (2021)
Atrial fibrillation in registries
Eur Heart J Cardiovasc Pharmacother, 7 (1), 1-2
DOI 10.1093/ehjcvp/pvaa142, PubMed 33367509

De Caterina R, Patti G, Westerbergh J, Horowitz J, Ezekowitz JA, Lewis BS, Lopes RD, McMurray JJV, Atar D, Bahit MC, Keltai M, López-Sendón JL, Ruzyllo W, Granger CB, Alexander JH, Wallentin L (2022)
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
Eur Heart J Cardiovasc Pharmacother, 8 (3), 227-235
DOI 10.1093/ehjcvp/pvaa140, PubMed 33367487

Abraham WT, Lindenfeld J, Ponikowski P, Agostoni P, Butler J, Desai AS, Filippatos G, Gniot J, Fu M, Gullestad L, Howlett JG, Nicholls SJ, Redon J, Schenkenberger I, Silva-Cardoso J, Störk S, Krzysztof Wranicz J, Savarese G, Brueckmann M, Jamal W, Nordaby M, Peil B, Ritter I, Ustyugova A, Zeller C et al. (2021)
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Eur Heart J, 42 (6), 700-710
DOI 10.1093/eurheartj/ehaa943, PubMed 33351892

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2020)
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers
Blood Press, 30 (1), 1-3
DOI 10.1080/08037051.2021.1862483, PubMed 33349063

Tollisen KH, Hadley CL, Bjerva M, Dahl GT, Högvall LM, Sandvik L, Andersen GØ, Heyerdahl F, Jacobsen D (2020)
Clinical impact of chronic substance abuse in a Norwegian ICU-population
Acta Anaesthesiol Scand, 65 (4), 515-524
DOI 10.1111/aas.13766, PubMed 33340102

Sinning C, Ahrens I, Cariou A, Beygui F, Lamhaut L, Halvorsen S, Nikolaou N, Nolan JP, Price S, Monsieurs K, Behringer W, Cecconi M, Van Belle E, Jouven X, Hassager C (2020)
The cardiac arrest centre for the treatment of sudden cardiac arrest due to presumed cardiac cause - aims, function and structure: Position paper of the Association for Acute CardioVascular Care of the European Society of Cardiology (AVCV), European Association of Percutaneous Coronary Interventions (EAPCI), European Heart Rhythm Association (EHRA), European Resuscitation Council (ERC), European Society for Emergency Medicine (EUSEM) and European Society of Intensive Care Medicine (ESICM)
Eur Heart J Acute Cardiovasc Care, 9 (4_suppl), S193-S202
DOI 10.1177/2048872620963492, PubMed 33327761

Blichfeldt-Ærø SC, Knutsen TM, Hagen HM, Diep LM, Trondalen G, Halvorsen S (2020)
Music therapy as an adjunct in cardiac device lead extraction procedures: A randomized controlled trial
Appl Nurs Res, 56, 151376
DOI 10.1016/j.apnr.2020.151376, PubMed 33280783

Opstad TB, Berg TJ, Holte KB, Arnesen H, Solheim S, Seljeflot I (2020)
Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long-term survivors of type 1 diabetes: A Dialong substudy
J Diabetes Investig, 12 (7), 1183-1192
DOI 10.1111/jdi.13470, PubMed 33249778

Tveit SH, Cwikiel J, Myhre PL, Omland T, Berge E, Seljeflot I, Flaa A (2020)
Differential associations of cardiac troponin T and cardiac troponin I with coronary artery pathology and dynamics in response to short-duration exercise
Clin Biochem, 88, 23-29
DOI 10.1016/j.clinbiochem.2020.11.005, PubMed 33245871

Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Stiksrud B, Trøseid M, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Reikvam DH (2022)
Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
J Infect Dis, 225 (4), 661-674
DOI 10.1093/infdis/jiaa714, PubMed 33216130

Agewall S (2020)
Focus on blood pressure and risk factor intervention
Eur Heart J Cardiovasc Pharmacother, 6 (6), 339-340
DOI 10.1093/ehjcvp/pvaa130, PubMed 33197927

Kalstad AA, Myhre PL, Laake K, Tveit SH, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Fagerland MW, Solheim S, Seljeflot I, Arnesen H, OMEMI Investigators (2020)
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial
Circulation, 143 (6), 528-539
DOI 10.1161/CIRCULATIONAHA.120.052209, PubMed 33191772

Cramariuc D, Bahlmann E, Egstrup K, Rossebø AB, Ray S, Kesäniemi YA, Nienaber CA, Gerdts E (2020)
Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis
Echocardiography, 38 (1), 31-38
DOI 10.1111/echo.14916, PubMed 33146452

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2020)
Was it optimal to drop a diuretic as a first-line choice of drug treatment in the 2020 International Society of Hypertension Guidelines?
Blood Press, 29 (6), 341-343
DOI 10.1080/08037051.2020.1838766, PubMed 33140684

Maqsood MH, Alam M, Atar D, Birnbaum Y (2021)
Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis
J Cardiovasc Pharmacol, 77 (1), 87-93
DOI 10.1097/FJC.0000000000000922, PubMed 33136764

Drexel H, Lewis BS, Rosano GMC, Saely CH, Tautermann G, Huber K, Dopheide JF, Kaski JC, Mader A, Niessner A, Savarese G, Schmidt TA, Semb A, Tamargo J, Wassmann S, Per Kjeldsen K, Agewall S, Pocock SJ (2021)
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials
Eur Heart J Cardiovasc Pharmacother, 7 (5), 453-459
DOI 10.1093/ehjcvp/pvaa126, PubMed 33135079

Langseth MS, Andersen GØ, Husebye T, Arnesen H, Zucknick M, Solheim S, Eritsland J, Seljeflot I, Opstad TB, Helseth R (2020)
Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
PLoS One, 15 (10), e0241333
DOI 10.1371/journal.pone.0241333, PubMed 33119664

Krogstad V, Peric A, Robertsen I, Kringen MK, Vistnes M, Hjelmesæth J, Sandbu R, Johnson LK, Angeles PC, Jansson-Löfmark R, Karlsson C, Andersson S, Åsberg A, Andersson TB, Christensen H (2020)
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes
J Pharm Sci, 110 (1), 432-437
DOI 10.1016/j.xphs.2020.10.027, PubMed 33091408

Iversen PO, von Lueder TG, Kardel KR, Lien K (2020)
Cardiac Dimensions and Function Are Not Altered among Females with the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Healthcare (Basel), 8 (4)
DOI 10.3390/healthcare8040406, PubMed 33081294

Szarek M, Bittner VA, Aylward P, Baccara-Dinet M, Bhatt DL, Diaz R, Fras Z, Goodman SG, Halvorsen S, Harrington RA, Jukema JW, Moriarty PM, Pordy R, Ray KK, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GG, ODYSSEY OUTCOMES Investigators (2020)
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
Eur Heart J, 41 (44), 4245-4255
DOI 10.1093/eurheartj/ehaa649, PubMed 33051646

Bergland OU, Søraas CL, Larstorp ACK, Halvorsen LV, Hjørnholm U, Hoffman P, Høieggen A, Fadl Elmula FEM (2020)
The randomised Oslo study of renal denervation vs. Antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up
Blood Press, 30 (1), 41-50
DOI 10.1080/08037051.2020.1828818, PubMed 33030064

Kreutz R, Kjeldsen SE, Burnier M, Narkiewicz K, Oparil S, Mancia G (2020)
Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime
J Hypertens, 38 (11), 2144-2145
DOI 10.1097/HJH.0000000000002671, PubMed 33027108

Arnesen H, Myhre PL, Seljeflot I (2020)
Very Long Chain Marine n-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic Effects
Nutrients, 12 (10)
DOI 10.3390/nu12103014, PubMed 33008057

Broberg AM, Geisler J, Tuohinen S, Skytta T, Hrafnkelsdóttir ÞJ, Nielsen KM, Hedayati E, Omland T, Offersen BV, Lyon AR, Gulati G (2020)
Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer
Curr Heart Fail Rep, 17 (6), 397-408
DOI 10.1007/s11897-020-00486-8, PubMed 32979150

Piuhola J, Kerkelä R, Laine M, Andersen GØ, Ērglis A, Kumsārs I, Thuesen L, Sinisalo J, Niemelä M, Junttila MJ (2020)
Lower ST-elevation myocardial infarction incidence during COVID-19 epidemic in Northern Europe
Scand Cardiovasc J, 54 (6), 358-360
DOI 10.1080/14017431.2020.1820563, PubMed 32945201

Marciniak TA, Atar D, Serebruany V (2021)
The perils of data sharing, meta-analyses, and estimating cardiovascular risk
Eur Heart J Cardiovasc Pharmacother, 7 (3), e55-e57
DOI 10.1093/ehjcvp/pvaa109, PubMed 32941601

El Hadidi S, Rosano G, Tamargo J, Agewall S, Drexel H, Kaski JC, Niessner A, Lewis BS, Coats AJS, Savarese G (2022)
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing
Eur Heart J Cardiovasc Pharmacother, 8 (2), 187-210
DOI 10.1093/ehjcvp/pvaa108, PubMed 32941594

Agewall S (2020)
Minimizing bleeding events
Eur Heart J Cardiovasc Pharmacother, 6 (5), 271-272
DOI 10.1093/ehjcvp/pvaa100, PubMed 32932523

Niyonzima N, Bakke SS, Gregersen I, Holm S, Sandanger Ø, Orrem HL, Sporsheim B, Ryan L, Kong XY, Dahl TB, Skjelland M, Sørensen KK, Rokstad AM, Yndestad A, Latz E, Gullestad L, Andersen GØ, Damås JK, Aukrust P, Mollnes TE, Halvorsen B, Espevik T (2020)
Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
EBioMedicine, 60, 102985
DOI 10.1016/j.ebiom.2020.102985, PubMed 32927275

Mirza Y, Prestgaard EE, Selmer R, Liestøl K, Grundvold I, Erikssen JE, Kjeldsen SE, Gjesdal K (2020)
[Ten-year prediction of cardiovascular disease in healthy Norwegian men, based on NORRISK-2]
Tidsskr Nor Laegeforen, 140 (12)
DOI 10.4045/tidsskr.20.0089, PubMed 32900157

Khatami M, Pope MK, Le Page S, Radic P, Schirripa V, Grundvold I, Atar D (2020)
Cardioversion Safety - Are We Doing Enough?
Cardiology, 145 (11), 740-745
DOI 10.1159/000509343, PubMed 32898849

Kluge KE, Langseth MS, Bratseth V, Pettersen AÅ, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2020)
Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease
Thromb Res, 196, 106-108
DOI 10.1016/j.thromres.2020.08.023, PubMed 32853976

Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2020)
Markers of remodeling in subcutaneous adipose tissue are strongly associated with overweight and insulin sensitivity in healthy non-obese men
Sci Rep, 10 (1), 14055
DOI 10.1038/s41598-020-71109-4, PubMed 32820223

Ihle-Hansen H, Berge T, Ernø PE, Rønning EJ, Svendsen J, Wien TN, Tveita A, Andersen EL, Thallinger M, Tveit A, Myrstad M (2020)
[Complications and mortality among patients hospitalised with COVID-19]
Tidsskr Nor Laegeforen, 140 (11)
DOI 10.4045/tidsskr.20.0432, PubMed 32815354

Zamorano JL, Gottfridsson C, Asteggiano R, Atar D, Badimon L, Bax JJ, Cardinale D, Cardone A, Feijen EAM, Ferdinandy P, López-Fernández T, Gale CP, Maduro JH, Moslehi J, Omland T, Plana Gomez JC, Scott J, Suter TM, Minotti G (2020)
The cancer patient and cardiology
Eur J Heart Fail, 22 (12), 2290-2309
DOI 10.1002/ejhf.1985, PubMed 32809231

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2020)
The International Society of Hypertension Guidelines 2020 - a new drug treatment recommendation in the wrong direction?
Blood Press, 29 (5), 264-266
DOI 10.1080/08037051.2020.1806494, PubMed 32808555

Eriksen-Volnes T, Westheim A, Gullestad L, Slind EK, Grundtvig M (2020)
β-Blocker Doses and Heart Rate in Patients with Heart Failure: Results from the National Norwegian Heart Failure Registry
Biomed Hub, 5 (1), 9-18
DOI 10.1159/000505474, PubMed 32775329

Johannessen TR, Vallersnes OM, Halvorsen S, Larstorp ACK, Mdala I, Atar D (2020)
Pre-hospital One-Hour Troponin in a Low-Prevalence Population of Acute Coronary Syndrome: OUT-ACS study
Open Heart, 7 (2)
DOI 10.1136/openhrt-2020-001296, PubMed 32719074

Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LM, Husebye T, Ivancan V, Karason K et al. (2020)
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
Card Fail Rev, 6, e19
DOI 10.15420/cfr.2020.03, PubMed 32714567

Ghanima W, Brodin E, Schultze A, Shepherd L, Lambrelli D, Ulvestad M, Ramagopalan S, Halvorsen S (2020)
Incidence and prevalence of venous thromboembolism in Norway 2010-2017
Thromb Res, 195, 165-168
DOI 10.1016/j.thromres.2020.07.011, PubMed 32707359

Bassand JP, Apenteng PN, Atar D, Camm AJ, Cools F, Corbalan R, Fitzmaurice DA, Fox KA, Goto S, Haas S, Hacke W, Jerjes-Sanchez C, Koretsune Y, Heuzey JL, Sawhney JP, Oh S, Stępińska J, Cate VT, Verheugt FW, Kayani G, Pieper KS, Kakkar AK, Garfield-Af Investigators FT (2020)
GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke
Future Cardiol, 17 (1), 19-38
DOI 10.2217/fca-2020-0014, PubMed 32696663

Hilde JM, Hisdal J, Skjørten I, Hansteen V, Melsom MN, Grøtta OJ, Småstuen MC, Seljeflot I, Arnesen H, Humerfelt S, Steine K (2020)
Left ventricular dysfunction in COPD without pulmonary hypertension
PLoS One, 15 (7), e0235075
DOI 10.1371/journal.pone.0235075, PubMed 32673327

Birnbaum Y, Levine GN, French J, Kaski JC, Atar D, Alam M, Hasdai D, Jneid H, Uretsky BF (2020)
Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?
Cardiovasc Drugs Ther, 34 (6), 865-870
DOI 10.1007/s10557-020-07039-0, PubMed 32671603

Agewall S (2020)
Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome?
Eur Heart J Cardiovasc Pharmacother, 6 (4), 201-202
DOI 10.1093/ehjcvp/pvaa075, PubMed 32668002

Wang X, Moullaali TJ, Li Q, Berge E, Robinson TG, Lindley R, Zheng D, Delcourt C, Arima H, Song L, Chen X, Yang J, Chalmers J, Anderson CS, Sandset EC (2020)
Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients
Stroke, 51 (8), 2411-2417
DOI 10.1161/STROKEAHA.119.028523, PubMed 32640944

Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LMA, Husebye T, Ivancan V, Karason K et al. (2020)
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
J Cardiovasc Pharmacol, 76 (1), 4-22
DOI 10.1097/FJC.0000000000000859, PubMed 32639325

Burnier M, Kreutz R, Narkiewicz K, Kjeldsen S, Oparil S, Mancia G (2020)
Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning?
J Hypertens, 38 (8), 1396-1406
DOI 10.1097/HJH.0000000000002532, PubMed 32618895

Sandven I, Eritsland J, Abdelnoor M (2020)
Remote Ischemic Conditioning in Patients with Acute Coronary Syndromes: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
Clin Epidemiol, 12, 595-605
DOI 10.2147/CLEP.S249785, PubMed 32606985

Pope MK, Ghanima W, Atar D (2020)
Intensification of antithrombotic therapy for chronic atherosclerosis
Tidsskr Nor Laegeforen, 140 (10)
DOI 10.4045/tidsskr.20.0066, PubMed 32602309

Stensjøen AL, Hommerstad A, Halvorsen S, Arheden H, Engblom H, Erlinge D, Larsen AI, Sejersten Ripa M, Clemmensen P, Atar D, Hall TS (2020)
Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Ann Noninvasive Electrocardiol, 25 (6), e12784
DOI 10.1111/anec.12784, PubMed 32592427

Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Julius S, Devereux RB (2020)
On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy
Blood Press, 29 (5), 319-326
DOI 10.1080/08037051.2020.1782171, PubMed 32586143

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2020)
Intensive systolic blood pressure control and prevention of new onset atrial fibrillation in the SPRINT study: is the association really controversial?
Blood Press, 29 (4), 199-201
DOI 10.1080/08037051.2020.1782595, PubMed 32584173

Malhotra K, Katsanos AH, Goyal N, Tayal A, Gensicke H, Mitsias PD, De Marchis GM, Berge E, Alexandrov AW, Alexandrov AV, Tsivgoulis G (2020)
Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis
Neurology, 95 (2), e121-e130
DOI 10.1212/WNL.0000000000009756, PubMed 32554767

Willeit P, Tschiderer L, Allara E, Reuber K, Seekircher L, Gao L, Liao X, Lonn E, Gerstein HC, Yusuf S, Brouwers FP, Asselbergs FW, van Gilst W, Anderssen SA, Grobbee DE, Kastelein JJP, Visseren FLJ, Ntaios G, Hatzitolios AI, Savopoulos C, Nieuwkerk PT, Stroes E, Walters M, Higgins P, Dawson J et al. (2020)
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Circulation, 142 (7), 621-642
DOI 10.1161/CIRCULATIONAHA.120.046361, PubMed 32546049

Ødegaard KM, Hallén J, Lirhus SS, Melberg HO, Halvorsen S (2020)
Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016
ESC Heart Fail, 7 (4), 1917-1926
DOI 10.1002/ehf2.12773, PubMed 32530563

Kreutz R, Kjeldsen SE, Burnier M, Narkiewicz K, Oparil S, Mancia G (2020)
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project
J Hypertens (in press) (Retracted)
DOI 10.1097/HJH.0000000000002479, PubMed 32516290

Agewall S (2018)
Adherence to guidelines, compliance to treatment, and treatment quality
Eur Heart J Cardiovasc Pharmacother, 4 (4), 189-190
DOI 10.1093/ehjcvp/pvy033, PubMed 32420591

Bogsrud MP, Øyri LKL, Halvorsen S, Atar D, Leren TP, Holven KB (2020)
Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction
J Clin Lipidol, 14 (3), 339-345
DOI 10.1016/j.jacl.2020.04.002, PubMed 32418822

Agewall S (2020)
Focus on subpopulations of atrial fibrillation patients
Eur Heart J Cardiovasc Pharmacother, 6 (3), 131-132
DOI 10.1093/ehjcvp/pvaa034, PubMed 32412082

Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan GL, Gilard M, Halvorsen S, Huber K, James S, Neumann FJ, Möllmann H, Roffi M, Tavazzi G, Mauri Ferré J, Windecker S, Dudek D, Baumbach A (2020)
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
Eur Heart J, 41 (19), 1839-1851
DOI 10.1093/eurheartj/ehaa381, PubMed 32405641

Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan GL, Gilard M, Halvorsen S, Huber K, James S, Neumann FJ, Möllmann H, Roffi M, Tavazzi G, Ferré JM, Windecker S, Dudek D, Baumbach A (2020)
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
EuroIntervention, 16 (3), 233-246
DOI 10.4244/EIJY20M05_01, PubMed 32404302

Butt N, Bache-Mathiesen LK, Ushakova A, Nordrehaug JE, Jensen SE, Munk PS, Danchin N, Dubois-Rande JL, Hansen HS, Paganelli F, Corvoisier PL, Firat H, Erlinge D, Atar D, Larsen AI (2020)
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size
Eur Heart J Acute Cardiovasc Care, 9 (4), 302-312
DOI 10.1177/2048872620923641, PubMed 32403934

Holte KB, Svanteson M, Hanssen KF, Sveen KA, Seljeflot I, Solheim S, Sell DR, Monnier VM, Berg TJ (2020)
Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
PLoS One, 15 (5), e0233174
DOI 10.1371/journal.pone.0233174, PubMed 32401813

Kreutz R, Kjeldsen SE, Burnier M, Narkiewicz K, Oparil S, Mancia G (2020)
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project
Blood Press, 29 (3), 135-136
DOI 10.1080/08037051.2020.1747696, PubMed 32338542

Mehlum MH, Liestøl K, Kjeldsen SE, Wyller TB, Julius S, Rothwell PM, Mancia G, Parati G, Weber MA, Berge E (2020)
Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers
Hypertension, 75 (6), 1584-1592
DOI 10.1161/HYPERTENSIONAHA.119.14443, PubMed 32336236

Täger T, Atar D, Agewall S, Katus HA, Grundtvig M, Cleland JGF, Clark AL, Fröhlich H, Frankenstein L (2021)
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
Heart Fail Rev, 26 (6), 1421-1435
DOI 10.1007/s10741-020-09954-8, PubMed 32314085

Bratseth V, Margeirsdottir HD, Chiva-Blanch G, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
Annexin V⁺ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study
J Diabetes Res, 2020, 7216863
DOI 10.1155/2020/7216863, PubMed 32309448

Kluge KE, Langseth MS, Opstad TB, Pettersen AÅ, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2020)
Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease
Mediators Inflamm, 2020, 5080743
DOI 10.1155/2020/5080743, PubMed 32308555

Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Kjeldsen S, Grundvold I, Berge E (2020)
Change in Body Weight and Long-Term Risk of Stroke and Death in Healthy Men
Stroke, 51 (5), 1435-1441
DOI 10.1161/STROKEAHA.119.027233, PubMed 32268850

Danielsen SO, Moons P, Leegaard M, Solheim S, Tønnessen T, Lie I (2020)
Facilitators of and barriers to reducing thirty-day readmissions and improving patient-reported outcomes after surgical aortic valve replacement: a process evaluation of the AVRre trial
BMC Health Serv Res, 20 (1), 256
DOI 10.1186/s12913-020-05125-5, PubMed 32220252

Kummen M, Solberg OG, Storm-Larsen C, Holm K, Ragnarsson A, Trøseid M, Vestad B, Skårdal R, Yndestad A, Ueland T, Svardal A, Berge RK, Seljeflot I, Gullestad L, Karlsen TH, Aaberge L, Aukrust P, Hov JR (2020)
Rosuvastatin alters the genetic composition of the human gut microbiome
Sci Rep, 10 (1), 5397
DOI 10.1038/s41598-020-62261-y, PubMed 32214138

Mahfoud F, Azizi M, Ewen S, Pathak A, Ukena C, Blankestijn PJ, Böhm M, Burnier M, Chatellier G, Durand Zaleski I, Grassi G, Joner M, Kandzari DE, Kirtane A, Kjeldsen SE, Lobo MD, Lüscher TF, McEvoy JW, Parati G, Rossignol P, Ruilope L, Schlaich MP, Shahzad A, Sharif F, Sharp ASP et al. (2020)
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
Eur Heart J, 41 (16), 1588-1599
DOI 10.1093/eurheartj/ehaa121, PubMed 32211888

Kjeldsen SE, Halvorsen S, Wyller TB, Bath PM, Sandercock P (2020)
Eivind Berge, MD, PhD, 1964-2020: Cardiologist Who Was Fighting Stroke
Stroke, 51 (5), 1353-1355
DOI 10.1161/STROKEAHA.120.029351, PubMed 32200755

Langseth MS, Helseth R, Ritschel V, Hansen CH, Andersen GØ, Eritsland J, Halvorsen S, Fagerland MW, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2020)
Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
Sci Rep, 10 (1), 5007
DOI 10.1038/s41598-020-61971-7, PubMed 32193509

Jortveit J, Halvorsen S, Langørgen J (2020)
Pharmacy-dispensed drugs for secondary prevention after myocardial infarction
Tidsskr Nor Laegeforen, 140 (4)
DOI 10.4045/tidsskr.19.0416, PubMed 32192264

Agewall S (2020)
Lipids and antithrombotic treatment
Eur Heart J Cardiovasc Pharmacother, 6 (2), 71
DOI 10.1093/ehjcvp/pvaa014, PubMed 32176294

Jortveit J, Pripp AH, Langørgen J, Halvorsen S (2020)
Incidence, risk factors and outcome of young patients with myocardial infarction
Heart, 106 (18), 1420-1426
DOI 10.1136/heartjnl-2019-316067, PubMed 32111640

Bjørkavoll-Bergseth M, Kleiven Ø, Auestad B, Eftestøl T, Oskal K, Nygård M, Skadberg Ø, Aakre KM, Melberg T, Gjesdal K, Ørn S (2020)
Duration of Elevated Heart Rate Is an Important Predictor of Exercise-Induced Troponin Elevation
J Am Heart Assoc, 9 (4), e014408
DOI 10.1161/JAHA.119.014408, PubMed 32065043

Trøseid M, Andersen GØ, Broch K, Hov JR (2020)
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
EBioMedicine, 52, 102649
DOI 10.1016/j.ebiom.2020.102649, PubMed 32062353

Burnier M, Kjeldsen SE, Narkiewicz K, Oparil S (2020)
How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers
Blood Press, 29 (2), 68-69
DOI 10.1080/08037051.2020.1726101, PubMed 32049554

Gorog DA, Price S, Sibbing D, Baumbach A, Capodanno D, Gigante B, Halvorsen S, Huber K, Lettino M, Leonardi S, Morais J, Rubboli A, Siller-Matula JM, Storey RF, Vranckx P, Rocca B (2021)
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Eur Heart J Cardiovasc Pharmacother, 7 (2), 125-140
DOI 10.1093/ehjcvp/pvaa009, PubMed 32049278

Tancin Lambert A, Kong XY, Ratajczak-Tretel B, Atar D, Russell D, Skjelland M, Bjerkeli V, Skagen K, Coq M, Schordan E, Firat H, Halvorsen B, Aamodt AH (2020)
Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study
Cerebrovasc Dis Extra, 10 (1), 11-20
DOI 10.1159/000504529, PubMed 32028277

Herum KM, Romaine A, Wang A, Melleby AO, Strand ME, Pacheco J, Braathen B, Dunér P, Tønnessen T, Lunde IG, Sjaastad I, Brakebusch C, McCulloch AD, Gomez MF, Carlson CR, Christensen G (2020)
Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
J Am Heart Assoc, 9 (3), e013518
DOI 10.1161/JAHA.119.013518, PubMed 32000579

Klijn CJ, Paciaroni M, Berge E, Korompoki E, Kõrv J, Lal A, Putaala J, Werring DJ (2019)
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline
Eur Stroke J, 4 (3), 198-223
DOI 10.1177/2396987319841187, PubMed 31984228

Mayerhofer CCK, Kummen M, Holm K, Broch K, Awoyemi A, Vestad B, Storm-Larsen C, Seljeflot I, Ueland T, Bohov P, Berge RK, Svardal A, Gullestad L, Yndestad A, Aukrust P, Hov JR, Trøseid M (2020)
Low fibre intake is associated with gut microbiota alterations in chronic heart failure
ESC Heart Fail, 7 (2), 456-466
DOI 10.1002/ehf2.12596, PubMed 31978943

Gorenek B, Halvorsen S, Kudaiberdieva G, Bueno H, Van Gelder IC, Lettino M, Marin F, Masip J, Mueller C, Okutucu S, Poess J, Potpara TS, Price S, Lip GYH (2020)
Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology
Eur Heart J Acute Cardiovasc Care, 9 (4), 348-357
DOI 10.1177/2048872619894255, PubMed 31976747

Stepinska J, Lettino M, Ahrens I, Bueno H, Garcia-Castrillo L, Khoury A, Lancellotti P, Mueller C, Muenzel T, Oleksiak A, Petrino R, Guimenez MR, Zahger D, Vrints CJ, Halvorsen S, de Maria E, Lip GY, Rossini R, Claeys M, Huber K (2020)
Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association
Eur Heart J Acute Cardiovasc Care, 9 (1), 76-89
DOI 10.1177/2048872619885346, PubMed 31958018

Bittner VA, Szarek M, Aylward PE, Bhatt DL, Diaz R, Edelberg JM, Fras Z, Goodman SG, Halvorsen S, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Moriarty PM, Moryusef A, Pordy R, Roe MT, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GG et al. (2020)
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
J Am Coll Cardiol, 75 (2), 133-144
DOI 10.1016/j.jacc.2019.10.057, PubMed 31948641

Bratseth V, Margeirsdottir HD, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
Procoagulant activity in children and adolescents on intensive insulin therapy
Pediatr Diabetes, 21 (3), 496-504
DOI 10.1111/pedi.12978, PubMed 31943582

Rutherford OW, Jonasson C, Ghanima W, Söderdahl F, Halvorsen S (2020)
Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
Eur Heart J Cardiovasc Pharmacother, 6 (2), 75-85
DOI 10.1093/ehjcvp/pvz086, PubMed 31942972

Nakstad ER, Stær-Jensen H, Wimmer H, Henriksen J, Alteheld LH, Reichenbach A, Drægni T, Šaltytė-Benth J, Wilson JA, Etholm L, Øijordsbakken M, Eritsland J, Seljeflot I, Jacobsen D, Andersen GØ, Lundqvist C, Sunde K (2020)
Late awakening, prognostic factors and long-term outcome in out-of-hospital cardiac arrest - results of the prospective Norwegian Cardio-Respiratory Arrest Study (NORCAST)
Resuscitation, 149, 170-179
DOI 10.1016/j.resuscitation.2019.12.031, PubMed 31926258

Aamodt IT, Lycholip E, Celutkiene J, von Lueder T, Atar D, Falk RS, Hellesø R, Jaarsma T, Strömberg A, Lie I (2020)
Self-Care Monitoring of Heart Failure Symptoms and Lung Impedance at Home Following Hospital Discharge: Longitudinal Study
J Med Internet Res, 22 (1), e15445
DOI 10.2196/15445, PubMed 31909717

Agewall S (2020)
Focus on pharma in acute coronary syndrome
Eur Heart J Cardiovasc Pharmacother, 6 (1), 1-2
DOI 10.1093/ehjcvp/pvz074, PubMed 31909430

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2020)
The Health Outcomes Prevention and Evaluation 4 (HOPE 4) project: A successful community-based intervention to lower cardiovascular risk in people with hypertension
Blood Press, 29 (1), 1-2
DOI 10.1080/08037051.2020.1707440, PubMed 31902246

Tveit SH, Myhre PL, Hoff NJS, Le TM, Seljeflot I, Røysland R, Høiseth AD, Røsjø H, Omland T (2019)
Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study
Clin Biochem, 78, 10-17
DOI 10.1016/j.clinbiochem.2019.12.016, PubMed 31899280

Garcia DA, Fisher DA, Mulder H, Wruck L, De Caterina R, Halvorsen S, Granger CB, Held C, Wallentin L, Alexander JH, Lopes RD (2019)
Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Am Heart J, 221, 1-8
DOI 10.1016/j.ahj.2019.10.013, PubMed 31896036

Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial
Diabetol Metab Syndr, 11, 109
DOI 10.1186/s13098-019-0508-9, PubMed 31890043

Appleton JP, Woodhouse LJ, Adami A, Becker JL, Berge E, Cala LA, Casado AM, Caso V, Christensen HK, Dineen RA, Gommans J, Koumellis P, Szatmari S, Sprigg N, Bath PM, Wardlaw JM, ENOS Investigators (2019)
Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke
Neurology, 94 (5), e439-e452
DOI 10.1212/WNL.0000000000008881, PubMed 31882527

Kalstad AA, Tveit S, Myhre PL, Laake K, Opstad TB, Tveit A, Schmidt EB, Solheim S, Arnesen H, Seljeflot I (2019)
Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients
BMC Geriatr, 19 (1), 376
DOI 10.1186/s12877-019-1383-9, PubMed 31881852

Lunde NN, Gregersen I, Ueland T, Shetelig C, Holm S, Kong XY, Michelsen AE, Otterdal K, Yndestad A, Broch K, Gullestad L, Nyman TA, Bendz B, Eritsland J, Hoffmann P, Skagen K, Gonçalves I, Nilsson J, Grenegård M, Poreba M, Drag M, Seljeflot I, Sporsheim B, Espevik T, Skjelland M et al. (2019)
Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
Atherosclerosis, 296, 74-82
DOI 10.1016/j.atherosclerosis.2019.12.008, PubMed 31870625

Piira A, Lannem AM, Gjesdal K, Knutsen R, Jørgensen L, Glott T, Hjeltnes N, Knutsen SF, Sørensen M (2019)
Quality of life and psychological outcomes of body-weight supported locomotor training in spinal cord injured persons with long-standing incomplete lesions
Spinal Cord, 58 (5), 560-569
DOI 10.1038/s41393-019-0401-2, PubMed 31848443

Kotecha D, Gill SK, Flather MD, Holmes J, Packer M, Rosano G, Böhm M, McMurray JJV, Wikstrand J, Anker SD, van Veldhuisen DJ, Manzano L, von Lueder TG, Rigby AS, Andersson B, Kjekshus J, Wedel H, Ruschitzka F, Cleland JGF, Damman K, Redon J, Coats AJS, Beta-Blockers in Heart Failure Collaborative Group (2019)
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
J Am Coll Cardiol, 74 (23), 2893-2904
DOI 10.1016/j.jacc.2019.09.059, PubMed 31806133

Opstad TB, Kalstad AA, Holte KB, Berg TJ, Solheim S, Arnesen H, Seljeflot I (2020)
Shorter Leukocyte Telomere Lengths in Healthy Relatives of Patients with Coronary Heart Disease
Rejuvenation Res, 23 (4), 324-332
DOI 10.1089/rej.2019.2258, PubMed 31805818

Karlsen H, Bergan HA, Halvorsen PS, Sunde K, Qvigstad E, Andersen GØ, Bugge JF, Olasveengen TM (2019)
Esmolol for cardioprotection during resuscitation with adrenaline in an ischaemic porcine cardiac arrest model
Intensive Care Med Exp, 7 (1), 65
DOI 10.1186/s40635-019-0279-5, PubMed 31802327

Kjeldsen SE, von Lueder TG, Smiseth OA, Wachtell K, Mistry N, Westheim AS, Hopper I, Julius S, Pitt B, Reid CM, Devereux RB, Zannad F (2019)
Medical Therapies for Heart Failure With Preserved Ejection Fraction
Hypertension, 75 (1), 23-32
DOI 10.1161/HYPERTENSIONAHA.119.14057, PubMed 31786973

Helseth R, Shetelig C, Andersen GØ, Langseth MS, Limalanathan S, Opstad TB, Arnesen H, Hoffmann P, Eritsland J, Seljeflot I (2019)
Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
Mediators Inflamm, 2019, 7816491
DOI 10.1155/2019/7816491, PubMed 31772506

Kjeldsen SE, Os I (2020)
Assessing hypertension therapies: randomization or confounding by indication?
Nat Rev Cardiol, 17 (2), 73-74
DOI 10.1038/s41569-019-0313-z, PubMed 31768007

Atar D, Berge E, Le Heuzey JY, Virdone S, Camm AJ, Steffel J, Gibbs H, Goldhaber SZ, Goto S, Kayani G, Misselwitz F, Stepinska J, Turpie AGG, Bassand JP, Kakkar AK, GARFIELD-AF Investigators (2020)
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
Europace, 22 (2), 195-204
DOI 10.1093/europace/euz292, PubMed 31747004

Berntsen KS, Raastad T, Marstein H, Kirkhus E, Merckoll E, Cumming KT, Flatø B, Sjaastad I, Sanner H (2020)
Functional and Structural Adaptations of Skeletal Muscle in Long-Term Juvenile Dermatomyositis: A Controlled Cross-Sectional Study
Arthritis Rheumatol, 72 (5), 837-848
DOI 10.1002/art.41174, PubMed 31746550

Marstein H, Schwartz T, Aaløkken TM, Lund MB, Flatø B, Sjaastad I, Sanner H (2020)
Novel associations between cytokines and pulmonary involvement in juvenile dermatomyositis - a cross-sectional study of long-term disease
Rheumatology (Oxford), 59 (8), 1862-1870
DOI 10.1093/rheumatology/kez531, PubMed 31740970

Mariampillai JE, Liestøl K, Kjeldsen SE, Prestgaard EE, Engeseth K, Bodegard J, Berge E, Gjesdal K, Erikssen J, Grundvold I, Skretteberg PT (2019)
Exercise Systolic Blood Pressure at Moderate Workload Is Linearly Associated With Coronary Disease Risk in Healthy Men
Hypertension, 75 (1), 44-50
DOI 10.1161/HYPERTENSIONAHA.119.13528, PubMed 31735088

Carcel C, Wang X, Sandset EC, Delcourt C, Arima H, Lindley R, Hackett ML, Lavados P, Robinson TG, Muñoz Venturelli P, Olavarría VV, Brunser A, Berge E, Chalmers J, Woodward M, Anderson CS (2019)
Sex differences in treatment and outcome after stroke: Pooled analysis including 19,000 participants
Neurology, 93 (24), e2170-e2180
DOI 10.1212/WNL.0000000000008615, PubMed 31719135

Bjørnnes AK, Moons P, Parry M, Halvorsen S, Tønnessen T, Lie I (2019)
Experiences of informal caregivers after cardiac surgery: a systematic integrated review of qualitative and quantitative studies
BMJ Open, 9 (11), e032751
DOI 10.1136/bmjopen-2019-032751, PubMed 31719093

Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
Blood Press, 29 (2), 123-134
DOI 10.1080/08037051.2019.1684817, PubMed 31718316

Bhatt AS, Luo N, Solomon N, Pagidipati NJ, Ambrosio G, Green JB, McGuire DK, Standl E, Cornel JH, Halvorsen S, Lopes RD, White HD, Holman RR, Peterson ED, Mentz RJ, TECOS Study Group (2019)
International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS
Am Heart J, 218, 57-65
DOI 10.1016/j.ahj.2019.08.016, PubMed 31707329

Kvakkestad KM, Gran JM, Eritsland J, Holst Hansen C, Fossum E, Andersen GØ, Halvorsen S (2019)
Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study
Cardiology, 144 (3-4), 79-89
DOI 10.1159/000503442, PubMed 31689705

Pollesello P, Ben Gal T, Bettex D, Cerny V, Comin-Colet J, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Harjola VP, Herpain A, Heringlake M, Heunks L, Husebye T, Ivancan V, Karason K, Kaul S, Kubica J, Mebazaa A, Mølgaard H, Parissis J, Parkhomenko A, Põder P, Pölzl G, Vrtovec B et al. (2019)
Short-Term Therapies for Treatment of Acute and Advanced Heart Failure-Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
J Clin Med, 8 (11)
DOI 10.3390/jcm8111834, PubMed 31683969

Gelbenegger G, Postula M, Pecen L, Halvorsen S, Lesiak M, Schoergenhofer C, Jilma B, Hengstenberg C, Siller-Matula JM (2019)
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
BMC Med, 17 (1), 198
DOI 10.1186/s12916-019-1428-0, PubMed 31679516

Anstensrud AK, Woxholt S, Sharma K, Broch K, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2019)
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
Open Heart, 6 (2), e001108
DOI 10.1136/openhrt-2019-001108, PubMed 31673391

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2019)
Systolic blood pressure control prevents cognitive decline and slows development of white matter lesions in the brain: the SPRINT MIND study outcomes
Blood Press, 28 (6), 356-357
DOI 10.1080/08037051.2019.1678261, PubMed 31623467

Bahls M, Lorenz MW, Dörr M, Gao L, Kitagawa K, Tuomainen TP, Agewall S, Berenson G, Catapano AL, Norata GD, Bots ML, van Gilst W, Asselbergs FW, Brouwers FP, Uthoff H, Sander D, Poppert H, Hecht Olsen M, Empana JP, Schminke U, Baldassarre D, Veglia F, Franco OH, Kavousi M, de Groot E et al. (2019)
Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium
Eur J Prev Cardiol, 27 (3), 234-243
DOI 10.1177/2047487319877078, PubMed 31619084

Helseth R, Knudsen EC, Eritsland J, Opstad TB, Arnesen H, Andersen GØ, Seljeflot I (2019)
Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
BMC Cardiovasc Disord, 19 (1), 221
DOI 10.1186/s12872-019-1205-1, PubMed 31615411

Kjeldsen SE, Os I (2020)
Poor reproducibility of masked and white coat uncontrolled hypertension: important new information on MUCH and WUCH
Eur Heart J, 41 (16), 1572-1574
DOI 10.1093/eurheartj/ehz703, PubMed 31580419

Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J et al. (2019)
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Circulation, 140 (23), 1921-1932
DOI 10.1161/CIRCULATIONAHA.119.043308, PubMed 31557056

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2019)
The PARAGON-Heart failure trial - another disappointment for heart failure patients with hypertension and preserved ejection fraction
Blood Press, 28 (5), 276-278
DOI 10.1080/08037051.2019.1664717, PubMed 31542958

Agewall S (2019)
European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723
Eur Heart J Cardiovasc Pharmacother, 5 (4), 183-184
DOI 10.1093/ehjcvp/pvz041, PubMed 31531677

Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ et al. (2020)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Eur Heart J, 41 (3), 407-477
DOI 10.1093/eurheartj/ehz425, PubMed 31504439

Marciniak TA, Atar D, Serebruany V (2019)
Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?
Am J Med, 133 (3), 347-351
DOI 10.1016/j.amjmed.2019.07.046, PubMed 31442391

Allencherril J, Jneid H, Atar D, Alam M, Levine G, Kloner RA, Birnbaum Y (2019)
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon
Cardiovasc Drugs Ther, 33 (5), 589-597
DOI 10.1007/s10557-019-06901-0, PubMed 31418141

Hollan I, Ronda N, Dessein P, Agewall S, Karpouzas G, Tamargo J, Niessner A, Savarese G, Rosano G, Kaski JC, Wassmann S, Meroni PL (2020)
Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 6 (2), 104-114
DOI 10.1093/ehjcvp/pvz033, PubMed 31397840

Savarese G, Reiner MF, Uijl A, D'Amario D, Agewall S, Atar D, Baumgartner I, Borghi C, De Carlo M, Drexel H, Kaski JC, Kjeldsen KP, Kucher N, Lund LH, Niessner A, Semb AG, Schmidt TA, Sulzgruber P, Tamargo J, Vitale C, Wassmann S, Aboyans V, Lewis BS (2020)
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
Eur Heart J Cardiovasc Pharmacother, 6 (2), 86-93
DOI 10.1093/ehjcvp/pvz036, PubMed 31392312

Danielsen SO, Moons P, Sandvik L, Leegaard M, Solheim S, Tønnessen T, Lie I (2019)
Impact of telephone follow-up and 24/7 hotline on 30-day readmission rates following aortic valve replacement -A randomized controlled trial
Int J Cardiol, 300, 66-72
DOI 10.1016/j.ijcard.2019.07.087, PubMed 31387822

Al-Ani A, Hoffmann P, von Lueder T, Opdahl A (2019)
Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation
Catheter Cardiovasc Interv, 95 (6), 1171-1175
DOI 10.1002/ccd.28419, PubMed 31379116

Frankenstein L, Seide S, Täger T, Jensen K, Fröhlich H, Clark AL, Seiz M, Katus HA, Nee P, Uhlmann L, Naci H, Atar D (2020)
Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials
Heart Fail Rev, 25 (2), 161-171
DOI 10.1007/s10741-019-09832-y, PubMed 31364027

Fox KAA, Metra M, Morais J, Atar D (2019)
The myth of 'stable' coronary artery disease
Nat Rev Cardiol, 17 (1), 9-21
DOI 10.1038/s41569-019-0233-y, PubMed 31358978

Marti HP, Serebruany V, Atar D (2019)
Challenging Anticoagulation in Advanced Renal Failure
Am J Med, 132 (11), 1258-1259
DOI 10.1016/j.amjmed.2019.07.002, PubMed 31356767

Hokstad I, Deyab G, Wang Fagerland M, Lyberg T, Hjeltnes G, Førre Ø, Agewall S, Mollnes TE, Hollan I (2019)
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
PLoS One, 14 (7), e0220079
DOI 10.1371/journal.pone.0220079, PubMed 31335881

Kjeldsen SE, Os I (2019)
Are People With Masked Hypertension Adherent to Their Antihypertensive Medication?
Hypertension, 74 (3), 497-498
DOI 10.1161/HYPERTENSIONAHA.119.13350, PubMed 31327260

Ahrens I, Averkov O, Zúñiga EC, Fong AYY, Alhabib KF, Halvorsen S, Abdul Kader MABSK, Sanz-Ruiz R, Welsh R, Yan H, Aylward P (2019)
Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox
Clin Cardiol, 42 (10), 1028-1040
DOI 10.1002/clc.23232, PubMed 31317575

Verheugt FWA, Ambrosio G, Atar D, Bassand JP, Camm AJ, Costabel JP, Fitzmaurice DA, Illingworth L, Goldhaber SZ, Goto S, Haas S, Jansky P, Kayani G, Stepinska J, Turpie AGG, van Eickels M, Kakkar AK, GARFIELD-AF Investigators (2019)
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF
Am J Med, 132 (12), 1431-1440.e7
DOI 10.1016/j.amjmed.2019.06.008, PubMed 31306621

Pradhan B, Kjellstrom T, Atar D, Sharma P, Kayastha B, Bhandari G, Pradhan PK (2019)
Heat Stress Impacts on Cardiac Mortality in Nepali Migrant Workers in Qatar
Cardiology, 143 (1), 37-48
DOI 10.1159/000500853, PubMed 31302648

Drexel H, Rosano GMC, Lewis BS, Huber K, Vonbank A, Dopheide JF, Mader A, Niessner A, Savarese G, Wassmann S, Agewall S (2020)
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials
Eur Heart J Cardiovasc Pharmacother, 6 (2), 97-103
DOI 10.1093/ehjcvp/pvz029, PubMed 31298686

Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Solomon SD, Dickstein K, Atar D, Agewall S, Girerd N, High-Risk Myocardial Infarction Database Initiative investigators (2019)
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
Am Heart J, 215, 83-90
DOI 10.1016/j.ahj.2019.06.004, PubMed 31291604

Abdelnoor M, Sandven I, Vengen Ø, Risnes I (2019)
Mediastinitis in open heart surgery: a systematic review and meta-analysis of risk factors
Scand Cardiovasc J, 53 (5), 226-234
DOI 10.1080/14017431.2019.1642508, PubMed 31290699

Nordlund D, Engblom H, Bonnet JL, Hansen HS, Atar D, Erlinge D, Ekelund U, Heiberg E, Carlsson M, Arheden H (2019)
Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients - data from the CHILL-MI, MITOCARE and SOCCER trials
BMC Cardiovasc Disord, 19 (1), 161
DOI 10.1186/s12872-019-1139-7, PubMed 31269907

Ratajczak-Tretel B, Lambert AT, Johansen H, Halvorsen B, Bjerkeli V, Russell D, Sandset EC, Ihle-Hansen H, Eriksen E, Næss H, Novotny V, Khanevski AN, Truelsen TC, Idicula T, Ægidius KL, Tobro H, Krogseth SB, Ihle-Hansen H, Hagberg G, Kruuse C, Arntzen K, Bakkejord GK, Villseth M, Nakstad I, Eldøen G et al. (2019)
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design
Eur Stroke J, 4 (2), 172-180
DOI 10.1177/2396987319837089, PubMed 31259265

Sandset EC, Appleton JP, Berge E, Christensen H, Gommans J, Krishnan K, Ntaios G, Phillips S, Pocock S, Sprigg N, Woodhouse LJ, Bath PM, ENOS trial investigators* (2019)
Associations between change in blood pressure and functional outcome, early events and death: results from the Efficacy of Nitric Oxide in Stroke trial
J Hypertens, 37 (10), 2104-2109
DOI 10.1097/HJH.0000000000002154, PubMed 31246895

Mohammadzadeh N, Lunde IG, Andenæs K, Strand ME, Aronsen JM, Skrbic B, Marstein HS, Bandlien C, Nygård S, Gorham J, Sjaastad I, Chakravarti S, Christensen G, Engebretsen KVT, Tønnessen T (2019)
The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload
Sci Rep, 9 (1), 9206
DOI 10.1038/s41598-019-45651-9, PubMed 31235849

Agewall S (2019)
Antiplatelet treatment in acute coronary syndrome. Still an issue
Eur Heart J Cardiovasc Pharmacother, 5 (3), 125-126
DOI 10.1093/ehjcvp/pvz018, PubMed 31210265

Warlo EMK, Arnesen H, Seljeflot I (2019)
A brief review on resistance to P2Y₁₂ receptor antagonism in coronary artery disease
Thromb J, 17, 11
DOI 10.1186/s12959-019-0197-5, PubMed 31198410

Fossum S, Næss Ø, Halvorsen S, Tell GS, Vikanes ÅV (2019)
Long-term cardiovascular morbidity following hyperemesis gravidarum: A Norwegian nationwide cohort study
PLoS One, 14 (6), e0218051
DOI 10.1371/journal.pone.0218051, PubMed 31188868

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2019)
The PARAGON Heart Failure trial - ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction
Blood Press, 28 (4), 215-216
DOI 10.1080/08037051.2019.1625523, PubMed 31184508

Jusufovic M, Berge TE, Guo R, You S, Delcourt C, Anderson C, Bath PM, Karlson BW, Berge E, Sandset EC, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2019)
Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage
J Stroke Cerebrovasc Dis, 28 (8), 2262-2267
DOI 10.1016/j.jstrokecerebrovasdis.2019.05.010, PubMed 31178359

Kvisvik B, Aagaard EN, Mørkrid L, Røsjø H, Lyngbakken M, Smedsrud MK, Eek C, Bendz B, Haugaa KH, Edvardsen T, Gravning J (2019)
Mechanical dispersion as a marker of left ventricular dysfunction and prognosis in stable coronary artery disease
Int J Cardiovasc Imaging, 35 (7), 1265-1275
DOI 10.1007/s10554-019-01583-z, PubMed 31165941

Aimo A, Januzzi JL, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C et al. (2019)
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome
Eur J Prev Cardiol, 26 (16), 1751-1759
DOI 10.1177/2047487319852809, PubMed 31154828

Gerdts E, Saeed S, Midtbø H, Rossebø A, Chambers JB, Einarsen E, Bahlmann E, Devereux R (2019)
Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis
Heart, 105 (21), 1629-1633
DOI 10.1136/heartjnl-2018-314462, PubMed 31154431

von Lueder TG, Atar D, Agewall S, Jensen JK, Hopper I, Kotecha D, Mentz RJ, Kim MH, Serebruany VL (2019)
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
Am J Ther, 26 (6), e671-e678
DOI 10.1097/MJT.0000000000000883, PubMed 31145139

Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A (2019)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Eur Heart J Cardiovasc Pharmacother, 5 (3), 171-180
DOI 10.1093/ehjcvp/pvz016, PubMed 31119266

Ellingsen DG, Chashchin M, Seljeflot I, Berlinger B, Chashchin V, Stockfelt L, Thomassen Y (2019)
A study of atherothrombotic biomarkers in welders
Int Arch Occup Environ Health, 92 (7), 1023-1031
DOI 10.1007/s00420-019-01441-4, PubMed 31114965

Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2019)
High Adherence to the Nordic Diet Is Associated with Lower Levels of Total and Platelet-Derived Circulating Microvesicles in a Norwegian Population
Nutrients, 11 (5)
DOI 10.3390/nu11051114, PubMed 31109111

Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2019)
Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population
Atherosclerosis, 286, 53-59
DOI 10.1016/j.atherosclerosis.2019.05.004, PubMed 31100620

Fernandes A, McEvoy JW, Halvorsen S (2019)
"Doctor, Should I Keep Taking an Aspirin a Day?"
N Engl J Med, 380 (20), 1967-1970
DOI 10.1056/NEJMclde1903004, PubMed 31091380

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2019)
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited
Blood Press, 28 (3), 144-145
DOI 10.1080/08037051.2019.1614278, PubMed 31076016

Hjort M, Eggers KM, Lindhagen L, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Malmqvist K, Spaak J, Sörensson P, Y-Hassan S, Tornvall P, Lindahl B (2019)
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries
Clin Chem, 65 (8), 1023-1030
DOI 10.1373/clinchem.2018.301085, PubMed 31072836

Mayerhofer CCK, Awoyemi A, Hov JR, Trøseid M, Broch K (2019)
Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure
ESC Heart Fail, 6 (3), 557-558
DOI 10.1002/ehf2.12437, PubMed 31034162

Bratseth V, Chiva-Blanch G, Byrkjeland R, Solheim S, Arnesen H, Seljeflot I (2019)
Elevated levels of circulating microvesicles in coronary artery disease patients with type 2 diabetes and albuminuria: Effects of exercise training
Diab Vasc Dis Res, 16 (5), 431-439
DOI 10.1177/1479164119843094, PubMed 31023084

Cwikiel J, Seljeflot I, Fagerland MW, Wachtell K, Arnesen H, Berge E, Flaa A (2019)
High-sensitive cardiac Troponin T and exercise stress test for evaluation of angiographically significant coronary disease
Int J Cardiol, 287, 1-6
DOI 10.1016/j.ijcard.2019.04.019, PubMed 31006595

Hausvater A, Pasupathy S, Tornvall P, Gandhi H, Tavella R, Beltrame J, Agewall S, Ekenbäck C, Brolin EB, Hochman JS, Collste O, Reynolds HR (2019)
ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries
Int J Cardiol, 287, 128-131
DOI 10.1016/j.ijcard.2019.04.028, PubMed 31003795

Knudsen EC, Seljeflot I, Aksnes TA, Eritsland J, Arnesen H, Andersen GØ (2019)
IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
PLoS One, 14 (4), e0215640
DOI 10.1371/journal.pone.0215640, PubMed 31002684

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2018)
Take a Blood Pressure Pill or Benefit from Renal Denervation?
Eur Heart J, 39 (33), 3010-3012
DOI 10.1093/eurheartj/ehy440, PubMed 30990870

Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, Lunde IG, Wakimoto H, Smith AM, Toepfer CN, Getz K, Gorham J, Patel P, Ito K, Willcox JA, Arany Z, Li J, Owens AT, Govind R, Nuñez B, Mazaika E, Bayes-Genis A, Walsh R, Finkelman B, Lupon J, Whiffin N, Serrano I, Midwinter W et al. (2019)
Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy
Circulation, 140 (1), 31-41
DOI 10.1161/CIRCULATIONAHA.118.037934, PubMed 30987448

Jortveit J, Pripp AH, Langørgen J, Halvorsen S (2019)
Poor adherence to guideline recommendations among patients with atrial fibrillation and acute myocardial infarction
Eur J Prev Cardiol, 26 (13), 1373-1382
DOI 10.1177/2047487319841940, PubMed 30966816

Strømnes LA, Ree H, Gjesdal K, Ariansen I (2019)
Sex Differences in Quality of Life in Patients With Atrial Fibrillation: A Systematic Review
J Am Heart Assoc, 8 (8), e010992
DOI 10.1161/JAHA.118.010992, PubMed 30957624

Kjeldsen SE, Fadl Elmula FEM, Persu A (2019)
Future of Renal Sympathetic Denervation in the Treatment of Hypertension
J Am Coll Cardiol, 73 (13), 1643-1645
DOI 10.1016/j.jacc.2019.02.008, PubMed 30947916

Kotecha D, Flather MD, Atar D, Collins P, Pepper J, Jenkins E, Reid CM, Eccleston D, Alternative Risk Markers in Coronary Artery Disease (ARM-CAD) Study (2019)
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease
BMC Med, 17 (1), 72
DOI 10.1186/s12916-019-1306-9, PubMed 30943979

Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
Effects of exercise training on inflammasome-related mediators and their associations to glucometabolic variables in patients with combined coronary artery disease and type 2 diabetes mellitus: Sub-study of a randomized control trial
Diab Vasc Dis Res, 16 (4), 360-368
DOI 10.1177/1479164119836922, PubMed 30939905

Hoffmann P, Al-Ani A, von Lueder T, Skoe ØW, Tran TT, Opdahl A (2018)
Late Pseudoaneurysm After Access Site Closure with Manta in Transfemoral Aortic Valve Implantation
EJVES Short Rep, 42, 34-36
DOI 10.1016/j.ejvssr.2018.10.003, PubMed 30931405

Jortveit J, Halvorsen S, Kaldal A, Pripp AH, Govatsmark RES, Langørgen J (2019)
Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease
BMC Cardiovasc Disord, 19 (1), 71
DOI 10.1186/s12872-019-1062-y, PubMed 30922234

Smiseth OA, Kjeldsen SE, Andersen ØS, Mistry N, Westheim AS, Skulstad H, Gude E (2019)
[Heart failure with preserved ejection fraction]
Tidsskr Nor Laegeforen, 139 (6)
DOI 10.4045/tidsskr.18.0523, PubMed 30917641

Schultz NH, Holme PA, Henriksson CE, Mowinckel MC, Sandset PM, Bratseth V, Jacobsen EM (2019)
The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
Thromb Res, 177, 154-156
DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875

Hov KR, Neerland BE, Undseth Ø, Wyller VBB, MacLullich AMJ, Qvigstad E, Skovlund E, Wyller TB (2019)
The Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial
Int J Geriatr Psychiatry, 34 (7), 974-981
DOI 10.1002/gps.5098, PubMed 30901487

Piira A, Lannem AM, Sørensen M, Glott T, Knutsen R, Jørgensen L, Gjesdal K, Hjeltnes N, Knutsen SF (2019)
Robot-assisted locomotor training did not improve walking function in patients with chronic incomplete spinal cord injury: A randomized clinical trial
J Rehabil Med, 51 (5), 385-389
DOI 10.2340/16501977-2547, PubMed 30895326

Witczak BN, Hetlevik SO, Sanner H, Barth Z, Schwartz T, Flatø B, Lilleby V, Sjaastad I (2019)
Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study
J Rheumatol, 46 (7), 739-747
DOI 10.3899/jrheum.180526, PubMed 30877222

Agewall S (2019)
European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor
Eur Heart J Cardiovasc Pharmacother, 5 (2), 59
DOI 10.1093/ehjcvp/pvz009, PubMed 30874813

Agewall S (2019)
Unsolved issues in oral anticoagulation treatment in atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 5 (2), 60-61
DOI 10.1093/ehjcvp/pvz008, PubMed 30874812

Atar D (2019)
Editor's Note
Cardiology, 142 (1), 1
DOI 10.1159/000497089, PubMed 30852568

Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ (2019)
Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
J Diabetes Complications, 33 (5), 383-389
DOI 10.1016/j.jdiacomp.2019.01.006, PubMed 30846232

Rosano GMC, Spoletini I, Agewall S (2019)
Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
Eur Heart J Suppl, 21 (Suppl A), A28-A33
DOI 10.1093/eurheartj/suy035, PubMed 30837802

Täger T, Fröhlich H, Grundtvig M, Seiz M, Schellberg D, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L (2019)
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis
Int J Cardiol, 289, 83-90
DOI 10.1016/j.ijcard.2019.01.109, PubMed 30827731

Serebruany VL, Marciniak TA, Atar D (2019)
Predicting clinical outcomes after clopidogrel use: easier to postulate than to prove and implement
Pol Arch Intern Med, 129 (2), 78-79
DOI 10.20452/pamw.4467, PubMed 30816102

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2019)
Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?
Blood Press, 28 (2), 75-76
DOI 10.1080/08037051.2019.1584975, PubMed 30806086

Fröhlich H, Rosenfeld N, Täger T, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L, Grundtvig M (2019)
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe
Heart, 105 (16), 1252-1259
DOI 10.1136/heartjnl-2018-314256, PubMed 30792238

Solberg OG, Stavem K, Ragnarsson A, Beitnes JO, Skårdal R, Seljeflot I, Ueland T, Aukrust P, Gullestad L, Aaberge L (2019)
Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
Catheter Cardiovasc Interv, 94 (5), 660-668
DOI 10.1002/ccd.28157, PubMed 30790446

Steen T, Sciaraffia E, Normand C, Bogale N, Dickstein K, Linde C, Philbert BT (2019)
Contemporary practice of CRT implantation in scandinavia compared to Europe
Scand Cardiovasc J, 53 (1), 9-13
DOI 10.1080/14017431.2019.1583364, PubMed 30761919

Atar D, Grundvold I (2019)
On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient?
Eur Heart J, 40 (19), 1501-1503
DOI 10.1093/eurheartj/ehz014, PubMed 30753396

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation: Vet the Message!
J Cardiovasc Pharmacol, 73 (2), 61-62
DOI 10.1097/FJC.0000000000000648, PubMed 30730472

Aamodt IT, Lycholip E, Celutkiene J, Strömberg A, Atar D, Falk RS, von Lueder T, Hellesø R, Jaarsma T, Lie I (2019)
Health Care Professionals' Perceptions of Home Telemonitoring in Heart Failure Care: Cross-Sectional Survey
J Med Internet Res, 21 (2), e10362
DOI 10.2196/10362, PubMed 30724744

Burnier M, Narkiewicz K, Kjeldsen SE, Oparil S (2019)
New data on antihypertensive drugs and risk of cancer: should we worry?
Blood Press, 28 (1), 1-3
DOI 10.1080/08037051.2019.1568182, PubMed 30714837

Søraas A, Matsuyama M, de Lima M, Wald D, Buechner J, Gedde-Dahl T, Søraas CL, Chen B, Ferrucci L, Dahl JA, Horvath S, Matsuyama S (2019)
Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells
Aging Cell, 18 (2), e12897
DOI 10.1111/acel.12897, PubMed 30712319

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: Vet the message!
Heart Rhythm, 16 (3), 332-333
DOI 10.1016/j.hrthm.2018.12.030, PubMed 30703343

Kjeldsen SE, Atar D, von Lueder TG (2019)
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (2), 122-123
DOI 10.1093/ehjcvp/pvz005, PubMed 30698668

Stokke IM, Li ZB, Cicala S, Okin PM, Kjeldsen SE, Devereux RB, Wachtell K (2019)
Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study
Blood Press, 28 (2), 84-92
DOI 10.1080/08037051.2019.1569463, PubMed 30698038

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: vet the message!
Eur Heart J Qual Care Clin Outcomes, 5 (2), 83-84
DOI 10.1093/ehjqcco/qcy057, PubMed 30689789

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: vet the message!
Eur Heart J Cardiovasc Pharmacother, 5 (2), 62-63
DOI 10.1093/ehjcvp/pvz001, PubMed 30689786

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: vet the message!
Cardiovasc Res, 115 (14), e187-e188
DOI 10.1093/cvr/cvz007, PubMed 30689762

Opstad TB, Kalstad AA, Pettersen AÅ, Arnesen H, Seljeflot I (2019)
Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease
Exp Gerontol, 119, 53-60
DOI 10.1016/j.exger.2019.01.020, PubMed 30684534

Hoffmann P, Al-Ani A, von Lueder T, Hoffmann J, Majak P, Hagen O, Loose H, Kløw NE, Opdahl A (2018)
Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide
CVIR Endovasc, 1 (1), 20
DOI 10.1186/s42155-018-0026-0, PubMed 30652151

Braathen B, Husebye T, Lunde IG, Tønnessen T (2018)
Trifecta has lower gradient and less prosthesis-patient mismatch than Mosaic Ultra in the aortic position: A prospective randomized study
J Thorac Cardiovasc Surg, 158 (4), 1032-1039
DOI 10.1016/j.jtcvs.2018.11.020, PubMed 30635187

Egan BM, Kjeldsen SE, Grassi G, Esler M, Mancia G (2019)
The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard?
J Hypertens, 37 (6), 1148-1153
DOI 10.1097/HJH.0000000000002021, PubMed 30624370

Agewall S (2019)
Old and new drugs in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (1), 1-2
DOI 10.1093/ehjcvp/pvy046, PubMed 30615170

Mehlum MH, Liestøl K, Wyller TB, Hua TA, Rostrup M, Berge E (2019)
Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial
Blood Press, 28 (2), 77-83
DOI 10.1080/08037051.2018.1524707, PubMed 30614275

Rutherford OW, Jonasson C, Ghanima W, Holst R, Halvorsen S (2018)
New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
Open Heart, 5 (2), e000931
DOI 10.1136/openhrt-2018-000931, PubMed 30613418

Stubnova V, Os I, Høieggen A, Solbu MD, Grundtvig M, Westheim AS, Atar D, Waldum-Grevbo B (2019)
Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
BMC Cardiovasc Disord, 19 (1), 4
DOI 10.1186/s12872-018-0989-8, PubMed 30611196

Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen S, Grundvold I, Berge E (2018)
Change in Cardiorespiratory Fitness and Risk of Stroke and Death: Long-Term Follow-Up of Healthy Middle-Aged Men
Stroke, 50 (1), 155-161
DOI 10.1161/STROKEAHA.118.021798, PubMed 30580727

Alexander KP, Brouwer MA, Mulder H, Vinereanu D, Lopes RD, Proietti M, Al-Khatib SM, Hijazi Z, Halvorsen S, Hylek EM, Verheugt FWA, Alexander JH, Wallentin L, Granger CB, ARISTOTLE Investigators (2018)
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
Am Heart J, 208, 123-131
DOI 10.1016/j.ahj.2018.09.017, PubMed 30579505

Bugge C, Sether EM, Pahle A, Halvorsen S, Sonbo Kristiansen I (2018)
Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study
BJGP Open, 2 (3), bjgpopen18X101596
DOI 10.3399/bjgpopen18X101596, PubMed 30564729

Allencherril J, Alam M, Levine G, Jneid H, Atar D, Kloner RA, Birnbaum Y (2018)
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?
J Cardiovasc Pharmacol Ther, 24 (3), 215-224
DOI 10.1177/1074248418812167, PubMed 30563349

Tjora S, Hall TS, Larstorp AC, Hallen J, Atar D (2018)
Increases in Circulating Cardiac Troponin Are Not Always Associated with Myocardial Cell Death
Clin Lab, 64 (11)
DOI 10.7754/Clin.Lab.2018.180615, PubMed 30549980

Munkhaugen J, Ruddox V, Halvorsen S, Dammen T, Fagerland MW, Hernæs KH, Vethe NT, Prescott E, Jensen SE, Rødevand O, Jortveit J, Bendz B, Schirmer H, Køber L, Bøtker HE, Larsen AI, Vikenes K, Steigen T, Wiseth R, Pedersen T, Edvardsen T, Otterstad JE, Atar D (2018)
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
Am Heart J, 208, 37-46
DOI 10.1016/j.ahj.2018.10.005, PubMed 30530121

Berntsen KS, Edvardsen E, Hansen BH, Flatø B, Sjaastad I, Sanner H (2019)
Cardiorespiratory fitness in long-term juvenile dermatomyositis: a controlled, cross-sectional study of active/inactive disease
Rheumatology (Oxford), 58 (3), 492-501
DOI 10.1093/rheumatology/key342, PubMed 30508195

Nero D, Agewall S, Daniel M, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sörensson P, Sundin Ö, Y-Hassan S, Hofman-Bang C, Tornvall P (2018)
Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries
Am J Med, 132 (3), 374-381.e1
DOI 10.1016/j.amjmed.2018.11.010, PubMed 30503881

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A, Blood Pressure Lowering Treatment Trialists’ Collaboration (2019)
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials
J Hypertens, 37 (1), 16-23
DOI 10.1097/HJH.0000000000001994, PubMed 30499920

Kjeldsen SE, Mancia G (2019)
Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results
J Hypertens, 37 (1), 6-8
DOI 10.1097/HJH.0000000000001874, PubMed 30499916

Mehlum MH, Liestøl K, Kjeldsen SE, Berge E (2018)
Response to letters from Torp-Pedersen and colleagues and de Courson and colleagues
Eur Heart J, 39 (47), 4221
DOI 10.1093/eurheartj/ehy605, PubMed 30496492

Sandhu RK, Ezekowitz JA, Hijazi Z, Westerbergh J, Aulin J, Alexander JH, Granger CB, Halvorsen S, Hanna MS, Lopes RD, Siegbahn A, Wallentin L (2018)
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
Open Heart, 5 (2), e000908
DOI 10.1136/openhrt-2018-000908, PubMed 30487982

Piira A, Lannem AM, Sørensen M, Glott T, Knutsen R, Jørgensen L, Gjesdal K, Hjeltnes N, Knutsen SF (2019)
Manually assisted body-weight supported locomotor training does not re-establish walking in non-walking subjects with chronic incomplete spinal cord injury: A randomized clinical trial
J Rehabil Med, 51 (2), 113-119
DOI 10.2340/16501977-2508, PubMed 30483724

Chin KL, Ofori-Asenso R, Hopper I, von Lueder TG, Reid CM, Zoungas S, Wang BH, Liew D (2019)
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
Cardiovasc Res, 115 (2), 266-276
DOI 10.1093/cvr/cvy295, PubMed 30475996

Skjørten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, Humerfelt S (2018)
Exercise capacity in COPD patients with exercise-induced pulmonary hypertension
Int J Chron Obstruct Pulmon Dis, 13, 3599-3610
DOI 10.2147/COPD.S161175, PubMed 30464443

Aimo A, Januzzi JL, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Rocca HB, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K et al. (2018)
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure
Int J Cardiol, 277, 166-172
DOI 10.1016/j.ijcard.2018.10.079, PubMed 30416028

Bethke A, Shanmuganathan L, Shetelig C, Swanson D, Andersen GØ, Eritsland J, Kløw NE, Hoffmann P (2018)
MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
PLoS One, 13 (11), e0206723
DOI 10.1371/journal.pone.0206723, PubMed 30412607

Emdin M, Aimo A, Vergaro G, Bayes-Genis A, Lupón J, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Gullestad L, Broch K, Ueland T, Nymo SH, Brunner-La Rocca HP, de Boer RA, Gaggin HK, Ripoli A, Passino C, Januzzi JL (2018)
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T
J Am Coll Cardiol, 72 (19), 2309-2320
DOI 10.1016/j.jacc.2018.08.2165, PubMed 30384887

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E et al. (2018)
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension
Blood Press, 27 (6), 314-340
DOI 10.1080/08037051.2018.1527177, PubMed 30380928

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2018)
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension
Blood Press, 27 (6), 313
DOI 10.1080/08037051.2018.1530564, PubMed 30380927

Lindekleiv H, Berge E, Bruins Slot KM, Wardlaw JM (2018)
Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke
Cochrane Database Syst Rev, 10 (10), CD009292
DOI 10.1002/14651858.CD009292.pub2, PubMed 30365156

Heier M, Espeland CN, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Fugelseth D, Dahl-Jørgensen K (2018)
Preserved endothelial function in young adults with type 1 diabetes
PLoS One, 13 (10), e0206523
DOI 10.1371/journal.pone.0206523, PubMed 30359432

Kjeldsen SE, Mariampillai JE, Nilsson PM (2018)
Optimal Blood Pressure Target in Diabetic and Nondiabetic Hypertensive Patients
Circ Res, 123 (5), 528-530
DOI 10.1161/CIRCRESAHA.118.312763, PubMed 30355140

Røe ÅT, Ruud M, Espe EK, Manfra O, Longobardi S, Aronsen JM, Nordén ES, Husebye T, Kolstad TRS, Cataliotti A, Christensen G, Sejersted OM, Niederer SA, Andersen GØ, Sjaastad I, Louch WE (2019)
Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
Cardiovasc Res, 115 (4), 752-764
DOI 10.1093/cvr/cvy257, PubMed 30351410

Espeland T, Lunde IG, H Amundsen B, Gullestad L, Aakhus S (2018)
Myocardial fibrosis
Tidsskr Nor Laegeforen, 138 (16)
DOI 10.4045/tidsskr.17.1027, PubMed 30344312

Mariampillai JE, Prestgaard EE, Kjeldsen SE, Liestøl K, Engeseth K, Erikssen J, Bodegard J, Berge E, Grundvold I, Skretteberg PT (2019)
SBP above 180 mmHg at moderate exercise workload increases coronary heart disease risk in healthy men during 28-year follow-up
J Hypertens, 37 (5), 949-955
DOI 10.1097/HJH.0000000000001959, PubMed 30325341

Dhillon AK, Kummen M, Trøseid M, Åkra S, Liaskou E, Moum B, Vesterhus M, Karlsen TH, Seljeflot I, Hov JR (2018)
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
Liver Int, 39 (2), 371-381
DOI 10.1111/liv.13979, PubMed 30269440

Orrem HL, Nilsson PH, Pischke SE, Kleveland O, Yndestad A, Ekholt K, Damås JK, Espevik T, Bendz B, Halvorsen B, Gregersen I, Wiseth R, Andersen GØ, Ueland T, Gullestad L, Aukrust P, Barratt-Due A, Mollnes TE (2018)
IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
Front Immunol, 9, 2035
DOI 10.3389/fimmu.2018.02035, PubMed 30258440

Navarese EP, Andreotti F, Raggi P, Kolodziejczak M, Buffon A, Bliden K, Tantry U, Kubica J, Sardella G, Lauten A, Agewall S, Gurbel PA, Brouwer MA (2019)
Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review
Eur Heart J Cardiovasc Pharmacother, 5 (1), 47-54
DOI 10.1093/ehjcvp/pvy038, PubMed 30247574

Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M, Huber K, Hylek EM, Lopes RD, Oh BH, Siegbahn A (2018)
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
Heart, 105 (3), 235-242
DOI 10.1136/heartjnl-2018-313351, PubMed 30209126

Serebruany VL, Hall TS, Atar D, Agewall S, Hyun Kim M, Geudelin B, Lomakin N, Marciniak TA (2019)
Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
Eur Heart J Cardiovasc Pharmacother, 5 (4), 210-215
DOI 10.1093/ehjcvp/pvy035, PubMed 30192939

Dahl Aarvik M, Sandven I, Dondo TB, Gale CP, Ruddox V, Munkhaugen J, Atar D, Otterstad JE (2019)
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
Eur Heart J Cardiovasc Pharmacother, 5 (1), 12-20
DOI 10.1093/ehjcvp/pvy034, PubMed 30192930

Sørensen E, Myrstad M, Ihle-Hansen H, Berge T (2018)
[Not Available]
Tidsskr Nor Laegeforen, 138 (13)
DOI 10.4045/tidsskr.18.0627, PubMed 30180491

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2018)
Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study
Blood Press, 27 (5), 247-248
DOI 10.1080/08037051.2018.1507621, PubMed 30175661

Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Dickstein K, Atar D, Agewall S, Girerd N, High-Risk Myocardial Infarction Database Initiative investigators (2018)
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
Int J Cardiol, 272, 260-266
DOI 10.1016/j.ijcard.2018.07.137, PubMed 30144995

Talvik A, Rebora P, Heinpalu-Kuum M, Salerno S, Miszkowska-Nagórna E, Liu X, Comotti T, Świerblewska E, Valsecchi MG, Fadl Elmula FEM, Larstorp AC, Narkiewicz K, Parati G, Laurent S, Viigimaa M, BEtter control of blood pressure in hypertensive pAtients monitored Using the hoTman® sYstem (BEAUTY) Study Investigators (2018)
Non-invasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients: effects on home blood pressure in the BEAUTY study
Blood Press, 27 (6), 368-375
DOI 10.1080/08037051.2018.1505425, PubMed 30129785

Roaldsen MB, Lindekleiv H, Mathiesen EB, Berge E (2018)
Recanalisation therapies for wake-up stroke
Cochrane Database Syst Rev, 8 (8), CD010995
DOI 10.1002/14651858.CD010995.pub2, PubMed 30129656

Niessner A, Agewall S (2018)
Critical appraisal of the COMPASS trial
Eur Heart J Cardiovasc Pharmacother, 4 (4), 191-192
DOI 10.1093/ehjcvp/pvy027, PubMed 30113628

Engeseth K, Prestgaard EE, Mariampillai JE, Grundvold I, Liestol K, Kjeldsen SE, Bodegard J, Erikssen JE, Gjesdal K, Skretteberg PT (2018)
Physical fitness is a modifiable predictor of early cardiovascular death: A 35-year follow-up study of 2014 healthy middle-aged men
Eur J Prev Cardiol, 25 (15), 1655-1663
DOI 10.1177/2047487318793459, PubMed 30103630

Vonbank A, Drexel H, Agewall S, Lewis BS, Dopheide JF, Kjeldsen K, Ceconi C, Savarese G, Rosano G, Wassmann S, Niessner A, Schmidt TA, Saely CH, Baumgartner I, Tamargo J (2018)
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review
Eur Heart J Cardiovasc Pharmacother, 4 (4), 230-236
DOI 10.1093/ehjcvp/pvy028, PubMed 30099530

Jia X, Heiberg E, Sejersten Ripa M, Engblom H, Carlsson M, Halvorsen S, Arheden H, Atar D, Clemmensen P, Birnbaum Y (2018)
Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1-V3: Analysis from the MITOCARE Study
Cardiology, 140 (3), 178-185
DOI 10.1159/000491745, PubMed 30099440

Berwanger O, Abdelhamid M, Alexander T, Alzubaidi A, Averkov O, Aylward P, Contreras Zúñiga E, Halvorsen S, Iglesias R, A Sk Abdul Kader M, Zubaid M, AlHabib KF (2018)
Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study
Clin Cardiol, 41 (10), 1322-1327
DOI 10.1002/clc.23043, PubMed 30098028

Ruddox V, Otterstad JE, Atar D, Bendz B, Edvardsen T (2018)
In Current Clinical Practice, after Percutaneous Coronary Intervention for Acute Myocardial Infarction, Are β-Blockers Prescribed for Heart Failure or as Secondary Prevention? A Pilot Study
Cardiology, 140 (3), 152-154
DOI 10.1159/000490656, PubMed 30089282

Mayerhofer CCK, Awoyemi AO, Moscavitch SD, Lappegård KT, Hov JR, Aukrust P, Hovland A, Lorenzo A, Halvorsen S, Seljeflot I, Gullestad L, Trøseid M, Broch K (2018)
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
ESC Heart Fail, 5 (5), 977-984
DOI 10.1002/ehf2.12332, PubMed 30088346

Munkhaugen J, Hjelmesæth J, Otterstad JE, Helseth R, Sollid ST, Gjertsen E, Gullestad L, Perk J, Moum T, Husebye E, Dammen T (2018)
Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study
BMC Cardiovasc Disord, 18 (1), 160
DOI 10.1186/s12872-018-0896-z, PubMed 30075751

Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K, ESC Scientific Document Group (2019)
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
Europace, 21 (2), 192-193
DOI 10.1093/europace/euy174, PubMed 30052888

Agewall S (2018)
New input on antiplatelet treatment and registry studies
Eur Heart J Cardiovasc Pharmacother, 4 (3), 129-130
DOI 10.1093/ehjcvp/pvy016, PubMed 30052852

Lewis BS, Atar D (2018)
Peripheral arterial disease and limb salvage: a new arena for the cardiologist
Eur Heart J Cardiovasc Pharmacother, 4 (3), 136-137
DOI 10.1093/ehjcvp/pvy014, PubMed 30052851

Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018)
Author's response to: letter to the editor
Heart Fail Rev, 23 (5), 819
DOI 10.1007/s10741-018-9728-6, PubMed 30043131

Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2018)
Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
Diabetol Metab Syndr, 10, 59
DOI 10.1186/s13098-018-0360-3, PubMed 30038669

von Lueder TG, Agewall S (2018)
The burden of heart failure in the general population: a clearer and more concerning picture
J Thorac Dis, 10 (Suppl 17), S1934-S1937
DOI 10.21037/jtd.2018.04.153, PubMed 30023084

Farkhooy A, Bodegård J, Erikssen JE, Janson C, Hedenström H, Stavem K, Malinovschi A (2018)
Cross-sectional and longitudinal analyses of the association between lung function and exercise capacity in healthy Norwegian men
BMC Pulm Med, 18 (1), 118
DOI 10.1186/s12890-018-0655-z, PubMed 30021542

Saetre E, Abdelnoor M (2018)
Incidence rate of sudden death in epilepsy: A systematic review and meta-analysis
Epilepsy Behav, 86, 193-199
DOI 10.1016/j.yebeh.2018.06.037, PubMed 30017838

Hiis HG, Cosson MV, Dahl CP, Fiane AE, Levy FO, Andersen GØ, Krobert KA (2018)
Hypothermia elongates the contraction-relaxation cycle in explanted human failing heart decreasing the time for ventricular filling during diastole
Am J Physiol Heart Circ Physiol, 315 (5), H1137-H1147
DOI 10.1152/ajpheart.00208.2018, PubMed 30004809

Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Ripa MS, Birnbaum Y (2018)
Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging
J Electrocardiol, 51 (4), 563-568
DOI 10.1016/j.jelectrocard.2018.03.016, PubMed 29996989

Bethke A, Shanmuganathan L, Andersen GØ, Eritsland J, Swanson D, Kløw NE, Hoffmann P (2018)
Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
Eur Radiol, 29 (2), 941-950
DOI 10.1007/s00330-018-5588-7, PubMed 29980929

Shetelig C, Limalanathan S, Hoffmann P, Seljeflot I, Gran JM, Eritsland J, Andersen GØ (2018)
Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
J Am Coll Cardiol, 72 (2), 187-198
DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293

Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2018)
Interleukin-18 and the NLR family pyrin domain containing-3 inflammasome in adipose tissue are strongly associated with glucometabolic variables in a cohort of middle-aged men
Diab Vasc Dis Res, 15 (5), 458-464
DOI 10.1177/1479164118785307, PubMed 29972041

Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Ripa MS, Birnbaum Y (2018)
The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging
Ann Noninvasive Electrocardiol, 23 (6), e12580
DOI 10.1111/anec.12580, PubMed 29971868

Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018)
Response to the editor
Heart Fail Rev (in press)
DOI 10.1007/s10741-018-9723-y, PubMed 29968222

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2018)
Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure
Blood Press, 27 (4), 185-187
DOI 10.1080/08037051.2018.1486178, PubMed 29936868

Horjen AW, Ulimoen SR, Norseth J, Svendsen JH, Smith P, Arnesen H, Seljeflot I, Tveit A (2018)
High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis
Scand J Clin Lab Invest, 78 (5), 386-392
DOI 10.1080/00365513.2018.1481224, PubMed 29933716

Hov KR, Neerland BE, Andersen AM, Undseth Ø, Wyller VB, MacLullich AMJ, Skovlund E, Qvigstad E, Wyller TB (2018)
The use of clonidine in elderly patients with delirium; pharmacokinetics and hemodynamic responses
BMC Pharmacol Toxicol, 19 (1), 29
DOI 10.1186/s40360-018-0218-1, PubMed 29884231

Melleby AO, Romaine A, Aronsen JM, Veras I, Zhang L, Sjaastad I, Lunde IG, Christensen G (2018)
A novel method for high precision aortic constriction that allows for generation of specific cardiac phenotypes in mice
Cardiovasc Res, 114 (12), 1680-1690
DOI 10.1093/cvr/cvy141, PubMed 29878127

Fossum S, Halvorsen S, Vikanes ÅV, Roseboom TJ, Ariansen I, Næss Ø (2018)
Cardiovascular risk profile at the age of 40-45 in women with previous hyperemesis gravidarum or hypertensive disorders in pregnancy: A population-based study
Pregnancy Hypertens, 12, 129-135
DOI 10.1016/j.preghy.2018.04.013, PubMed 29858105

Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, Aukrust P, Seljeflot I, Hoffmann P, Eritsland J, Mollnes TE, Andersen GØ, Yndestad A (2018)
Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
Int J Cardiol, 268, 187-192
DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279

Kjeldsen SE, Esler MD (2018)
Take a blood pressure pill or undergo renal denervation?
Lancet, 391 (10137), 2298-2300
DOI 10.1016/S0140-6736(18)31126-7, PubMed 29803587

Danielsen SO, Moons P, Sandven I, Leegaard M, Solheim S, Tønnessen T, Lie I (2018)
Thirty-day readmissions in surgical and transcatheter aortic valve replacement: A systematic review and meta-analysis
Int J Cardiol, 268, 85-91
DOI 10.1016/j.ijcard.2018.05.026, PubMed 29779575

Rosano GMC, Tamargo J, Kjeldsen KP, Lainscak M, Agewall S, Anker SD, Ceconi C, Coats AJS, Drexel H, Filippatos G, Kaski JC, Lund L, Niessner A, Ponikowski P, Savarese G, Schmidt TA, Seferovic P, Wassmann S, Walther T, Lewis BS (2018)
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 4 (3), 180-188
DOI 10.1093/ehjcvp/pvy015, PubMed 29726985

Hoel H, Hove-Skovsgaard M, Hov JR, Gaardbo JC, Holm K, Kummen M, Rudi K, Nwosu F, Valeur J, Gelpi M, Seljeflot I, Ueland PM, Gerstoft J, Ullum H, Aukrust P, Nielsen SD, Trøseid M (2018)
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
Sci Rep, 8 (1), 6725
DOI 10.1038/s41598-018-25168-3, PubMed 29712976

Wachtell K (2018)
What is not to like about large national or international registries and databases?
Int J Cardiol, 262, 117-118
DOI 10.1016/j.ijcard.2018.03.062, PubMed 29706389

Pahlm U, Seemann F, Engblom H, Gyllenhammar T, Halvorsen S, Hansen HS, Erlinge D, Atar D, Heiberg E, Arheden H, Carlsson M (2018)
Longitudinal left ventricular function is globally depressed within a week of STEMI
Clin Physiol Funct Imaging, 38 (6), 1029-1037
DOI 10.1111/cpf.12521, PubMed 29701310

Hansen CH, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Seljeflot I (2018)
Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
Clin Appl Thromb Hemost, 24 (7), 1088-1094
DOI 10.1177/1076029618764847, PubMed 29695176

Lunde K, Al-Ani A, Bjørnerheim R, Hervold A, Opdahl A, Beitnes JO (2018)
Catheter-based left atrial appendage closure
Tidsskr Nor Laegeforen, 138 (7)
DOI 10.4045/tidsskr.17.0601, PubMed 29663763

Heimark S, Mariampillai JE, Narkiewicz K, Nilsson PM, Kjeldsen SE (2018)
Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials
High Blood Press Cardiovasc Prev, 25 (2), 151-158
DOI 10.1007/s40292-018-0258-z, PubMed 29663195

Aboyans V, Björck M, Brodmann M, Collet JP, Czerny M, De Carlo M, Naylor AR, Roffi M, Tendera M, Vlachopoulos C, Ricco JB, Task Force for the 2017 ESC Guidelines for the diagnosis and management of Peripheral Arterial Diseases, in collaboration with the ESVS, Document Reviewers, Widimsky P, Kolh P, Dick F, Vega de Ceniga M, Piepoli MF, Sievert H, Sulzenko J, Esc Committee For Practice Guidelines Cpg, Windecker S, Aboyans V, Agewall S, Barbato E et al. (2018)
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Eur J Vasc Endovasc Surg, 55 (4), 457-464
DOI 10.1016/j.ejvs.2017.08.014, PubMed 29628287

Jia X, Heiberg E, Ripa MS, Engblom H, Halvorsen S, Arheden H, Atar D, Clemmensen P, Birnbaum Y (2018)
Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMI
Scand Cardiovasc J, 52 (4), 189-195
DOI 10.1080/14017431.2018.1458145, PubMed 29595340

Andresen K, Atar D, Gjertsen E, Ghanima W, Roseth S, Johansen OE (2018)
Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants
Scand Cardiovasc J, 52 (3), 156-162
DOI 10.1080/14017431.2018.1453613, PubMed 29569500

Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J, Blood Pressure Lowering Treatment Trialists’ Collaboration (2018)
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
PLoS Med, 15 (3), e1002538
DOI 10.1371/journal.pmed.1002538, PubMed 29558462

Agewall S (2018)
Cardiovascular pharmacotherapy and real-world data
Eur Heart J Cardiovasc Pharmacother, 4 (2), 65-66
DOI 10.1093/ehjcvp/pvy008, PubMed 29554294

Bonaca MP, De Ferrari GM, Atar D, Bash LD, Lautsch D, Bohula EA, Horack M, Brudi P, Ferrieres J, Gitt AK (2018)
How does the TRS 2°P score relate to real-world patients?
Eur Heart J Cardiovasc Pharmacother, 4 (2), 72-74
DOI 10.1093/ehjcvp/pvy004, PubMed 29554293

Kompa AR, Lu J, Weller TJ, Kelly DJ, Krum H, von Lueder TG, Wang BH (2018)
Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction
Int J Cardiol, 258, 192-198
DOI 10.1016/j.ijcard.2018.01.077, PubMed 29544929

Staer-Jensen H, Sunde K, Nakstad ER, Eritsland J, Andersen GØ (2018)
Comparison of three haemodynamic monitoring methods in comatose post cardiac arrest patients
Scand Cardiovasc J, 52 (3), 141-148
DOI 10.1080/14017431.2018.1450992, PubMed 29544369

Kummen M, Mayerhofer CCK, Vestad B, Broch K, Awoyemi A, Storm-Larsen C, Ueland T, Yndestad A, Hov JR, Trøseid M (2018)
Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts
J Am Coll Cardiol, 71 (10), 1184-1186
DOI 10.1016/j.jacc.2017.12.057, PubMed 29519360

Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018)
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions
Heart Fail Rev, 23 (3), 303-323
DOI 10.1007/s10741-018-9685-0, PubMed 29516230

Bruins Slot KM, Berge E (2018)
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Cochrane Database Syst Rev, 3 (3), CD008980
DOI 10.1002/14651858.CD008980.pub3, PubMed 29509959

Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF (2018)
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
Eur Heart J, 39 (19), 1672-1686f
DOI 10.1093/eurheartj/ehy066, PubMed 29509886

Wisløff T, Atar D (2016)
Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention
Eur Heart J Qual Care Clin Outcomes, 2 (1), 52-57
DOI 10.1093/ehjqcco/qcv023, PubMed 29474586

Langseth MS, Opstad TB, Bratseth V, Solheim S, Arnesen H, Pettersen AÅ, Seljeflot I, Helseth R (2018)
Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease
Eur J Prev Cardiol, 25 (7), 762-769
DOI 10.1177/2047487318760618, PubMed 29473463

Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH (2017)
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial
Am Heart J, 197, 133-141
DOI 10.1016/j.ahj.2017.11.005, PubMed 29447773

Burnier M, Oparil S, Narkiewicz K, Kjeldsen SE (2018)
New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden?
Blood Press, 27 (2), 62-65
DOI 10.1080/08037051.2018.1430504, PubMed 29447001

Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Gorenek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumura K, Piccini JP, Potpara T, Poulsen BK, Saba M, Savelieva I, Tamargo JL, Wolpert C, ESC Scientific Document Group (2018)
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Europace, 20 (5), 731-732an
DOI 10.1093/europace/eux373, PubMed 29438514

Cwikiel J, Seljeflot I, Berge E, Njerve IU, Ulsaker H, Arnesen H, Flaa A (2018)
Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease
Cytokine, 105, 17-22
DOI 10.1016/j.cyto.2018.02.006, PubMed 29433015

Orrem HL, Nilsson PH, Pischke SE, Grindheim G, Garred P, Seljeflot I, Husebye T, Aukrust P, Yndestad A, Andersen GØ, Barratt-Due A, Mollnes TE (2018)
Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
ESC Heart Fail, 5 (3), 292-301
DOI 10.1002/ehf2.12266, PubMed 29424484

Pol T, Held C, Westerbergh J, Lindbäck J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z (2018)
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
J Am Heart Assoc, 7 (3)
DOI 10.1161/JAHA.117.007444, PubMed 29419390

Seiffge DJ, Kägi G, Michel P, Fischer U, Béjot Y, Wegener S, Zedde M, Turc G, Cordonnier C, Sandor PS, Rodier G, Zini A, Cappellari M, Schädelin S, Polymeris AA, Werring D, Thilemann S, Maestrini I, Berge E, Traenka C, Vehoff J, De Marchis GM, Kapauer M, Peters N, Sirimarco G et al. (2018)
Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage
Ann Neurol, 83 (3), 451-459
DOI 10.1002/ana.25165, PubMed 29394504

Mehlum MH, Liestøl K, Kjeldsen SE, Julius S, Hua TA, Rothwell PM, Mancia G, Parati G, Weber MA, Berge E (2018)
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks
Eur Heart J, 39 (24), 2243-2251
DOI 10.1093/eurheartj/ehx760, PubMed 29365085

Skjørten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, Humerfelt S (2017)
Cardiopulmonary exercise test and PaO₂ in evaluation of pulmonary hypertension in COPD
Int J Chron Obstruct Pulmon Dis, 13, 91-100
DOI 10.2147/COPD.S150034, PubMed 29339921

Christensen G, Herum KM, Lunde IG (2018)
Sweet, yet underappreciated: Proteoglycans and extracellular matrix remodeling in heart disease
Matrix Biol, 75-76, 286-299
DOI 10.1016/j.matbio.2018.01.001, PubMed 29337052

Aimo A, Januzzi JL, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K et al. (2018)
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis
Circulation, 137 (3), 286-297
DOI 10.1161/CIRCULATIONAHA.117.031560, PubMed 29335288

Agewall S (2018)
Cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 4 (1), 1
DOI 10.1093/ehjcvp/pvx036, PubMed 29315398

Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, Calkins H, Casadei B, Castellá M, Chua W, Crijns H, Dobrev D, Fabritz L, Feuring M, Freedman B, Gerth A et al. (2018)
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
Europace, 20 (3), 395-407
DOI 10.1093/europace/eux318, PubMed 29300976

Horjen AW, Seljeflot I, Berge T, Smith P, Arnesen H, Tveit A (2017)
Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation
Thromb J, 15, 30
DOI 10.1186/s12959-017-0153-1, PubMed 29299030

Verheugt FWA, Gao H, Al Mahmeed W, Ambrosio G, Angchaisuksiri P, Atar D, Bassand JP, Camm AJ, Cools F, Eikelboom J, Kayani G, Lim TW, Misselwitz F, Pieper KS, van Eickels M, Kakkar AK, GARFIELD-AF Investigators (2018)
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry
Eur Heart J, 39 (6), 464-473
DOI 10.1093/eurheartj/ehx730, PubMed 29281086

Kaluzna-Oleksy M, Aunan K, Rao-Skirbekk S, Kjellstrom T, Ezekowitz JA, Agewall S, Atar D (2017)
Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017
Scand Cardiovasc J, 52 (1), 1-3
DOI 10.1080/14017431.2017.1405069, PubMed 29202608

Warlo EMK, Pettersen AR, Arnesen H, Seljeflot I (2017)
vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
Thromb J, 15, 28
DOI 10.1186/s12959-017-0151-3, PubMed 29200971

Ibánez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P (2017)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Rev Esp Cardiol (Engl Ed), 70 (12), 1082
DOI 10.1016/j.rec.2017.11.010, PubMed 29198432

Atar D, Hanssen KF (2017)
Type 2 Diabetes and Heart Failure - More Scrutiny Wanted!
Cardiology, 139 (1), 37-39
DOI 10.1159/000484345, PubMed 29186706

Bang CN, Greve AM, Rossebø AB, Ray S, Egstrup K, Boman K, Nienaber C, Okin PM, Devereux RB, Wachtell K (2017)
Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events
J Am Heart Assoc, 6 (12)
DOI 10.1161/JAHA.117.006709, PubMed 29180457

Lüscher TF, Kjeldsen SE, Mancia G, Papademetriou V (2017)
From 'essential' hypertension to intensive blood pressure lowering: the pros and cons of lower target values
Eur Heart J, 38 (44), 3258-3271
DOI 10.1093/eurheartj/ehx643, PubMed 29177419

Agewall S (2017)
European Heart Journal - Cardiovascular Pharmacotherapy: A fast growing baby-filling an important gap in the literature
Eur Heart J, 38 (44), 3251
DOI 10.1093/eurheartj/ehx619, PubMed 29177414

Fakhri Y, Sejersten M, Schoos MM, Hansen HS, Dubois-Rande JL, Hall TS, Larsen AI, Jensen SE, Engblom H, Arheden H, Kastrup J, Atar D, Clemmensen P (2017)
Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction
J Electrocardiol, 51 (2), 195-202
DOI 10.1016/j.jelectrocard.2017.11.002, PubMed 29174706

Kvakkestad KM, Sandvik L, Andersen GØ, Sunde K, Halvorsen S (2017)
Long-term survival in patients with acute myocardial infarction and out-of-hospital cardiac arrest: A prospective cohort study
Resuscitation, 122, 41-47
DOI 10.1016/j.resuscitation.2017.11.047, PubMed 29155294

Opstad TB, Seljeflot I, Bøhmer E, Arnesen H, Halvorsen S (2017)
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
Cardiology, 139 (1), 17-24
DOI 10.1159/000481684, PubMed 29141241

Russo JJ, Goodman SG, Cantor WJ, Ko DT, Bagai A, Tan MK, Di Mario C, Halvorsen S, Le May M, Fernandez-Avilés F, Scheller B, Armstrong PW, Borgia F, Piscione F, Sanchez PL, Yan AT (2017)
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis
Am Heart J, 193, 46-54
DOI 10.1016/j.ahj.2017.07.015, PubMed 29129254

Kjeldsen SE (2017)
Hypertension and cardiovascular risk: General aspects
Pharmacol Res, 129, 95-99
DOI 10.1016/j.phrs.2017.11.003, PubMed 29127059

Niessner A, Tamargo J, Koller L, Saely CH, Schmidt TA, Savarese G, Wassmann S, Rosano G, Ceconi C, Torp-Pedersen C, Kaski JC, Kjeldsen KP, Agewall S, Walther T, Drexel H, Lewis BS (2018)
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J, 39 (24), 2274-2281
DOI 10.1093/eurheartj/ehx625, PubMed 29126266

Graham I, Filippatos G, Atar D, Vardas PE, Pinto FJ, Fitzsimons D (2017)
Patient engagement
Eur Heart J, 38 (42), 3114-3115
DOI 10.1093/eurheartj/ehx600, PubMed 29121227

Gulati G, Heck SL, Røsjø H, Ree AH, Hoffmann P, Hagve TA, Norseth J, Gravdehaug B, Steine K, Geisler J, Omland T (2017)
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
J Am Heart Assoc, 6 (11)
DOI 10.1161/JAHA.117.006513, PubMed 29118031

Heck SL, Gulati G, Hoffmann P, von Knobelsdorff-Brenkenhoff F, Storås TH, Ree AH, Gravdehaug B, Røsjø H, Steine K, Geisler J, Schulz-Menger J, Omland T (2018)
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial
Eur Heart J Cardiovasc Imaging, 19 (5), 544-552
DOI 10.1093/ehjci/jex159, PubMed 29106497

Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Shah DJ, Cheong B, Sejersten M, Birnbaum Y (2017)
Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imaging
J Electrocardiol, 51 (2), 218-223
DOI 10.1016/j.jelectrocard.2017.09.013, PubMed 29103621

Vinereanu D, Lopes RD, Mulder H, Gersh BJ, Hanna M, de Barros E Silva PGM, Atar D, Wallentin L, Granger CB, Alexander JH, ARISTOTLE Investigators (2017)
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin
Stroke, 48 (12), 3266-3273
DOI 10.1161/STROKEAHA.117.017574, PubMed 29089455

Liang Y, Deng M, Chen YK, Mok V, Wang DF, Ungvari GS, Chu CW, Berge E, Tang WK (2017)
Enlarged perivascular spaces are associated with health-related quality of life in patients with acute ischemic stroke
CNS Neurosci Ther, 23 (12), 973-979
DOI 10.1111/cns.12766, PubMed 29052954

Deyab G, Hokstad I, Whist JE, Smastuen MC, Agewall S, Lyberg T, Ronda N, Mikkelsen K, Hjeltnes G, Hollan I (2017)
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Arthritis Res Ther, 19 (1), 232
DOI 10.1186/s13075-017-1439-1, PubMed 29041979

Burnier M, Narkiewicz K, Kjeldsen SE, Oparil S (2017)
Renal denervation in hypertension: is it the end or the beginning of a SPYRAL?
Blood Press, 26 (6), 319-320
DOI 10.1080/08037051.2017.1386539, PubMed 28975817

Røe ÅT, Sjaastad I, Louch WE (2017)
Heart failure with preserved ejection fraction
Tidsskr Nor Laegeforen, 137 (18)
DOI 10.4045/tidsskr.16.1068, PubMed 28972354

Agewall S, Tjessem LH, Rossignol P, Zannad F, Atar D, Lamiral Z, Machu JL, Dickstein K, Kjekshus J, von Lueder TG, Girerd N, High Risk Myocardial Infarction Database Initiative investigators (2017)
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative
Int J Cardiol, 249, 274-281
DOI 10.1016/j.ijcard.2017.09.182, PubMed 28964557

Patrono C, Morais J, Baigent C, Collet JP, Fitzgerald D, Halvorsen S, Rocca B, Siegbahn A, Storey RF, Vilahur G (2017)
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
J Am Coll Cardiol, 70 (14), 1760-1776
DOI 10.1016/j.jacc.2017.08.037, PubMed 28958334

Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, de Leeuw PW, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB et al. (2017)
Reply
J Hypertens, 35 (11), 2327-2328
DOI 10.1097/HJH.0000000000001526, PubMed 28953595

Heier M, Stensæth KH, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K (2018)
Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
Eur Heart J Cardiovasc Imaging, 19 (6), 694-700
DOI 10.1093/ehjci/jex178, PubMed 28950341

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Norseth J, Arnesen H, Solheim S (2017)
Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study
JRSM Cardiovasc Dis, 6, 2048004017729984
DOI 10.1177/2048004017729984, PubMed 28932392

Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
Sci Rep, 7 (1), 11945
DOI 10.1038/s41598-017-12372-w, PubMed 28931920

Prestgaard E, Hodnesdal C, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen SE, Grundvold I, Berge E (2017)
Long-term predictors of stroke in healthy middle-aged men
Int J Stroke, 13 (3), 292-300
DOI 10.1177/1747493017730760, PubMed 28929941

Sejersten M, Fakhri Y, Pape M, Jensen SE, Heiberg E, Engblom H, Hall TS, Atar D, Clemmensen P (2017)
Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudy
J Electrocardiol, 50 (6), 725-731
DOI 10.1016/j.jelectrocard.2017.08.019, PubMed 28918213

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P, ESC Scientific Document Group (2018)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Eur Heart J, 39 (2), 119-177
DOI 10.1093/eurheartj/ehx393, PubMed 28886621

Agewall S (2017)
Morphine in acute heart failure
J Thorac Dis, 9 (7), 1851-1854
DOI 10.21037/jtd.2017.06.129, PubMed 28839982

Campo G, Pavasini R, Morciano G, Lincoff MA, C Gibson M, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F (2017)
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
Data Brief, 14, 197-205
DOI 10.1016/j.dib.2017.07.033, PubMed 28795098

von Lueder TG, Kotecha D, Atar D, Hopper I (2017)
Neurohormonal Blockade in Heart Failure
Card Fail Rev, 3 (1), 19-24
DOI 10.15420/cfr.2016:22:2, PubMed 28785471

Woodhouse LJ, Scutt P, Hamdy S, Smithard DG, Cohen DL, Roffe C, Bereczki D, Berge E, Bladin CF, Caso V, Christensen HK, Collins R, Czlonkowska A, de Silva A, Etribi A, Laska AC, Ntaios G, Ozturk S, Phillips SJ, Prasad K, Szatmari S, Sprigg N, Bath PM (2017)
Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial
Transl Stroke Res, 9 (2), 120-129
DOI 10.1007/s12975-017-0548-0, PubMed 28770403

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2017)
Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials
Blood Press, 26 (5), 257-258
DOI 10.1080/08037051.2017.1357110, PubMed 28724313

Meier S, Andressen KW, Aronsen JM, Sjaastad I, Hougen K, Skomedal T, Osnes JB, Qvigstad E, Levy FO, Moltzau LR (2017)
PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts
Eur J Pharmacol, 812, 174-183
DOI 10.1016/j.ejphar.2017.07.014, PubMed 28697992

Lie I, Danielsen SO, Tønnessen T, Solheim S, Leegaard M, Sandvik L, Wisløff T, Vangen J, Røsstad TH, Moons P (2017)
Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial
Trials, 18 (1), 246
DOI 10.1186/s13063-017-1971-y, PubMed 28693599

Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K, Oda MN (2017)
Reduced HDL function in children and young adults with type 1 diabetes
Cardiovasc Diabetol, 16 (1), 85
DOI 10.1186/s12933-017-0570-2, PubMed 28683835

Manner IW, Waldum-Grevbo B, Witczak BN, Bækken M, Øktedalen O, Os I, Schwartz T, Sjaastad I (2017)
Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients
Blood Press, 26 (6), 332-340
DOI 10.1080/08037051.2017.1346459, PubMed 28675304

Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P et al. (2017)
Expertise: no longer a sine qua non for guideline authors?
J Hypertens, 35 (8), 1564-1566
DOI 10.1097/HJH.0000000000001435, PubMed 28657972

Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P et al. (2017)
Expertise: No Longer a Sine Qua Non for Guideline Authors?
Hypertension, 70 (2), 235-237
DOI 10.1161/HYPERTENSIONAHA.117.09470, PubMed 28652465

Butt N, Bache-Mathiesen LK, Nordrehaug JE, Tuseth V, Munk PS, Bonarjee V, Hall TS, Jensen SE, Halvorsen S, Firat H, Atar D, Larsen AI (2017)
Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins
Cardiology, 138 (2), 122-132
DOI 10.1159/000475460, PubMed 28651249

Haissman JM, Haugaard AK, Ostrowski SR, Berge RK, Hov JR, Trøseid M, Nielsen SD (2017)
Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection
BMC Infect Dis, 17 (1), 445
DOI 10.1186/s12879-017-2547-x, PubMed 28645263

Campo G, Pavasini R, Morciano G, Lincoff AM, Gibson CM, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F (2017)
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials
Int J Cardiol, 244, 59-66
DOI 10.1016/j.ijcard.2017.06.040, PubMed 28634037

Steen T, Dickstein K (2017)
Do real world data support and extend our ability to predict reverse remodelling following cardiac resynchronization therapy based on QRS morphology and width?
Eur J Heart Fail, 19 (9), 1152-1153
DOI 10.1002/ejhf.904, PubMed 28626904

Pagidipati NJ, Navar AM, Pieper KS, Green JB, Bethel MA, Armstrong PW, Josse RG, McGuire DK, Lokhnygina Y, Cornel JH, Halvorsen S, Strandberg TE, Delibasi T, Holman RR, Peterson ED, TECOS Study Group (2017)
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)
Circulation, 136 (13), 1193-1203
DOI 10.1161/CIRCULATIONAHA.117.027252, PubMed 28626088

Stubnova V, Os I, Grundtvig M, Atar D, Waldum-Grevbo B (2017)
Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study
Cardiorenal Med, 7 (2), 128-136
DOI 10.1159/000454933, PubMed 28611786

Njerve IU, Åkra S, Weiss TW, Solheim S, Øvstebø R, Aass HCD, Byrkjeland R, Arnesen H, Seljeflot I (2017)
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
Mediators Inflamm, 2017, 5380638
DOI 10.1155/2017/5380638, PubMed 28596642

Burnier M, Narkiewicz K, Kjeldsen SE (2017)
Prevention of heart failure mortality and hospitalizations in SPRINT, EMPA-REG, ALLHAT and HYVET: are diuretics the clue?
Blood Press, 26 (4), 193-194
DOI 10.1080/08037051.2017.1332478, PubMed 28566004

Herum KM, Lunde IG, McCulloch AD, Christensen G (2017)
The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart
J Clin Med, 6 (5)
DOI 10.3390/jcm6050053, PubMed 28534817

Larssen MS, Steine K, Hilde JM, Skjørten I, Hodnesdal C, Liestøl K, Gjesdal K (2017)
Mechanisms of ECG signs in chronic obstructive pulmonary disease
Open Heart, 4 (1), e000552
DOI 10.1136/openhrt-2016-000552, PubMed 28533915

Shavadia J, Welsh R, Gershlick A, Zheng Y, Huber K, Halvorsen S, Steg PG, Van de Werf F, Armstrong PW (2016)
Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study
J Am Heart Assoc, 5 (6)
DOI 10.1161/JAHA.116.003559, PubMed 28525886

Jacobs L, Persu A, Huang QF, Lengelé JP, Thijs L, Hammer F, Yang WY, Zhang ZY, Renkin J, Sinnaeve P, Wei FF, Pasquet A, Fadl Elmula FEM, Carlier M, Elvan A, Wunder C, Kjeldsen SE, Toennes SW, Janssens S, Verhamme P, Staessen JA, European Network Coordinating Research on Renal Denervation (2017)
Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension
Blood Press, 26 (6), 321-331
DOI 10.1080/08037051.2017.1320939, PubMed 28489464

Fröhlich H, Henning F, Täger T, Schellberg D, Grundtvig M, Goode K, Corletto A, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Frankenstein L, Clark AL (2018)
Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study
Eur Heart J Cardiovasc Pharmacother, 4 (2), 82-92
DOI 10.1093/ehjcvp/pvx013, PubMed 28475676

Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, Packer M, Coats AJS, Manzano L, Böhm M, van Veldhuisen DJ, Andersson B, Wedel H, von Lueder TG, Rigby AS, Hjalmarson Å, Kjekshus J, Cleland JGF, Beta-Blockers in Heart Failure Collaborative Group (2017)
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure
J Am Coll Cardiol, 69 (24), 2885-2896
DOI 10.1016/j.jacc.2017.04.001, PubMed 28467883

Lønnebakken MT, De Simone G, Saeed S, Boman K, Rossebø AB, Bahlmann E, Gohlke-Bärwolf C, Gerdts E (2017)
Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis
Heart, 103 (18), 1443-1448
DOI 10.1136/heartjnl-2016-310917, PubMed 28455295

Fadl Elmula FEM, Feng YM, Jacobs L, Larstorp AC, Kjeldsen SE, Persu A, Staessen JA, European Network COordinating research on Renal Denervation (ENCOReD) (2017)
Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis
Blood Press, 26 (4), 195-203
DOI 10.1080/08037051.2017.1311769, PubMed 28443356

Berge E (2017)
Should elevated blood pressure be lowered in the acute phase of ischaemic stroke?
J Hypertens, 35 (6), 1166-1167
DOI 10.1097/HJH.0000000000001338, PubMed 28441257

Kjeldsen SE, Os I (2017)
Interventions to improve adherence of antihypertensive medication in African-Americans
J Hypertens, 35 (6), 1164-1165
DOI 10.1097/HJH.0000000000001249, PubMed 28441256

Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L (2017)
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure
Clin Res Cardiol, 106 (9), 711-721
DOI 10.1007/s00392-017-1115-0, PubMed 28434020

Lorenz MW, Abdi NA, Scheckenbach F, Pflug A, Bülbül A, Catapano AL, Agewall S, Ezhov M, Bots ML, Kiechl S, Orth A, PROG-IMT study group (2017)
Automatic identification of variables in epidemiological datasets using logic regression
BMC Med Inform Decis Mak, 17 (1), 40
DOI 10.1186/s12911-017-0429-1, PubMed 28407816

Abdelnoor M, Andersen JG, Arnesen H, Johansen O (2017)
Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost
Vasc Health Risk Manag, 13, 101-109
DOI 10.2147/VHRM.S122951, PubMed 28356750

Hove-Skovsgaard M, Gaardbo JC, Kolte L, Winding K, Seljeflot I, Svardal A, Berge RK, Gerstoft J, Ullum H, Trøseid M, Nielsen SD (2017)
HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
BMC Infect Dis, 17 (1), 234
DOI 10.1186/s12879-017-2334-8, PubMed 28356058

Fröhlich H, Raman N, Täger T, Schellberg D, Goode KM, Kazmi S, Grundtvig M, Hole T, Cleland JGF, Katus HA, Agewall S, Clark AL, Atar D, Frankenstein L (2017)
Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure
Int J Cardiol, 238, 97-104
DOI 10.1016/j.ijcard.2017.03.028, PubMed 28342630

Wexels F, Dahl OE, Pripp AH, Seljeflot I (2017)
Thrombin Generation in Patients With Suspected Venous Thromboembolism
Clin Appl Thromb Hemost, 23 (5), 416-421
DOI 10.1177/1076029617700999, PubMed 28335612

Papp J, Zima E, Bover R, Karaliute R, Rossi A, Szymanski C, Troccoli R, Schneider J, Fagerland MW, Camm AJ, Atar D (2017)
Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry
Eur Heart J Cardiovasc Pharmacother, 3 (3), 147-150
DOI 10.1093/ehjcvp/pvx003, PubMed 28329309

Tamargo J, Rosano G, Walther T, Duarte J, Niessner A, Kaski JC, Ceconi C, Drexel H, Kjeldsen K, Savarese G, Torp-Pedersen C, Atar D, Lewis BS, Agewall S (2017)
Gender differences in the effects of cardiovascular drugs
Eur Heart J Cardiovasc Pharmacother, 3 (3), 163-182
DOI 10.1093/ehjcvp/pvw042, PubMed 28329228

Kvakkestad KM, Wang Fagerland M, Eritsland J, Halvorsen S (2017)
Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study
BMC Cardiovasc Disord, 17 (1), 75
DOI 10.1186/s12872-017-0508-3, PubMed 28288586

Mariampillai JE, Engeseth K, Kjeldsen SE, Grundvold I, Liestøl K, Erikssen G, Erikssen J, Bodegard J, Skretteberg PT (2017)
Exercise systolic blood pressure at moderate workload predicts cardiovascular disease and mortality through 35 years of follow-up in healthy, middle-aged men
Blood Press, 26 (4), 229-236
DOI 10.1080/08037051.2017.1291276, PubMed 28276720

Sanders MF, van Doormaal PJ, Beeftink MMA, Bots ML, Fadl Elmula FEM, Habets J, Hammer F, Hoffmann P, Jacobs L, Mark PB, Persu A, Renkin J, Roditi G, Spiering W, Staessen JA, Taylor AH, Verloop WL, Vink EE, Vonken EJ, Voskuil M, Leiner T, Blankestijn PJ, European Network COordinating research on Renal Denervation (ENCOReD) Consortium (2017)
Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiography
Eur Radiol, 27 (9), 3934-3941
DOI 10.1007/s00330-017-4770-7, PubMed 28271154

Woodhouse LJ, Manning L, Potter JF, Berge E, Sprigg N, Wardlaw J, Lees KR, Bath PM, Robinson TG, Blood Pressure in Acute Stroke Collaboration (2017)
Continuing or Temporarily Stopping Prestroke Antihypertensive Medication in Acute Stroke: An Individual Patient Data Meta-Analysis
Hypertension, 69 (5), 933-941
DOI 10.1161/HYPERTENSIONAHA.116.07982, PubMed 28264916

Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
PLoS One, 12 (3), e0173034
DOI 10.1371/journal.pone.0173034, PubMed 28253327

Seemann F, Pahlm U, Steding-Ehrenborg K, Ostenfeld E, Erlinge D, Dubois-Rande JL, Jensen SE, Atar D, Arheden H, Carlsson M, Heiberg E (2017)
Time-resolved tracking of the atrioventricular plane displacement in Cardiovascular Magnetic Resonance (CMR) images
BMC Med Imaging, 17 (1), 19
DOI 10.1186/s12880-017-0189-5, PubMed 28241751

Deyab G, Hokstad I, Whist JE, Småstuen MC, Agewall S, Lyberg T, Bottazzi B, Meroni PL, Leone R, Hjeltnes G, Hollan I (2017)
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
PLoS One, 12 (2), e0169830
DOI 10.1371/journal.pone.0169830, PubMed 28225768

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2017)
The INTERSTROKE Study: hypertension is by far the most important modifiable risk factor for stroke
Blood Press, 26 (3), 131-132
DOI 10.1080/08037051.2017.1292456, PubMed 28224820

Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2017)
Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
PLoS One, 12 (2), e0172558
DOI 10.1371/journal.pone.0172558, PubMed 28207887

Helseth R, Opstad T, Solheim S, Lunde K, Arnesen H, Seljeflot I (2015)
The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction
Cardiol Res, 6 (1), 209-215
DOI 10.14740/cr375w, PubMed 28197227

Messerli FH, Bangalore S, Kjeldsen SE (2017)
Letter by Messerli et al Regarding Article, "The Implications of Blood Pressure Measurement Methods on Treatment Targets for Blood Pressure"
Circulation, 135 (7), e45-e46
DOI 10.1161/CIRCULATIONAHA.116.025301, PubMed 28193803

Nilsson PM, Kjeldsen SE (2017)
Blood pressure goals in type 2 diabetes-assessing the evidence
Lancet Diabetes Endocrinol, 5 (5), 319-321
DOI 10.1016/S2213-8587(17)30035-9, PubMed 28169174

Brolin EB, Agewall S, Cederlund K, Ekenbäck C, Henareh L, Malmqvist K, Rück A, Svensson A, Tornvall P (2017)
Plasma biomarker levels and non-obstructive coronary artery disease determined by coronary computed tomography angiography
Clin Physiol Funct Imaging, 38 (2), 246-253
DOI 10.1111/cpf.12407, PubMed 28168796

Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P, WG on Cardiovascular Pharmacotherapy (2017)
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries
Eur Heart J, 38 (3), 143-153
DOI 10.1093/eurheartj/ehw149, PubMed 28158518

Ellingsen DG, Seljeflot I, Thomassen Y, Thomassen M, Bakke B, Ulvestad B (2017)
Biomarkers of endothelial activation and thrombosis in tunnel construction workers exposed to airborne contaminants
Int Arch Occup Environ Health, 90 (4), 309-317
DOI 10.1007/s00420-017-1199-x, PubMed 28124139

Mancia G, Kjeldsen SE (2017)
Adopting Systolic Pressure Intervention Trial (SPRINT)-like office blood pressure measurements in clinical practice
J Hypertens, 35 (3), 471-472
DOI 10.1097/HJH.0000000000001229, PubMed 28121838

Barer D, Berge E (2017)
Thrombolytic Treatment for Ischaemic Stroke: Could the Crisis of Confidence Have Been Avoided by Better Analysis of Trial Data?
Drugs Aging, 34 (2), 79-88
DOI 10.1007/s40266-016-0432-8, PubMed 28120326

Cwikiel J, Seljeflot I, Berge E, Arnesen H, Wachtell K, Ulsaker H, Flaa A (2017)
Pro-coagulant activity during exercise testing in patients with coronary artery disease
Thromb J, 15, 3
DOI 10.1186/s12959-016-0127-8, PubMed 28115916

Byrkjeland R, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2017)
Reduced endothelial activation after exercise is associated with improved HbA_1c in patients with type 2 diabetes and coronary artery disease
Diab Vasc Dis Res, 14 (2), 94-103
DOI 10.1177/1479164116679077, PubMed 28111980

Bratseth V, Byrkjeland R, Njerve IU, Solheim S, Arnesen H, Seljeflot I (2017)
Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training
Diab Vasc Dis Res, 14 (2), 144-151
DOI 10.1177/1479164116679080, PubMed 28111966

Kjeldsen SE, Mancia G (2017)
The Un-Observed Automated Office Blood Pressure Measurement Technique Used in the SPRINT Study Points to a Standard Target Office Systolic Blood Pressure <140 mmHg
Curr Hypertens Rep, 19 (1), 3
DOI 10.1007/s11906-017-0700-y, PubMed 28091868

Rubboli A, Agewall S, Huber K, Lip GYH (2017)
New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose
Eur J Intern Med, 40, e11-e12
DOI 10.1016/j.ejim.2017.01.003, PubMed 28087220

Mariampillai JE, Eskås PA, Heimark S, Larstorp AC, Fadl Elmula FE, Høieggen A, Nortvedt P (2017)
Apparent treatment-resistant hypertension - patient-physician relationship and ethical issues
Blood Press, 26 (3), 133-138
DOI 10.1080/08037051.2016.1277129, PubMed 28078909

Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, Funck-Brentano C, Kaski JC, Niessner A, Tamargo J, Walther T, Wassmann S, Rosano G, Schmidt H, Saely CH, Drexel H (2017)
Comprehensive efforts to increase adherence to statin therapy
Eur Heart J, 38 (32), 2473-2479
DOI 10.1093/eurheartj/ehw628, PubMed 28077470

Helseth R, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2016)
The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
Mediators Inflamm, 2016, 2182358
DOI 10.1155/2016/2182358, PubMed 28074081

Atar D (2017)
European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition
Eur Heart J Cardiovasc Pharmacother, 3 (1), 3-4
DOI 10.1093/ehjcvp/pvw024, PubMed 28062654

Agewall S (2017)
Anticoagulation, atherosclerosis, and heart failure
Eur Heart J Cardiovasc Pharmacother, 3 (1), 1-2
DOI 10.1093/ehjcvp/pvw037, PubMed 28062653

Olsen MB, Hildrestrand GA, Scheffler K, Vinge LE, Alfsnes K, Palibrk V, Wang J, Neurauter CG, Luna L, Johansen J, Øgaard JDS, Ohm IK, Slupphaug G, Kuśnierczyk A, Fiane AE, Brorson SH, Zhang L, Gullestad L, Louch WE, Iversen PO, Østlie I, Klungland A, Christensen G, Sjaastad I, Sætrom P et al. (2017)
NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture
Cell Rep, 18 (1), 82-92
DOI 10.1016/j.celrep.2016.12.009, PubMed 28052262

Myhre PL, Stridsberg M, Linko R, Okkonen M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H, FINNALI Study Group (2017)
Circulating chromogranin B levels in patients with acute respiratory failure: data from the FINNALI Study
Biomarkers, 22 (8), 775-781
DOI 10.1080/1354750X.2016.1269200, PubMed 28049363

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2017)
The INTERSALT Study and the complex relationship between salt intake and blood pressure
Blood Press, 26 (2), 65-66
DOI 10.1080/08037051.2016.1274957, PubMed 28049345

Husebye T, Eritsland J, Bjørnerheim R, Andersen GØ (2017)
Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure
Eur Heart J Acute Cardiovasc Care, 7 (4), 321-329
DOI 10.1177/2048872616687114, PubMed 28045338

Fossum S, Vikanes ÅV, Naess Ø, Vos L, Grotmol T, Halvorsen S (2016)
Hyperemesis gravidarum and long-term mortality: a population-based cohort study
BJOG, 124 (7), 1080-1087
DOI 10.1111/1471-0528.14454, PubMed 27981734

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2016)
The Global Burden of Disease Study 2015 and Blood Pressure
Blood Press, 26 (1), 1
DOI 10.1080/08037051.2016.1267557, PubMed 27951726

Atar D, Benussi S, Kirchhof P (2016)
'Ten Commandments' of 2016 ESC Guidelines for the management of atrial fibrillation
Eur Heart J, 37 (38), 2853
DOI 10.1093/eurheartj/ehw370, PubMed 27923817

Chiva-Blanch G, Bratseth V, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Badimon L, Seljeflot I (2016)
Monocyte-derived circulating microparticles (CD14⁺, CD14⁺/CD11b⁺ and CD14⁺/CD142⁺) are related to long-term prognosis for cardiovascular mortality in STEMI patients
Int J Cardiol, 227, 876-881
DOI 10.1016/j.ijcard.2016.11.302, PubMed 27915085

Thienpont B, Aronsen JM, Robinson EL, Okkenhaug H, Loche E, Ferrini A, Brien P, Alkass K, Tomasso A, Agrawal A, Bergmann O, Sjaastad I, Reik W, Roderick HL (2016)
The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy
J Clin Invest, 127 (1), 335-348
DOI 10.1172/JCI88353, PubMed 27893464

Engeseth K, Hodnesdal C, Grundvold I, Liestøl K, Gjesdal K, Kjeldsen SE, Erikssen JE, Bodegard J, Skretteberg PT (2016)
Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle-Aged Men: a 28-Year Follow-Up Study
J Am Heart Assoc, 5 (12)
DOI 10.1161/JAHA.116.004555, PubMed 27881424

Halvorsen S, Storey RF, Rocca B, Sibbing D, Ten Berg J, Grove EL, Weiss TW, Collet JP, Andreotti F, Gulba DC, Lip GYH, Husted S, Vilahur G, Morais J, Verheugt FWA, Lanas A, Al-Shahi Salman R, Steg PG, Huber K, ESC Working Group on Thrombosis (2017)
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis
Eur Heart J, 38 (19), 1455-1462
DOI 10.1093/eurheartj/ehw454, PubMed 27789570

Opstad TB, Brusletto BS, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
Cigarette smoking represses expression of cytokine IL-12 and its regulator miR-21-An observational study in patients with coronary artery disease
Immunobiology, 222 (2), 169-175
DOI 10.1016/j.imbio.2016.10.007, PubMed 27765464

Schwartz T, Diederichsen LP, Lundberg IE, Sjaastad I, Sanner H (2016)
Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies
RMD Open, 2 (2), e000291
DOI 10.1136/rmdopen-2016-000291, PubMed 27752355

Gjesdal K (2016)
Scandinavian Cardiovascular Journal - 50 years anniversary
Scand Cardiovasc J, 50 (5-6), 251-252
DOI 10.1080/14017431.2016.1249021, PubMed 27735190

Masefield S, Powell P, Jiménez-Ruiz C, Hajek P, Lewis K, Andreas S, Tønnesen P, van Schayck O, Gratziou C, Dautzenberg B, Tonstad S, Hering T, Nardini S, Fletcher M (2016)
Recommendations to improve smoking cessation outcomes from people with lung conditions who smoke
ERJ Open Res, 2 (2)
DOI 10.1183/23120541.00009-2016, PubMed 27730185

Beitland S, Waldum-Grevbo BE, Nakstad ER, Berg JP, Trøseid AS, Brusletto BS, Brunborg C, Andersen GØ, Sunde K (2016)
Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest
Crit Care, 20 (1), 314
DOI 10.1186/s13054-016-1503-2, PubMed 27716377

Agewall S, Lewis BS, Atar D (2016)
Cardiovascular pharmacotherapy
Int J Cardiol, 224, 412-415
DOI 10.1016/j.ijcard.2016.09.065, PubMed 27690338

Halvorsen S, Ghanima W, Fride Tvete I, Hoxmark C, Falck P, Solli O, Jonasson C (2016)
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
Eur Heart J Cardiovasc Pharmacother, 3 (1), 28-36
DOI 10.1093/ehjcvp/pvw031, PubMed 27680880

Kjeldsen SE, Dzongowski P, Li N, Wang L, Radlmaier A (2016)
Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study
J Clin Pharm Ther, 41 (6), 695-702
DOI 10.1111/jcpt.12451, PubMed 27670639

Camm AJ, Accetta G, Ambrosio G, Atar D, Bassand JP, Berge E, Cools F, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Kayani G, Koretsune Y, Mantovani LG, Misselwitz F, Oh S, Turpie AG, Verheugt FW, Kakkar AK, GARFIELD-AF Investigators (2016)
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
Heart, 103 (4), 307-314
DOI 10.1136/heartjnl-2016-309832, PubMed 27647168

Kjeldsen SE, Stenehjem A, Os I, Van de Borne P, Burnier M, Narkiewicz K, Redon J, Agabiti Rosei E, Mancia G (2016)
Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets
Blood Press, 25 (6), 333-336
DOI 10.1080/08037051.2016.1236329, PubMed 27644446

Mariampillai JE, Eskås PA, Heimark S, Kjeldsen SE, Narkiewicz K, Mancia G (2016)
A Case for Less Intensive Blood Pressure Control: It Matters to Achieve Target Blood Pressure Early and Sustained Below 140/90mmHg
Prog Cardiovasc Dis, 59 (3), 209-218
DOI 10.1016/j.pcad.2016.09.002, PubMed 27619341

Tanoue MT, Kjeldsen SE, Devereux RB, Okin PM (2016)
Relationship between abnormal P-wave terminal force in lead V₁ and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study
Blood Press, 26 (2), 94-101
DOI 10.1080/08037051.2016.1215765, PubMed 27601135

Agewall S (2016)
The application to MEDLINE from European Heart Journal-Cardiovascular Pharmacotherapy has been accepted!
Eur Heart J Cardiovasc Pharmacother, 2 (4), 207-8
DOI 10.1093/ehjcvp/pvw021, PubMed 27600901

Kjeldsen SE, Narkiewicz K, Oparil S (2016)
Blood Pressure in 2016: increased impact factor and change of editors
Blood Press, 25 (6), 331-332
DOI 10.1080/08037051.2016.1225493, PubMed 27592522

Bønaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nygård O, Nilsen DW, Kløw NE, Uchto M, Trovik T, Bendz B, Stavnes S, Bjørnerheim R, Larsen AI, Slette M, Steigen T, Jakobsen OJ, Bleie Ø, Fossum E, Hanssen TA, Dahl-Eriksen Ø, Njølstad I, Rasmussen K, Wilsgaard T, Nordrehaug JE et al. (2016)
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
N Engl J Med, 375 (13), 1242-52
DOI 10.1056/NEJMoa1607991, PubMed 27572953

Jortveit J, Govatsmark RE, Langørgen J, Hole T, Mannsverk J, Olsen S, Risøe C, Halvorsen S (2016)
Gender differences in the assessment and treatment of myocardial infarction
Tidsskr Nor Laegeforen, 136 (14-15), 1215-22
DOI 10.4045/tidsskr.16.0224, PubMed 27554562

Myhre PL, Ottesen AH, Okkonen M, Linko R, Stridsberg M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H, FINNALI Laboratory Study Group (2016)
Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study
Clin Chem, 62 (10), 1380-9
DOI 10.1373/clinchem.2016.258764, PubMed 27540029

Agewall S (2015)
Cardiovascular Pharmacotherapy is moving!
Eur Heart J Cardiovasc Pharmacother, 1 (3), 149
DOI 10.1093/ehjcvp/pvv025, PubMed 27533986

Ezekowitz JA, Lewis BS, Lopes RD, Wojdyla DM, McMurray JJ, Hanna M, Atar D, Cecilia Bahit M, Keltai M, Lopez-Sendon JL, Pais P, Ruzyllo W, Wallentin L, Granger CB, Alexander JH (2015)
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial
Eur Heart J Cardiovasc Pharmacother, 1 (2), 86-94
DOI 10.1093/ehjcvp/pvu024, PubMed 27533976

Agewall S (2015)
European Heart Journal - CVP: what is next?
Eur Heart J Cardiovasc Pharmacother, 1 (2), 73
DOI 10.1093/ehjcvp/pvv009, PubMed 27533970

Kjeldsen SE, Fadl Elmula FE, Os I, Persu A, Jin Y, Staessen JA (2015)
Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in patients with resistant hypertension to improve patients' adherence
Eur Heart J Cardiovasc Pharmacother, 1 (1), 48-56
DOI 10.1093/ehjcvp/pvu009, PubMed 27533966

Atar D, Agewall S (2015)
End of story? Studies on prevention of reperfusion injury encounter perpetual defeats
Eur Heart J Cardiovasc Pharmacother, 1 (1), 46-7
DOI 10.1093/ehjcvp/pvu018, PubMed 27533965

De Blois J, Fagerland MW, Grundtvig M, Semb AG, Gullestad L, Westheim A, Hole T, Atar D, Agewall S (2015)
ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry
Eur Heart J Cardiovasc Pharmacother, 1 (1), 31-6
DOI 10.1093/ehjcvp/pvu010, PubMed 27533962

Agewall S (2015)
European Heart Journal - Cardiovascular Pharmacotherapy: a new journal within the European Heart Journal family
Eur Heart J Cardiovasc Pharmacother, 1 (1), 1
DOI 10.1093/ehjcvp/pvu022, PubMed 27533955

Agewall S (2016)
News from EHJCVP
Eur Heart J Cardiovasc Pharmacother, 2 (3), 141
DOI 10.1093/ehjcvp/pvw010, PubMed 27533754

Schmidt M, Lamberts M, Olsen AM, Fosbøll EL, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C (2016)
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 2 (2), 108-18
DOI 10.1093/ehjcvp/pvv054, PubMed 27533522

Kjeldsen SE, Mancia G (2016)
Unobserved automated office blood pressure measurement in the Systolic Blood Pressure Intervention Trial (SPRINT): systolic blood pressure treatment target remains below 140 mmHg
Eur Heart J Cardiovasc Pharmacother, 2 (2), 79-80
DOI 10.1093/ehjcvp/pvw002, PubMed 27533517

Agewall S (2016)
Update from EHJ CVP
Eur Heart J Cardiovasc Pharmacother, 2 (2), 77-8
DOI 10.1093/ehjcvp/pvw004, PubMed 27533516

Agewall S (2016)
Second year of a journal
Eur Heart J Cardiovasc Pharmacother, 2 (1), 1-2
DOI 10.1093/ehjcvp/pvv049, PubMed 27533054

Agewall S (2015)
Starting up a new Journal within the European Heart Journal Family
Eur Heart J Cardiovasc Pharmacother, 1 (4), 213
DOI 10.1093/ehjcvp/pvv033, PubMed 27532442

Mancia G, Cha G, Gil-Extremera B, Harvey P, Lewin AJ, Villa G, Kjeldsen SE (2016)
Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial
J Hum Hypertens, 31 (3), 178-188
DOI 10.1038/jhh.2016.54, PubMed 27511476

Haissman JM, Haugaard AK, Knudsen A, Kristoffersen US, Seljeflot I, Pedersen KK, Lebech AM, Hasbak P, Kjær A, Ostrowski SR, Gerstoft J, Trøseid M, Nielsen SD (2016)
Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical Atherosclerosis
J Acquir Immune Defic Syndr, 73 (5), 507-513
DOI 10.1097/QAI.0000000000001148, PubMed 27509250

Alexander JH, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz JA, Halvorsen S, Hanna M, Commerford P, Ruzyllo W, Huber K, Al-Khatib SM, Granger CB, Wallentin L, Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation (ARISTOTLE) Investigators (2016)
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial
JAMA Cardiol, 1 (6), 673-81
DOI 10.1001/jamacardio.2016.1829, PubMed 27463942

Kjeldsen SE, Aksnes TA, Wachtell K, Okin PM (2016)
Arterial Stiffness Predicts Incident Atrial Fibrillation in the Framingham Heart Study: A Mechanistic Contribution in People With High Blood Pressure or History of Hypertension
Hypertension, 68 (3), 555-7
DOI 10.1161/HYPERTENSIONAHA.116.07671, PubMed 27456524

McGuire DK, Van de Werf F, Armstrong PW, Standl E, Koglin J, Green JB, Bethel MA, Cornel JH, Lopes RD, Halvorsen S, Ambrosio G, Buse JB, Josse RG, Lachin JM, Pencina MJ, Garg J, Lokhnygina Y, Holman RR, Peterson ED, Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) Study Group (2016)
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial
JAMA Cardiol, 1 (2), 126-35
DOI 10.1001/jamacardio.2016.0103, PubMed 27437883

Gresslien T, Agewall S (2016)
Troponin and exercise
Int J Cardiol, 221, 609-21
DOI 10.1016/j.ijcard.2016.06.243, PubMed 27420587

Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GØ (2016)
Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
J Am Heart Assoc, 5 (6)
DOI 10.1161/JAHA.115.003014, PubMed 27412895

Nordlund D, Heiberg E, Carlsson M, Fründ ET, Hoffmann P, Koul S, Atar D, Aletras AH, Erlinge D, Engblom H, Arheden H (2016)
Extent of Myocardium at Risk for Left Anterior Descending Artery, Right Coronary Artery, and Left Circumflex Artery Occlusion Depicted by Contrast-Enhanced Steady State Free Precession and T2-Weighted Short Tau Inversion Recovery Magnetic Resonance Imaging
Circ Cardiovasc Imaging, 9 (7)
DOI 10.1161/CIRCIMAGING.115.004376, PubMed 27412659

Tegn N, Abdelnoor M, Aaberge L, Endresen K, Bendz B (2016)
Invasive strategy in acute coronary syndrome - Authors' reply
Lancet, 387 (10037), 2504
DOI 10.1016/S0140-6736(16)30673-0, PubMed 27353680

Neerland BE, Hall RJ, Seljeflot I, Frihagen F, MacLullich AM, Raeder J, Wyller TB, Watne LO (2016)
Associations Between Delirium and Preoperative Cerebrospinal Fluid C-Reactive Protein, Interleukin-6, and Interleukin-6 Receptor in Individuals with Acute Hip Fracture
J Am Geriatr Soc, 64 (7), 1456-63
DOI 10.1111/jgs.14238, PubMed 27341529

Abdelnoor M, Vengen ØA, Johansen O, Sandven I, Abdelnoor AM (2016)
Latitude of the study place and age of the patient are associated with incidence of mediastinitis and microbiology in open-heart surgery: a systematic review and meta-analysis
Clin Epidemiol, 8, 151-63
DOI 10.2147/CLEP.S96107, PubMed 27330329

Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Floch CL, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M et al. (2016)
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]
Eur J Heart Fail, 18 (6), 727
DOI 10.1002/ejhf.591, PubMed 27324688

Beitland S, Nakstad ER, Staer-Jensen H, Draegni T, Andersen GØ, Jacobsen D, Brunborg C, Waldum-Grevbo B, Sunde K (2016)
Impact of acute kidney injury on patient outcome in out-of-hospital cardiac arrest: a prospective observational study
Acta Anaesthesiol Scand, 60 (8), 1170-81
DOI 10.1111/aas.12753, PubMed 27306254

Berra E, Azizi M, Capron A, Høieggen A, Rabbia F, Kjeldsen SE, Staessen JA, Wallemacq P, Persu A (2016)
Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension
Hypertension, 68 (2), 297-306
DOI 10.1161/HYPERTENSIONAHA.116.07464, PubMed 27296995

Helseth R (2016)
[Not Available]
Tidsskr Nor Laegeforen, 136 (10), 945
DOI 10.4045/tidsskr.16.0318, PubMed 27272379

Okin PM, Kamel H, Kjeldsen SE, Devereux RB (2016)
Electrocardiographic left atrial abnormalities and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy
J Hypertens, 34 (9), 1831-7
DOI 10.1097/HJH.0000000000000989, PubMed 27254312

Halvorsen S, Jortveit J, Hasvold P, Thuresson M, Øie E (2016)
Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
BMC Cardiovasc Disord, 16, 115
DOI 10.1186/s12872-016-0283-6, PubMed 27246583

Næss PA, Engeseth K, Grøtta O, Andersen GØ, Gaarder C (2016)
Minimal invasive treatment of life-threatening bleeding caused by cardiopulmonary resuscitation-associated liver injury: a case report
J Med Case Rep, 10 (1), 132
DOI 10.1186/s13256-016-0926-3, PubMed 27236329

Nieminen MS, Buerke M, Cohen-Solál A, Costa S, Édes I, Erlikh A, Franco F, Gibson C, Gorjup V, Guarracino F, Gustafsson F, Harjola VP, Husebye T, Karason K, Katsytadze I, Kaul S, Kivikko M, Marenzi G, Masip J, Matskeplishvili S, Mebazaa A, Møller JE, Nessler J, Nessler B, Ntalianis A et al. (2016)
The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion
Int J Cardiol, 218, 150-157
DOI 10.1016/j.ijcard.2016.05.009, PubMed 27232927

Jusufovic M, Sandset EC, Bath PM, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2016)
Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST)
J Hypertens, 34 (8), 1594-8
DOI 10.1097/HJH.0000000000000980, PubMed 27228435

Bliksøen M, Mariero LH, Torp MK, Baysa A, Ytrehus K, Haugen F, Seljeflot I, Vaage J, Valen G, Stensløkken KO (2016)
Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes
Basic Res Cardiol, 111 (4), 42
DOI 10.1007/s00395-016-0553-6, PubMed 27164906

Kjeldsen SE, Hedner T, Narkiewicz K (2016)
HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHg
Blood Press, 25 (3), 131-2
DOI 10.1080/08037051.2016.1182857, PubMed 27160151

Tanoue MT, Kjeldsen SE, Devereux RB, Okin PM (2016)
Relationship of diastolic function to new or persistent electrocardiographic left ventricular hypertrophy
Blood Press, 25 (6), 364-372
DOI 10.1080/08037051.2016.1179514, PubMed 27146272

Engblom H, Tufvesson J, Jablonowski R, Carlsson M, Aletras AH, Hoffmann P, Jacquier A, Kober F, Metzler B, Erlinge D, Atar D, Arheden H, Heiberg E (2016)
A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data
J Cardiovasc Magn Reson, 18 (1), 27
DOI 10.1186/s12968-016-0242-5, PubMed 27145749

Horjen AW, Ulimoen SR, Enger S, Norseth J, Seljeflot I, Arnesen H, Tveit A (2016)
Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing
BMC Cardiovasc Disord, 16, 79
DOI 10.1186/s12872-016-0255-x, PubMed 27142292

Heimark S, Eskås PA, Mariampillai JE, Larstorp AC, Høieggen A, Fadl Elmula FE (2016)
Tertiary work-up of apparent treatment-resistant hypertension
Blood Press, 25 (5), 312-8
DOI 10.3109/08037051.2016.1172865, PubMed 27124769

Berge E, Stapf C, Al-Shahi Salman R, Ford GA, Sandercock P, van der Worp HB, Petersson J, Dippel DW, Krieger DW, Lees KR, ESO Trials Network Committee (2016)
Methods to improve patient recruitment and retention in stroke trials
Int J Stroke, 11 (6), 663-76
DOI 10.1177/1747493016641963, PubMed 27118766

Graham JJ, Yan AT, Tan MK, Cantor WJ, DiMario C, Jolly SS, Halvorsen S, Fernandez-Aviles F, Le May MR, Scheller B, Borgia F, Piscione F, Madan M, Goodman SG (2016)
Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials
Cardiovasc Revasc Med, 17 (5), 295-301
DOI 10.1016/j.carrev.2016.03.008, PubMed 27116940

Myhre PL, Tiainen M, Pettilä V, Vaahersalo J, Hagve TA, Kurola J, Varpula T, Omland T, Røsjø H, FINNRESUSCI Laboratory Study Group (2016)
NT-proBNP in patients with out-of-hospital cardiac arrest: Results from the FINNRESUSCI Study
Resuscitation, 104, 12-8
DOI 10.1016/j.resuscitation.2016.04.007, PubMed 27109503

Kotecha D, Manzano L, Krum H, Rosano G, Holmes J, Altman DG, Collins PD, Packer M, Wikstrand J, Coats AJ, Cleland JG, Kirchhof P, von Lueder TG, Rigby AS, Andersson B, Lip GY, van Veldhuisen DJ, Shibata MC, Wedel H, Böhm M, Flather MD, Beta-Blockers in Heart Failure Collaborative Group (2016)
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
BMJ, 353, i1855
DOI 10.1136/bmj.i1855, PubMed 27098105

Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Le Floch C, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M et al. (2016)
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
Eur J Heart Fail, 18 (5), 482-9
DOI 10.1002/ejhf.516, PubMed 27071916

Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, Hanna M, Hijazi Z, Jansky P, Lopes RD, Wallentin L (2016)
The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
Eur Heart J, 37 (38), 2869-2878
DOI 10.1093/eurheartj/ehw124, PubMed 27071819

Hedner T, Kjeldsen SE, Narkiewicz K, Oparil S (2016)
The polypill: an emerging treatment alternative for secondary prevention of cardiovascular disease
Blood Press, 25 (5), 276-9
DOI 10.3109/08037051.2016.1139324, PubMed 27071504

Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
Combined Elevated Levels of the Proinflammatory Cytokines IL-18 and IL-12 Are Associated with Clinical Events in Patients with Coronary Artery Disease: An Observational Study
Metab Syndr Relat Disord, 14 (5), 242-8
DOI 10.1089/met.2015.0130, PubMed 27058587

Kjeldsen SE, Os I (2016)
Hypertension: When should we treat hypertension in patients with diabetes?
Nat Rev Cardiol, 13 (5), 252-3
DOI 10.1038/nrcardio.2016.49, PubMed 27053453

Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I (2016)
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
Diabetes Metab Syndr Obes, 9, 55-62
DOI 10.2147/DMSO.S96299, PubMed 27042130

Kjeldsen SE, Os I (2016)
High blood pressure in US diabetic veterans with normal renal function: a plea for the design of a more powerful and conclusive outcome trial
J Hypertens, 34 (5), 836-7
DOI 10.1097/HJH.0000000000000896, PubMed 27027378

von Lueder TG, Girerd N (2016)
The Prognostic Role of Serum Uric Acid (SUA) in Coronary Artery Disease: PerSUAsive Data Plea for a Large Morbidity-Mortality Trial
Cardiology, 134 (3), 357-9
DOI 10.1159/000444744, PubMed 27007801

Nordlund D, Klug G, Heiberg E, Koul S, Larsen TH, Hoffmann P, Metzler B, Erlinge D, Atar D, Aletras AH, Carlsson M, Engblom H, Arheden H (2016)
Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction
Eur Heart J Cardiovasc Imaging, 17 (7), 744-53
DOI 10.1093/ehjci/jew027, PubMed 27002140

Kjeldsen SE, Lund-Johansen P, Nilsson PM, Mancia G (2016)
Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials
Hypertension, 67 (5), 808-12
DOI 10.1161/HYPERTENSIONAHA.116.07257, PubMed 27001295

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Arnesen H, Solheim S (2016)
Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
J Lipids, 2016, 4945720
DOI 10.1155/2016/4945720, PubMed 26989512

Schmidt M, Lamberts M, Olsen AM, Fosbøll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C (2016)
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J, 37 (13), 1015-23
DOI 10.1093/eurheartj/ehv505, PubMed 26984863

Palatini P, Rosei EA, Casiglia E, Chalmers J, Ferrari R, Grassi G, Inoue T, Jelakovic B, Jensen MT, Julius S, Kjeldsen SE, Mancia G, Parati G, Pauletto P, Stella A, Zanchetti A (2016)
Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension
J Hypertens, 34 (5), 813-21
DOI 10.1097/HJH.0000000000000865, PubMed 26982382

Engblom H, Heiberg E, Erlinge D, Jensen SE, Nordrehaug JE, Dubois-Randé JL, Halvorsen S, Hoffmann P, Koul S, Carlsson M, Atar D, Arheden H (2016)
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint
J Am Heart Assoc, 5 (3), e002708
DOI 10.1161/JAHA.115.002708, PubMed 26961520

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Collet JP, Halvorsen S, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Ricci F, Sibbing D, Siegbahn A, Storey RF, Ten Berg J, Verheugt FW, Weitz JI (2016)
Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
Thromb Haemost, 115 (4), 685-711
DOI 10.1160/TH15-09-0703, PubMed 26952877

von Lueder TG, Hopper I, Kotecha D, Atar D (2016)
In memoriam Henry Krum, 1958-2015
Cardiology, 134 (2), 107-8
DOI 10.1159/000444294, PubMed 26950607

Tufvesson J, Carlsson M, Aletras AH, Engblom H, Deux JF, Koul S, Sörensson P, Pernow J, Atar D, Erlinge D, Arheden H, Heiberg E (2016)
Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT
BMC Med Imaging, 16, 19
DOI 10.1186/s12880-016-0124-1, PubMed 26946139

Jusufovic M, Mishra NK, Lansberg MG, Bath PM, Berge E, Sandset EC (2016)
Blood Pressure Management in Acute Stroke
Curr Hypertens Rev, 12 (2), 121-6
DOI 10.2174/1573402112666160302102711, PubMed 26931471

Hilde JM, Skjørten I, Hansteen V, Melsom MN, Atar D, Hisdal J, Humerfelt S, Steine K (2016)
Assessment of Right Ventricular Afterload in COPD
COPD, 13 (2), 176-85
DOI 10.3109/15412555.2015.1057275, PubMed 26914261

Blyme A, Asferg C, Nielsen OW, Boman K, Gohlke-Bärwolf C, Wachtell K, Olsen MH (2016)
Increased hsCRP is associated with higher risk of aortic valve replacement in patients with aortic stenosis
Scand Cardiovasc J, 50 (3), 138-45
DOI 10.3109/14017431.2016.1151928, PubMed 26911132

Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T (2016)
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Eur Heart J, 37 (21), 1671-80
DOI 10.1093/eurheartj/ehw022, PubMed 26903532

Elliott HL, Kjeldsen SE, Narkiewicz K, Hedner T (2016)
Peter Meredith
Blood Press, 25 (2), 129-30
DOI 10.3109/08037051.2016.1139360, PubMed 26873622

Myhre PL, Laake K, Seljeflot I, Solheim S, Arnesen H (2016)
[Clinical research on elderly]
Tidsskr Nor Laegeforen, 136 (3), 208
DOI 10.4045/tidsskr.15.1300, PubMed 26860377

Hopper I, Kotecha D, Chin KL, Mentz RJ, von Lueder TG (2016)
Comorbidities in Heart Failure: Are There Gender Differences?
Curr Heart Fail Rep, 13 (1), 1-12
DOI 10.1007/s11897-016-0280-1, PubMed 26829930

Kjeldsen SE, Cha G, Villa G, Mancia G, DISTINCT Investigators (2016)
Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses
J Clin Pharmacol, 56 (9), 1120-9
DOI 10.1002/jcph.712, PubMed 26829251

Santos-Gallego CG, Vahl TP, Goliasch G, Picatoste B, Arias T, Ishikawa K, Njerve IU, Sanz J, Narula J, Sengupta PP, Hajjar RJ, Fuster V, Badimon JJ (2016)
Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion
Circulation, 133 (10), 954-66
DOI 10.1161/CIRCULATIONAHA.115.012427, PubMed 26826180

Aksnes TA, Kjeldsen SE, Rostrup M, Holzhauer B, Hua TA, Julius S (2016)
Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial
Blood Press, 25 (4), 235-40
DOI 10.3109/08037051.2015.1134071, PubMed 26808585

Byrkjeland R, Stensæth KH, Anderssen S, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2016)
Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques
Cardiovasc Diabetol, 15, 13
DOI 10.1186/s12933-016-0336-2, PubMed 26801098

Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S, Gjertsen E, Dahl-Hofseth O, Ranhoff AH, Gullestad L, Bendz B, After Eighty study investigators (2016)
Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial
Lancet, 387 (10023), 1057-1065
DOI 10.1016/S0140-6736(15)01166-6, PubMed 26794722

Bainey KR, Fresco C, Zheng Y, Halvorsen S, Carvalho A, Ostojic M, Goldstein P, Gershlick AH, Westerhout CM, Van de Werf F, Armstrong PW, STREAM Investigators (2016)
Implications of ischaemic area at risk and mode of reperfusion in ST-elevation myocardial infarction
Heart, 102 (7), 527-33
DOI 10.1136/heartjnl-2015-308075, PubMed 26783237

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D et al. (2016)
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke
J Hypertens, 34 (3), 393-6
DOI 10.1097/HJH.0000000000000853, PubMed 26780185

Kjeldsen SE, Narkiewicz K, Hedner T, Mancia G (2016)
The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg
Blood Press, 25 (2), 63-6
DOI 10.3109/08037051.2015.1130775, PubMed 26743157

Persu A, Kjeldsen S, Staessen JA, Azizi M (2016)
Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges
Curr Hypertens Rep, 18 (1), 6
DOI 10.1007/s11906-015-0610-9, PubMed 26739586

Hasvold P, Thuresson M, Sundström J, Hammar N, Kjeldsen SE, Johansson G, Holme I, Bodegård J (2016)
Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting
Clin Drug Investig, 36 (3), 225-33
DOI 10.1007/s40261-015-0372-9, PubMed 26718960

Skårn SN, Eggesbø HB, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Aksnes TA (2015)
Predictors of abdominal adipose tissue compartments: 18-year follow-up of young men with and without family history of diabetes
Eur J Intern Med, 29, 26-31
DOI 10.1016/j.ejim.2015.11.027, PubMed 26712453

Horjen AW, Ulimoen SR, Seljeflot I, Smith P, Arnesen H, Norseth J, Tveit A (2015)
High-Sensitivity Troponin I and Rhythm Outcome after Electrical Cardioversion for Persistent Atrial Fibrillation
Cardiology, 133 (4), 233-8
DOI 10.1159/000442249, PubMed 26697854

Krishnan K, Scutt P, Woodhouse L, Adami A, Becker JL, Berge E, Cala LA, Casado AM, Caso V, Chen C, Christensen H, Collins R, Czlonkowska A, Dineen RA, Gommans J, Koumellis P, Lees KR, Ntaios G, Ozturk S, Phillips SJ, Pocock SJ, de Silva A, Sprigg N, Szatmari S, Wardlaw JM et al. (2015)
Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis
Stroke, 47 (1), 44-52
DOI 10.1161/STROKEAHA.115.010368, PubMed 26645254

Rao MP, Halvorsen S, Wojdyla D, Thomas L, Alexander JH, Hylek EM, Hanna M, Bahit MC, Lopes RD, De Caterina R, Erol C, Goto S, Lanas F, Lewis BS, Husted S, Gersh BJ, Wallentin L, Granger CB, Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Steering Committee and Investigators (2015)
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
J Am Heart Assoc, 4 (12)
DOI 10.1161/JAHA.115.002015, PubMed 26627878

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M et al. (2015)
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
Clin Infect Dis, 62 (5), 655-663
DOI 10.1093/cid/civ963, PubMed 26620652

Bang CN, Greve AM, La Cour M, Boman K, Gohlke-Bärwolf C, Ray S, Pedersen T, Rossebø A, Okin PM, Devereux RB, Wachtell K (2015)
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
Am J Cardiol, 116 (12), 1840-4
DOI 10.1016/j.amjcard.2015.09.026, PubMed 26602073

Wexels F, Seljeflot I, Pripp AH, Dahl OE (2016)
D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism
Blood Coagul Fibrinolysis, 27 (4), 396-400
DOI 10.1097/MBC.0000000000000461, PubMed 26595215

Mancia G, Kjeldsen SE, Zappe DH, Holzhauer B, Hua TA, Zanchetti A, Julius S, Weber MA (2015)
Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial
Eur Heart J, 37 (12), 955-64
DOI 10.1093/eurheartj/ehv633, PubMed 26590384

Steen T (2015)
[Re: The practice consultant scheme at a crossroads]
Tidsskr Nor Laegeforen, 135 (20), 1813
DOI 10.4045/tidsskr.15.1071, PubMed 26534792

Sunde K, Andersen GØ (2015)
Prediction of outcome after out-of-hospital cardiac arrest already on hospital admission-not reliable enough to be true!
Eur Heart J, 37 (42), 3229-3231
DOI 10.1093/eurheartj/ehv490, PubMed 26516178

Kjeldsen SE, Berge E, Bangalore S, Messerli FH, Mancia G, Holzhauer B, Hua TA, Zappe D, Zanchetti A, Weber MA, Julius S (2015)
No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial
Blood Press, 25 (2), 83-92
DOI 10.3109/08037051.2015.1106750, PubMed 26511535

Gjerdalen GF, Hisdal J, Solberg EE, Andersen TE, Radunovic Z, Steine K (2015)
Atrial Size and Function in Athletes
Int J Sports Med, 36 (14), 1170-6
DOI 10.1055/s-0035-1555780, PubMed 26509381

Barth Z, Nomeland Witczak B, Schwartz T, Gjesdal K, Flatø B, Koller A, Sanner H, Sjaastad I (2015)
In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset
Rheumatology (Oxford), 55 (3), 535-43
DOI 10.1093/rheumatology/kev376, PubMed 26500284

Atar D, Agewall S (2015)
Morphine in myocardial infarction: balancing on the tight rope
Eur Heart J, 37 (3), 253-5
DOI 10.1093/eurheartj/ehv546, PubMed 26491111

Gerdts E, Rossebø AB, Pedersen TR, Cioffi G, Lønnebakken MT, Cramariuc D, Rogge BP, Devereux RB (2015)
Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis
Circ Cardiovasc Imaging, 8 (11), e003644; discussion e003644
DOI 10.1161/CIRCIMAGING.115.003644, PubMed 26489804

Berge E, Cohen G, Lindley RI, Sandercock P, Wardlaw JM, Sandset EC, Whiteley W (2015)
Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke
Stroke, 46 (12), 3362-9
DOI 10.1161/STROKEAHA.115.010319, PubMed 26486868

Fadl Elmula FE, Rebora P, Talvik A, Salerno S, Miszkowska-Nagórna E, Liu X, Heinpalu-Kuum M, Comotti T, Larstorp AC, Rostrup M, Świerblewska E, Valsecchi MG, Kjeldsen SE, Viigimaa M, Narkiewicz K, Parati G, Laurent S, BEtter control of blood pressure in hypertensive pAtients monitored Using the HOTMAN sYstem (BEAUTY) Study Investigators (2015)
A randomized and controlled study of noninvasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients
J Hypertens, 33 (12), 2534-45
DOI 10.1097/HJH.0000000000000749, PubMed 26485460

Ellingsrud C, Agewall S (2015)
Morphine in the treatment of acute pulmonary oedema--Why?
Int J Cardiol, 202, 870-3
DOI 10.1016/j.ijcard.2015.10.014, PubMed 26476045

Helseth R, Weiss TW, Opstad TB, Siegbahn A, Solheim S, Freynhofer MK, Huber K, Arnesen H, Seljeflot S (2015)
Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction
Thromb Res, 136 (6), 1240-4
DOI 10.1016/j.thromres.2015.10.005, PubMed 26475405

Steffel J, Atar D (2015)
Non-vitamin K oral anticoagulants in 'valvular' atrial fibrillation: a call for action
Europace, 18 (1), 1-3
DOI 10.1093/europace/euv318, PubMed 26462701

Kjeldsen SE, Oparil S, Narkiewicz K, Hedner T (2015)
The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg
Blood Press, 25 (1), 1-3
DOI 10.3109/08037051.2016.1096564, PubMed 26462684

Stær-Jensen H, Nakstad ER, Fossum E, Mangschau A, Eritsland J, Drægni T, Jacobsen D, Sunde K, Andersen GØ (2015)
Post-Resuscitation ECG for Selection of Patients for Immediate Coronary Angiography in Out-of-Hospital Cardiac Arrest
Circ Cardiovasc Interv, 8 (10)
DOI 10.1161/CIRCINTERVENTIONS.115.002784, PubMed 26453688

Kjeldsen SE, Berge E (2015)
Blood pressure and early neurological deterioration in acute ischemic stroke
J Hypertens, 33 (10), 2020-1
DOI 10.1097/HJH.0000000000000689, PubMed 26431189

von Lueder TG, Girerd N, Atar D, Agewall S, Lamiral Z, Kanbay M, Pitt B, Dickstein K, Zannad F, Rossignol P, High-Risk Myocardial Infarction Database Initiative Investigators (2015)
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative
Eur J Heart Fail, 17 (11), 1144-51
DOI 10.1002/ejhf.419, PubMed 26424212

von Lueder TG, Krum H (2015)
New medical therapies for heart failure
Nat Rev Cardiol, 12 (12), 730-40
DOI 10.1038/nrcardio.2015.137, PubMed 26416006

Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K (2015)
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
Cardiovasc Diabetol, 14, 126
DOI 10.1186/s12933-015-0292-2, PubMed 26408307

Halvorsen B, Espeland MZ, Andersen GØ, Yndestad A, Sagen EL, Rashidi A, Knudsen EC, Skjelland M, Skagen KR, Krohg-Sørensen K, Holm S, Ritschel V, Holven KB, Biessen EA, Aukrust P, Dahl TB (2015)
Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages
Atherosclerosis, 243 (1), 204-10
DOI 10.1016/j.atherosclerosis.2015.09.010, PubMed 26402139

Hansen CH, Ritschel V, Halvorsen S, Andersen GØ, Bjørnerheim R, Eritsland J, Arnesen H, Seljeflot I (2015)
Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
Thromb J, 13, 31
DOI 10.1186/s12959-015-0061-1, PubMed 26396552

Lindholm D, Storey RF, Christersson C, Halvorsen S, Grove EL, Braun OÖ, Varenhorst C, James SK (2015)
Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr
Am Heart J, 170 (3), 465-70
DOI 10.1016/j.ahj.2015.06.014, PubMed 26385029

Vishram JK, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Mancia G, Okin PM, Rothwell PM, Wachtell K, Olsen MH (2015)
Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy
J Hypertens, 33 (12), 2422-30
DOI 10.1097/HJH.0000000000000739, PubMed 26378687

Vinereanu D, Stevens SR, Alexander JH, Al-Khatib SM, Avezum A, Bahit MC, Granger CB, Lopes RD, Halvorsen S, Hanna M, Husted S, Hylek EM, Mărgulescu AD, Wallentin L, Atar D (2015)
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial
Eur Heart J, 36 (46), 3268-75
DOI 10.1093/eurheartj/ehv447, PubMed 26371113

Dudek D, Siudak Z, Solheim S (2015)
New model of secondary cardiovascular prevention for patients after acute coronary syndromes in Poland with regard to Norwegian experiences
Kardiol Pol, 74 (2), 101-3
DOI 10.5603/KP.a2015.0176, PubMed 26365935

Shavadia J, Zheng Y, Dianati Maleki N, Huber K, Halvorsen S, Goldstein P, Gershlick AH, Wilcox R, Van de Werf F, Armstrong PW (2015)
Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
J Am Heart Assoc, 4 (8), e002049
DOI 10.1161/JAHA.115.002049, PubMed 26304934

Seiffge DJ, Hooff RJ, Nolte CH, Béjot Y, Turc G, Ikenberg B, Berge E, Persike M, Dequatre-Ponchelle N, Strbian D, Pfeilschifter W, Zini A, Tveiten A, Næss H, Michel P, Sztajzel R, Luft A, Gensicke H, Traenka C, Hert L, Scheitz JF, De Marchis GM, Bonati LH, Peters N, Charidimou A et al. (2015)
Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome
Circulation, 132 (13), 1261-9
DOI 10.1161/CIRCULATIONAHA.115.015484, PubMed 26232277

Gjesdal K, Grundvold I (2015)
Atrial fibrillation and exercise in women: some answers given, some questions remain
Heart, 101 (20), 1605-6
DOI 10.1136/heartjnl-2015-307836, PubMed 26206848

Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, Persu A, Sapoval M, Rosa J, Widimský P, Jacobs L, Renkin J, Petrák O, Chatellier G, Shimada K, Widimský J, Kario K, Azizi M, Kjeldsen SE, Staessen JA, European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium (2015)
Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension
Blood Press, 24 (5), 263-74
DOI 10.3109/08037051.2015.1058595, PubMed 26194721

Andric T, Weiss TW, Huber K, Arnesen H, Seljeflot I (2015)
Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly men
Scand J Clin Lab Invest, 75 (8), 646-51
DOI 10.3109/00365513.2015.1063002, PubMed 26179891

Fröhlich H, Zhao J, Täger T, Cebola R, Schellberg D, Katus HA, Grundtvig M, Hole T, Atar D, Agewall S, Frankenstein L (2015)
Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study
Circ Heart Fail, 8 (5), 887-96
DOI 10.1161/CIRCHEARTFAILURE.114.001701, PubMed 26175538

Abdel-Qadir H, Yan AT, Tan M, Borgia F, Piscione F, Di Mario C, Halvorsen S, Cantor WJ, Westerhout CM, Scheller B, Le May MR, Fernandez-Aviles F, Sánchez PL, Lee DS, Goodman SG (2015)
Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysis
Heart, 101 (19), 1554-61
DOI 10.1136/heartjnl-2015-307815, PubMed 26175478

Hopper I, Skiba M, von Lueder TG, Watanabe M, Funston R, Tonkin A, Krum H (2015)
Digoxin withdrawal worsens clinical status in stable patients with heart failure receiving optimal contemporaneous therapy--a randomized controlled trial
J Card Fail, 21 (9), 779-81
DOI 10.1016/j.cardfail.2015.07.003, PubMed 26169443

Andreotti F, Rocca B, Husted S, Ajjan RA, ten Berg J, Cattaneo M, Collet JP, De Caterina R, Fox KA, Halvorsen S, Huber K, Hylek EM, Lip GY, Montalescot G, Morais J, Patrono C, Verheugt FW, Wallentin L, Weiss TW, Storey RF, ESC Thrombosis Working Group (2015)
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
Eur Heart J, 36 (46), 3238-49
DOI 10.1093/eurheartj/ehv304, PubMed 26163482

Brolin EB, Agewall S, Brismar TB, Caidahl K, Tornvall P, Cederlund K (2015)
Neither endothelial function nor carotid artery intima-media thickness predicts coronary computed tomography angiography plaque burden in clinically healthy subjects: a cross-sectional study
BMC Cardiovasc Disord, 15, 63
DOI 10.1186/s12872-015-0061-x, PubMed 26148508

Hollan I, Dessein PH, Ronda N, Wasko MC, Svenungsson E, Agewall S, Cohen-Tervaert JW, Maki-Petaja K, Grundtvig M, Karpouzas GA, Meroni PL (2015)
Prevention of cardiovascular disease in rheumatoid arthritis
Autoimmun Rev, 14 (10), 952-69
DOI 10.1016/j.autrev.2015.06.004, PubMed 26117596

Khan R, Lopes RD, Neely ML, Stevens SR, Harrington RA, Diaz R, Cools F, Jansky P, Montalescot G, Atar D, Lopez-Sendon J, Flather M, Liaw D, Wallentin L, Alexander JH, Goodman SG, Apixaban for Prevention of Acute Ischemic Safety Events (APPRAISE)-2 Steering Committee and Investigators (2015)
Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome
Heart, 101 (18), 1475-84
DOI 10.1136/heartjnl-2014-307346, PubMed 26109589

Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA, Gulizia M, Halvorsen S, Hindricks G, Kuck KH, Moya A, Potpara T, Roldan V, Tilz R, Lip GY (2015)
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)
Europace, 17 (8), 1197-214
DOI 10.1093/europace/euv190, PubMed 26105732

Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
Family history of hypertension and serum triglycerides predict future insulin sensitivity: a 17-year follow-up study of young men
J Hypertens, 33 (9), 1845-51; discussion 1852
DOI 10.1097/HJH.0000000000000632, PubMed 26103130

Rubboli A, Agewall S, Huber K, Lip GY (2015)
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint
Int J Cardiol, 196, 133-8
DOI 10.1016/j.ijcard.2015.06.006, PubMed 26093527

Byrkjeland R, Njerve IU, Anderssen S, Arnesen H, Seljeflot I, Solheim S (2015)
Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: A randomised clinical trial
Diab Vasc Dis Res, 12 (5), 325-33
DOI 10.1177/1479164115590552, PubMed 26092822

Jackson N, Atar D, Borentain M, Breithardt G, van Eickels M, Endres M, Fraass U, Friede T, Hannachi H, Janmohamed S, Kreuzer J, Landray M, Lautsch D, Le Floch C, Mol P, Naci H, Samani NJ, Svensson A, Thorstensen C, Tijssen J, Vandzhura V, Zalewski A, Kirchhof P (2015)
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology
Eur Heart J, 37 (9), 747-54
DOI 10.1093/eurheartj/ehv213, PubMed 26077039

Cero FT, Hillestad V, Sjaastad I, Yndestad A, Aukrust P, Ranheim T, Lunde IG, Olsen MB, Lien E, Zhang L, Haugstad SB, Løberg EM, Christensen G, Larsen KO, Skjønsberg OH (2015)
Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice
Am J Physiol Lung Cell Mol Physiol, 309 (4), L378-87
DOI 10.1152/ajplung.00342.2014, PubMed 26071556

Hornslien AG, Sandset EC, Wyller TB, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2015)
Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months
J Hypertens, 33 (7), 1487-91
DOI 10.1097/HJH.0000000000000581, PubMed 26039534

Atar D (2015)
The National Cardiac Societies of the European Society of Cardiology
Eur Heart J, 36 (21), 1278
DOI 10.1093/eurheartj/ehv091, PubMed 26034059

Ladeiras-Lopes R, Agewall S, Tawakol A, Staels B, Stein E, Mentz RJ, Leite-Moreira A, Zannad F, Koenig W (2015)
Atherosclerosis: Recent trials, new targets and future directions
Int J Cardiol, 192, 72-81
DOI 10.1016/j.ijcard.2015.05.013, PubMed 26002254

De Blois J, Kjellstrom T, Agewall S, Ezekowitz JA, Armstrong PW, Atar D (2015)
The Effects of Climate Change on Cardiac Health
Cardiology, 131 (4), 209-17
DOI 10.1159/000398787, PubMed 25997478

Mahfoud F, Böhm M, Azizi M, Pathak A, Durand Zaleski I, Ewen S, Tsioufis K, Andersson B, Blankestijn PJ, Burnier M, Chatellier G, Gafoor S, Grassi G, Joner M, Kjeldsen SE, Lüscher TF, Lobo MD, Lotan C, Parati G, Redon J, Ruilope L, Sudano I, Ukena C, van Leeuwen E, Volpe M et al. (2015)
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design
Eur Heart J, 36 (33), 2219-27
DOI 10.1093/eurheartj/ehv192, PubMed 25990344

Berge E (2015)
Increased life expectancy for physically active Norwegians
Br J Sports Med, 49 (11), 702
DOI 10.1136/bjsports-2015-094867, PubMed 25979921

Steffel J, Giugliano RP, Braunwald E, Murphy SA, Atar D, Heidbuchel H, Camm AJ, Antman EM, Ruff CT (2015)
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial
Eur Heart J, 36 (33), 2239-45
DOI 10.1093/eurheartj/ehv201, PubMed 25971288

Tornvall P, Gerbaud E, Behaghel A, Chopard R, Collste O, Laraudogoitia E, Leurent G, Meneveau N, Montaudon M, Perez-David E, Sörensson P, Agewall S (2015)
Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data
Atherosclerosis, 241 (1), 87-91
DOI 10.1016/j.atherosclerosis.2015.04.816, PubMed 25967935

Opdal MS, Arnesen M, Müller LD, Hullstein I, Sayed K, Brørs O, Kringen M, Sagedal S, Gjesdal K, Krajci P (2015)
Effects of Hemodialysis on Methadone Pharmacokinetics and QTc
Clin Ther, 37 (7), 1594-9
DOI 10.1016/j.clinthera.2015.04.009, PubMed 25963997

Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, Drexel H, Patak A, Torp-Pedersen C, Kjeldsen KP, Tamargo J (2015)
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC
Eur Heart J, 36 (40), 2677-80
DOI 10.1093/eurheartj/ehv161, PubMed 25948737

Skrede K, Wyller TB, Watne LO, Seljeflot I, Juliebø V (2015)
Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients
BMC Res Notes, 8, 186
DOI 10.1186/s13104-015-1129-5, PubMed 25943983

Navarese EP, Kolodziejczak M, Schulze V, Gurbel PA, Tantry U, Lin Y, Brockmeyer M, Kandzari DE, Kubica JM, D'Agostino RB, Kubica J, Volpe M, Agewall S, Kereiakes DJ, Kelm M (2015)
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis
Ann Intern Med, 163 (1), 40-51
DOI 10.7326/M14-2957, PubMed 25915661

Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
High screening blood pressure at young age predicts future masked hypertension: A 17 year follow-up study
Blood Press, 24 (3), 131-8
DOI 10.3109/21695717.2015.1030889, PubMed 25901999

Kumar NT, Liestøl K, Løberg EM, Reims HM, Mæhlen J (2015)
Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease
Virchows Arch, 467 (2), 225-35
DOI 10.1007/s00428-015-1772-1, PubMed 25898889

Neerland BE, Hov KR, Bruun Wyller V, Qvigstad E, Skovlund E, MacLullich AM, Bruun Wyller T (2015)
The protocol of the Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial
BMC Geriatr, 15, 7
DOI 10.1186/s12877-015-0006-3, PubMed 25887557

Agewall S (2015)
How to save six million people per year
Atherosclerosis, 240 (2), 387-8
DOI 10.1016/j.atherosclerosis.2015.04.006, PubMed 25881201

Pettersen AA, Arnesen H, Seljeflot I (2015)
A brief review on high on-aspirin residual platelet reactivity
Vascul Pharmacol, 67-69, 6-9
DOI 10.1016/j.vph.2015.03.018, PubMed 25869498

Bethke A, Halvorsen S, Bøhmer E, Abdelnoor M, Arnesen H, Hoffmann P (2015)
Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty)
EuroIntervention, 11 (5), 518-24
DOI 10.4244/EIJY15M04_02, PubMed 25868877

Kjeldsen SE, Persu A, Azizi M (2015)
Design of renal denervation studies not confounded by antihypertensive drugs
J Am Soc Hypertens, 9 (5), 337-40
DOI 10.1016/j.jash.2015.02.015, PubMed 25863572

Kjeldsen SE, Fadl Elmula FEM, Persu A (2015)
The setback of renal denervation should not backfire on sympathetic overactivity in hypertension
J Am Coll Cardiol, 65 (13), 1322-1323
DOI 10.1016/j.jacc.2015.01.038, PubMed 25835444

Wang BH, von Lueder TG, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H (2015)
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis
Int J Cardiol, 186, 104-5
DOI 10.1016/j.ijcard.2015.03.116, PubMed 25828104

Hodt A, Hisdal J, Stugaard M, Stranden E, Atar D, Steine K (2015)
Increased LV apical untwist during preload reduction in healthy humans: an echocardiographic speckle tracking study during lower body negative pressure
Physiol Rep, 3 (3)
DOI 10.14814/phy2.12330, PubMed 25802362

Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Boman K, Dahlöf B, Devereux RB (2015)
Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation
J Hypertens, 33 (7), 1480-6
DOI 10.1097/HJH.0000000000000559, PubMed 25799208

Kvakkestad KM, Abdelnoor M, Claussen PA, Eritsland J, Fossum E, Halvorsen S (2015)
Long-term survival in octogenarians and older patients with ST-elevation myocardial infarction in the era of primary angioplasty: A prospective cohort study
Eur Heart J Acute Cardiovasc Care, 5 (3), 243-52
DOI 10.1177/2048872615574706, PubMed 25753053

Kotecha D, von Lueder TG (2015)
Qualifying the use of common cardiovascular drugs in cardiology
Circ J, 79 (3), 517-8
DOI 10.1253/circj.CJ-15-0088, PubMed 25746532

Ørstavik Ø, Manfra O, Andressen KW, Andersen GØ, Skomedal T, Osnes JB, Levy FO, Krobert KA (2015)
The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium
PLoS One, 10 (3), e0115547
DOI 10.1371/journal.pone.0115547, PubMed 25738589

Laake K, Seljeflot I, Fagerland MW, Njerve IU, Arnesen H, Solheim S (2015)
Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome
Mediators Inflamm, 2015, 373070
DOI 10.1155/2015/373070, PubMed 25733777

Fadl Elmula FE, Larstorp AC, Kjeldsen SE, Persu A, Jin Y, Staessen JA (2015)
Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension
Front Physiol, 6, 9
DOI 10.3389/fphys.2015.00009, PubMed 25709581

Stær-Jensen H, Sunde K, Andersen GØ (2015)
The authors reply
Crit Care Med, 43 (3), e98
DOI 10.1097/CCM.0000000000000812, PubMed 25700077

Gershlick AH, Westerhout CM, Armstrong PW, Huber K, Halvorsen S, Steg PG, Ostojic M, Goldstein P, Carvalho AC, Van de Werf F, Wilcox RG (2015)
Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged
Heart, 101 (9), 692-8
DOI 10.1136/heartjnl-2014-306686, PubMed 25691510

Blyme A, Asferg C, Nielsen OW, Sehestedt T, Kesäniemi YA, Gohlke-Bärwolf C, Boman K, Willenheimer R, Ray S, Nienaber CA, Rossebø A, Wachtell K, Olsen MH (2015)
High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy
Open Heart, 2 (1), e000152
DOI 10.1136/openhrt-2014-000152, PubMed 25685360

Holme I, Kjeldsen SE (2015)
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3
Eur J Intern Med, 26 (2), 123-6
DOI 10.1016/j.ejim.2015.01.013, PubMed 25681139

Mueller C, Auer J, Halvorsen S (2015)
Cardiac troponin elevations in acute non-coronary disease: Helpful or not?
Eur Heart J Acute Cardiovasc Care, 4 (5), 429-30
DOI 10.1177/2048872615573921, PubMed 25678669

Berg IJ, van der Heijde D, Dagfinrud H, Seljeflot I, Olsen IC, Kvien TK, Semb AG, Provan SA (2015)
Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study
J Rheumatol, 42 (4), 645-53
DOI 10.3899/jrheum.141018, PubMed 25641897

Ellingsen DG, Ulvestad B, Bakke B, Seljeflot I, Barregard L, Thomassen Y (2015)
Serum pneumoproteins in tunnel construction workers
Int Arch Occup Environ Health, 88 (7), 943-51
DOI 10.1007/s00420-015-1023-4, PubMed 25632885

Berge HM, Isern CB, Berge E (2015)
Blood pressure and hypertension in athletes: a systematic review
Br J Sports Med, 49 (11), 716-23
DOI 10.1136/bjsports-2014-093976, PubMed 25631543

Lindholm EE, Aune E, Seljeflot I, Otterstad JE, Kirkebøen KA (2015)
Biomarkers of inflammation in major vascular surgery: a prospective randomised trial
Acta Anaesthesiol Scand, 59 (6), 773-87
DOI 10.1111/aas.12466, PubMed 25626738

Heier M, Margeirsdottir HD, Torjesen PA, Seljeflot I, Stensæth KH, Gaarder M, Brunborg C, Hanssen KF, Dahl-Jørgensen K (2015)
The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes
Diab Vasc Dis Res, 12 (2), 139-45
DOI 10.1177/1479164114560910, PubMed 25616705

Persu A, Jin Y, Fadl Elmula FE, Renkin J, Høieggen A, Kjeldsen SE, Staessen JA (2015)
Renal denervation in treatment-resistant hypertension: a reappraisal
Curr Opin Pharmacol, 21, 48-52
DOI 10.1016/j.coph.2014.12.013, PubMed 25601357

Grundvold I, Bodegard J, Nilsson PM, Svennblad B, Johansson G, Östgren CJ, Sundström J (2015)
Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study
Cardiovasc Diabetol, 14, 5
DOI 10.1186/s12933-014-0170-3, PubMed 25589001

Trøseid M, Nestvold TK, Nielsen EW, Thoresen H, Seljeflot I, Lappegård KT (2015)
Soluble CD14 is associated with markers of vascular dysfunction in bariatric surgery patients
Metab Syndr Relat Disord, 13 (3), 119-24
DOI 10.1089/met.2014.0111, PubMed 25562385

Atar D, Ong S, Lansberg PJ (2015)
Expanding the Evidence Base: Comparing Randomized Controlled Trials and Observational Studies of Statins
Am J Ther, 22 (5), e141-50
DOI 10.1097/MJT.0b013e318245ce94, PubMed 22487773

Kreutz R, Cifkova R, Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S, Mancia G (2021)
InMemoriam: Jiri Widimsky Sr. 1925-2020
J. Hypertens., 39 (2), 386-388
DOI 10.1097/HJH.0000000000002768

Klemsdal TO, Gjelsvik B, Elling I, Johansen S, Kjeldsen SE, Kristensen O, Madsen S, Njolstad I, Selmer R, Tonstad S, Voie H (2017)
New guidelines for the prevention of cardiovascular disease
Tidsskr. Nor. Laegeforen., 137 (16), 1164-1168

Wyller TB, Kjeldsen SE, Halvorsen S, Bath PM, Sandercock P (2020)
In memoriam Eivind Berge, MD, PhD, 1964-2020: cardiologist, trialist and hypertension/stroke researcher
J. Hypertens., 38 (6), 1199-1200
DOI 10.1097/HJH.0000000000002488

Halvorsen S (2015)
Percutaneous coronary intervention in the patient on oral anticoagulation
Tidsskr. Nor. Laegeforen., 135 (1), 55
DOI 10.4045/tidsskr.14.1248

Perry LA, Berge E, Bowditch J, Forfang E, Ronning OM, Hankey GJ, Villanueva E, Salman RA (2017)
Antithrombotic Treatment After Stroke Because Of Intracerebral Hemorrhage
Stroke, 48 (9), E247
DOI 10.1161/STROKEAHA.117.018215

Kreutz R, Kjeldsen SE, Burnier M, Narkiewicz K, Oparil S, Mancia G (2020)
In memoriam: Peter Sleight 1929-2020
Blood Pressure, 29 (6), 382-384
DOI 10.1080/08037051.2020.1839224

Blichfeldt-AEro SC, Halvorsen S, Trondalen G (2021)
Music therapy in invasive cardiac procedures: Expanded perspective
BRIT. J. MUSIC THER., 13594575211039090
DOI 10.1177/13594575211039090

Hopp E, Skretteberg PT, Landa M, Lyseggen E, Tomterstad AH, Pedersen HK (2017)
MRI examination of patients with pacemaker or implanted cardiac arrest
Tidsskr. Nor. Laegeforen., 137 (21), 1668-1669

Steen T (2020)
Quality control of implanted defibrillators
Tidsskr. Nor. Laegeforen., 140 (13), 1309

Halvorsen S (2016)
Female hearts A medical textbook about common heart disease
Tidsskr. Nor. Laegeforen., 136 (4), 333
DOI 10.4045/tidsskr.15.1299

Smiseth OA, Kjeldsen SE, Andersen OS, Mistry N, Westheim AS, Skulstad H, Gude E (2019)
Heart Failure with normal ejection fraction
Tidsskr. Nor. Laegeforen., 139 (6), 522-527

Gjesdal K (2017)
Winston Churchill - Life story
Tidsskr. Nor. Laegeforen., 137 (14-15), 1065-1067

Eritsland J, Andersen GO (2019)
MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI (vol 13, e0206723, 2018)
PLoS One, 14 (3), e0213636
DOI 10.1371/journal.pone.0213636

Pope MK, Ghanima W, Atar D (2020)
Intensification of antithrombotic therapy for chronic atherosclerosis
Tidsskr. Nor. Laegeforen., 140 (10), 976-977

Kjeldsen SE, Stenehjem AE, Os I, van den Borne P (2018)
European Society of Hypertension Scientific Newsletter: Update on Hypertension Management 2016; 17: Nr. 63* Treatment of High Blood Pressure in Elderly and Octogenarians
J. Hyperton., 22 (2), 46-48

Kreutz R, Cifkova R, Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S, Mancia G (2021)
In memoriam: Jiri Widimsky Sr. 1925-2020
Blood Pressure, 30 (2), 140-142
DOI 10.1080/08037051.2020.1859212

Kreutz R, Kjeldsen SE, Burnier M, Narkiewicz K, Oparil S, Mancia G (2020)
In memoriam: Peter Sleight 1929-2020
J. Hypertens., 38 (12), 2546-2548
DOI 10.1097/HJH.0000000000002713

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2018)
In memoriam: Alberto Zanchetti
Blood Pressure, 27 (3), 123-124
DOI 10.1080/08037051.2018.1464383

Aamodt AH, Bjork MH, Tronvik EA, Buanes EA, Stovner LJ, Atar D (2020)
Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe Covid-19?
Tidsskr. Nor. Laegeforen., 140 (9), 859-860

Gjesdal K (2016)
Heart attack before and now - a 50-year perspective
Tidsskr. Nor. Laegeforen., 136 (9), 833-836

Roe AT, Sjaastad I, Louch WE (2017)
Heart failure with preserved ejection fraction
Tidsskr. Nor. Laegeforen., 137 (18), 1426-1431

Steen T (2020)
Not so fast with pacemakers for young people
Tidsskr. Nor. Laegeforen., 140 (1), 14

Steen T (2015)
Cardiac pacing and ICDs
Tidsskr. Nor. Laegeforen., 135 (2), 158
DOI 10.4045/tidsskr.14.1276

Rutherford OCW, Konig MSS, Risnes K, Raouf N, Atar D, Ghanima W (2018)
Serum concentration measurements of DOAK drugs Reply
Tidsskr. Nor. Laegeforen., 138 (7), 621

Blichfeldt-AEro SC, Trondalen G, Halvorsen S (2019)
Facilitated music listening: Music therapy in an invasive cardiac procedure
BRIT. J. MUSIC THER., 33 (1), 27-38
DOI 10.1177/1359457519840131

Kjeldsen SE, Mancia G (2017)
A critical review of the systolic blood pressure intervention trial (SPRINT)
Eur. Heart J., 38 (44), 3260-3265

Lindekleiv H, Slot KMHB, Wardlaw JM, Berge E (2019)
Percutaneous Vascular Interventions Versus Intravenous Thrombolytic Treatment for Acute Ischemic Stroke
Stroke, 50 (5), E119-E120
DOI 10.1161/STROKEAHA.118.024298

Slot KMHB, Berge E (2018)
Factor Xa Inhibitors Versus Vitamin K Antagonists for Prevention of Cerebral or Systemic Embolism in Patients With Atrial Fibrillation
Stroke, 49 (7), E235-E236
DOI 10.1161/STROKEAHA.118.021521

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2018)
Final Farewell to Alber to Zanchetti MD
Eur. Heart J., 39 (28), 2616-2617
DOI 10.1093/eurheartj/ehy327

Hopp E, Skretteberg PT, Landa M, Lyseggen E, Tomterstad AH, Pedersen HK (2018)
"It is important for the patient to carry with them the provided pacemaker card at any time"
Tidsskr. Nor. Laegeforen., 138 (1), 9-10

Slot KMHB, Berge E (2020)
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolismin patients with atrial fibrillation
Emergencias, 32 (4), 278-279

Gharagozlian S, Hansen R, Haugen M, Johansen O, Seierstad SL, Seljeflot I, Arnesen H (2017)
Changes in dietary pattern when including 700 g of salmon per week to patients with atherosclerotic heart disease
Clin. Nutr. ESPEN, 19, 38-44
DOI 10.1016/j.clnesp.2017.02.004